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Spinal cord injury
A spinal cord injury (SCI) represents one of the most physically and 
psychologically devastating traumas an individual can suffer. This type of injury often 
results in a lifelong functional disability for previously healthy individuals. In the 
Netherlands,  approximately 150-200 individuals are affected by an acute traumatic 
SCI (tSCI).1 With the current emergency medical services, surgical procedures, 
antibiotics, improved rehabilitation policies and services, life expectancies for 
persons with SCI have increased over the years and are expected to increase in the 
future.2, 3 
Once considered to be an injury of the young, the increasing elderly population 
has altered the epidemiology of tSCI, with the average age of SCI individuals rising 
from 29 years in the mid-1970s to 40 years in 2005.3 At any age, a SCI has an 
enormous impact, not only for the individual on a personal level, but also for society 
as a whole with respect to the costs of acute and chronic care.4, 5 
Neuroprotective interventions in spinal cord injury
Enormous progress has been made over the past 30 years in the medical care, 
surgical management and rehabilitation of individuals with acute and chronic 
spinal cord injuries.6-9 Despite considerable research efforts, the search for a “cure” 
for spinal cord injury has yet to produce a convincingly efficacious treatment that 
substantially improves neurologic function in SCI patients. To date, the focus 
of scientific attention is directed towards interventions that prevent secondary 
spinal cord damage in the acute phase. Within the first hours to days post-injury, 
neuroprotective interventions may protect the spinal cord which could benefit 
functional recovery. To date, no pharmacologic therapy has shown to improve the 
neurological or functional recovery in SCI patients. For instance, the results of the 
National Acute Spinal Cord Injury Study (NASCIS) II and III  led to widespread 
adoption of a high-dose methylprednisolone regimen for  SCI patients treated 
within eight hours of injury. At present, it cannot be recommended as a standard 
of care, since the statistical analysis was flawed and therefore the validity of the 
17
NASCIS conclusions can be questioned.10, 11
Although the role of the pharmacological therapy remains controversial in 
SCI patients, the surgical therapy has shown some potential with regard to the 
neurological recovery. Burrell already hypothesized about this topic more than a 
century ago. The author reported two key issues related to the surgical management 
of traumatic spinal cord injury: the severity of the injury and the timing of surgery.12 
Nowadays, the topic of severity and the timing of surgical treatment after tSCI 
continuous to spark vigorous debates among specialists involved in the treatment of 
SCI patients. However, a recent study showed that tSCI patients will neurologically 
benefit from an early decompression of the spinal cord when performed within 24 
hours post-injury.13 
Determination of the severity of spinal cord injury
The severity of the primary injury to the spinal cord is determinative for the 
success of neuroprotective interventions. The energy of primary traumatic impact 
to the spinal cord is directly related to the spinal cord damage. A trauma to the 
spinal cord causes an acute physical injury with neuronal necrosis. This is followed 
by a secondary axonal degeneration and further degeneration or death of nerve cells 
by either apoptosis or necrosis, processes that may last between days and weeks.14 
The available neuroprotective interventions all aim to diminish and/or prevent 
this secondary injury. It is assumed that patients with more severe SCI respond 
differently to neuroprotective interventions than do patients with less severe SCI. 
Exact and early determination of the severity of spinal cord injury is decisive for 
neuroprotective interventions. Determination of the severity of spinal cord injury 
can be assessed with the International Standards for Neurological Classification 
of Spinal Cord Injury. This neurological examination according to the American 
Spinal Injury Association (ASIA) scores15 is considered to be reliable and prognostic 
in patients when tested 72 hours after the initial trauma.16 Within 72 hours post-
injury several factors like spinal shock, medical instability, concomitant brain injury 
or coma may affect the reliability of the neurological examination.17 Considering 
that neuroprotective interventions like acute spinal cord decompression and/or 
1
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stabilization should be performed as soon as possible, i.e. within 24 hours post-
injury, the limitations of the neurological examination become clear. In addition, the 
variability in spontaneous neurological recovery is quite high, making it necessary 
to recruit large numbers of patients in order to have sufficient statistical power to 
detect a clinically important difference  in function.18 As an illustration of this, the 
post-hoc analysis of the variability in spontaneous neurologic recovery in the Sygen 
multicenter study revealed that in order to detect a 5 points difference in motor 
score in patients with a complete cervical spinal cord injury, one would need to 
enroll approximately 380 patients18, a number that was not achieved in 5 years of 
enrolment for the Sygen multicenter trial.19 Clearly, the dependence of clinical trials 
on functional neurologic metrics to recruit patients and then interpret the efficacy 
of the intervention is a major impediment because of two important issues – the 
inability to perform such measures reliably in many patients within 24 hours post-
injury and  the variability in spontaneous recovery in those patients in whom such 
neurological measures can be obtained. 
Spinal cord injury syndromes
Future clinical research purposes will also have to stratify and constrain the 
heterogeneity of samples for more sensitive detection of treatment effects. In this 
perspective, several SCI syndromes are often considered to be different entities 
from other nonsyndromic SCIs. Despite the various applications, the usefulness of 
syndrome classification is currently limited by the imprecise and variable definitions 
of the syndromes and by the difficulty of implementing the criteria for differentiating 
syndromes. In addition, patients with SCI syndromes are sometimes excluded while 
they are believed to have a more favourable outcome than non-SCI syndrome 
patients.21, 22 To illustrate, the international panel of SCI experts convened by the 
International Campaign for Cures of Spinal Cord Injury Paralysis, concluded that 
traumatic central cord patients might be stratified differently in clinical trials, as the 
different recovery pattern could increase the variability of the outcome data.22 
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Purpose of this thesis 
•	 To	provide	a	more	accurate	diagnostic	test	than	the	ASIA	score	to	differentiate		
	 between	the	severity	of	the	SCI	by	providing	reliable	base-line	measurements.		
	 This	thesis	will	focus	on	two	diagnostic	tests:	neurochemical	biomarkers	and		
	 diffusion-weighted	magnetic	resonance	imaging.	
	•	 To	address	the	problem	whether	patients	with	specific	SCI	syndromes	should	be		
	 stratified	or	excluded	in	future	SCI	trials.	
Neurochemical Biomarkers
 An approach for evaluating the primary cord damage in the acute phase 
is the assessment of biomarker concentrations in the cerebrospinal fluid (CSF). 
Trauma to the spinal cord causes an acute physical injury with neural cells being 
damaged. Since the spinal cord is surrounded by CSF, damage to the spinal cord 
may lead to the release of proteins and metabolites from the nervous tissue into 
the CSF. This process allows to study ‘biomarker’ concentrations after  spinal cord 
injury in the CSF.23-25 A biomarker is a characteristic that is objectively measured 
and evaluated as an indicator of normal or pathologic processes or pharmacologic 
responses to a therapeutic intervention.26 
In	this	thesis,	we	will	address	the	following	questions:
1.	 What	is	the	current	status	of	neurochemical	biomarkers	and	their	potential		
	 	 diagnostic	value	from	either	experimental	models	or	patient	series	of	acute	SCI?	
2.	 What	is	the	correlation	between	the	neurological	outcomes	in	tSCI	patients		and	 
	 	 the	concentrations	of	CSF	biomarkers	Tau,	S-100ß,	GFAP,	NFH	and	NSE?
Biomarkers of SCI can be approached in two ways: 1) a direct survey of primary 
structural damage using a specific unique marker (or markers) of tissue damage, 
and 2) measure aspects of the cellular, biochemical, or molecular cascades in the 
secondary injury (or repair) response phase.27 There has been growing interest in 
biomarkers as indicators of tissue destruction in CNS diseases. Several studies have 
indicated that monitoring the levels of neuron-, myelin- or astroglia-specific proteins 
in the serum and CSF may be a useful approach for evaluating the severity of non-
1
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traumatic CNS injury.23-25, 28, 29 To illustrate, a recent study was able to predict the 
ASIA impairment scale (AIS) grade with an accuracy of 89% using CSF biomarkers. 
Furthermore, the model that used the CSF levels of IL-8, S-100β, and GFAP at 24 
hours post-injury was able to predict motor recovery at 6 months post-injury in the 
cervical SCI patients as well as (if not slightly better than) the ASIA classification.30 
Diffusion-weighted Magnetic Resonance Imaging 
Conventional magnetic resonance imaging (MRI) is currently the best imaging 
modality for evaluating tSCI during the acute phase.31 Standard clinical MRI 
sequences effectively identify spinal cord compression, edema, and hemorrhage. 
Large intraparenchymal hemorrhages are a well-known predictor of poor outcome 
following SCI.32 The conventional MR sequences, however, do not provide enough 
information about the integrity of critical long white matter tracts responsible for 
the observed functional deficits after SCI. 
In	this	thesis,	we	will	address	the	following	question:
3.	 What	are	the	differences	in	the	detection	rates	for	spinal	cord	damage	on		
	 conventional	MR	and	diffusion-weighted	MRI	(DWI)	within	24	h	post	injury?
Although there are numerous reports about the sensitivity and usefulness of DWI in 
traumatic brain injury, the number of DWI studies in spinal cord injury is limited.33 
Only one study analyzed the prognostic value of DWI in SCI patients.34 The study 
showed restricted diffusion in the spinal cord lesion and concluded this to be a 
parameter for an unfavorable functional prognosis. The main reason for this limited 
DWI experience in the spinal cord is the much greater difficulty associated with 
obtaining proper DW images in the spinal canal. 
Traumatic Central Cord Syndrome
The traumatic central cord syndrome (TCCS) is a clinical diagnosis that 
was first described by Schneider et al. in 1954.35 TCCS is characterized by 1) a 
disproportionate impairment (weakness and reduced function) of the upper limbs as 
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compared with the lower limbs, 2) neurogenic bladder dysfunction, and 3) varying 
degrees of sensory loss at and below the level of the lesion.36 A TCCS is considered 
the most prevalent incomplete SCI syndrome, accounting for approximately 9% of 
all traumatic SCI’s.37, 38 In TCCS patients, recovery of a certain degree of ambulation, 
participation in daily life activities, bowel and bladder function has been reported to 
be favourable in several studies.38-46 
In	this	thesis,	we	will	address	the	following	questions:
4.	 What	diagnostic	criteria	and	quantitative	data	regarding	‘disproportionate		
	 weakness’	between	the	upper	and	lower	extremities	have	been	used	in	TCCS		
	 original	studies?
5.	 Is	there	a	need	for	the	introduction	of	quantitative	diagnostic	criteria	 
	 for	the	TCCS?
6.	 What	are	the	differences	between	the	neurological	recovery	and	functional		
	 outcomes	between	TCCS	patients	and	motor	incomplete	tetraplegic	patients?
TCCS occurs frequently in elderly subjects due to rather minor spine trauma 
(hyperextension injury) based on underlying cervical spondylosis. The 
pathophysiological mechanisms inducing the TCCS are probably multi-modal. One 
hypothesis is that a spinal cord compression occurs between bony spurs anteriorly 
and buckling of the ligamentum flavum posteriorly.47 This cord compression may 
cause direct damage of neural structures located in the central gray matter and/or 
attenuation of the segmental blood supply. These mechanisms affect the cervical 
enlargement at the levels of the alpha motor neurons supplying predominantly hand 
muscles and to a lesser extent fibers of the corticospinal tracts (CST). Such a pattern 
of injury that spares the descending CST’s but damages the alpha motor neurons 
is assumed to result in a syndrome of disproportionate arm versus leg weakness.48 
An alternative hypothesis is that the TCCS results from an injury to the CSTs. The 
CST tends to produce relatively greater dysfunction in the hand and arms than in 
the legs, as the main function of the CST is to support fine motor movements in the 
distal musculature, especially of the upper limbs.49, 50
 Since the introduction of the TCCS diagnostic criteria more than 5 decades 
ago, it has been one of the most frequently cited definitions of an incomplete SCI 
syndrome.37 However, the TCCS lacks uniform and broadly accepted diagnostic 
criteria. In other words, the diagnosis of TCCS is based on non-specific criteria and 
1
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interpretation of physical examination. Therefore the utility of currently applied 
TCCS diagnostic criteria can be considered as limited. 
Brown-Séquard-plus syndrome 
The Brown-Séquard syndrome (BSS) is a syndrome consisting of ipsilateral 
upper motor neuron paralysis (hemiplegia) and loss of proprioception with 
contralateral pain and temperature sensation deficits.1 Common causes of BSS 
include penetrating trauma, syringomyelia, spinal neoplasms, disc herniation, spinal 
cord herniation, viral myelitis, or blunt injury.51, 52 BSS accounts for approximately 
4% of all traumatic SCI’s.37 
In	this	thesis,	we	will	address	the	following	question:
7.	 What	are	the	differences	between	the	neurological	and	functional	outcomes		
	 between	tetraplegics	with	a	Brown-Séquard	plus	syndrome	(BSPS)	and		
	 incomplete	tetraplegic	patients.
Most descriptions of a BSS are less pure forms of the syndrome, therefore a 
derivative has been introduced with the term BSPS.53 BSPS is a SCI with bilateral 
involvement of upper and/or lower extremities and is defined as an incomplete 
SCI syndrome with ipsilateral weakness and contralateral loss of pinprick and 
temperature sensation.54, 55
According to the International Standards for Neurological and Functional 
Classification of Spinal Cord Injury Patients, BSS is a syndrome that produces 
relatively greater ipsilateral proprioceptive and motor loss and contralateral loss of 
sensitivity to pain and temperature.56 The definition for BSS of the ASIA standards 
is essentially the same as BSPS concept and therefore leads to SCI patients being 
classified as BSS instead of BSPS. For example, several case reports57-59 described 
patients with BSS, however, the reported neurological examinations were not 
descriptions of the ‘classic’ BSS.60
The clinical and scientific relevance of incomplete tetraplegic patients not 
being labeled as the ‘classic’ BSS or BSPS therefore can be questioned. The reason 
for defining BSPS may be based on the assumption that patients with BSPS act 
differently than other incomplete tetraplegic patients with regard to neurological and 
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functional outcome. To date however, there is no clear evidence for this assumption 
in the literature. 
Acute Spinal Cord Ischemia syndrome
  
In patients with SCI, the clinical diagnosis ‘acute spinal cord ischemia 
syndrome’ (ASCIS) is rare. Although the incidence is not precisely known, it 
probably accounts for 5-8% of all acute myelopathies.61 Most of these spinal cord 
infarctions are located in the thoracic or thoracolumbar spinal cord.62-64 
In	this	thesis,	we	will	address	the	following	question:
8.	 What	are	the	differences	between	the	neurological	and	functional	outcomes	in		
	 paraplegic	patients	with	an	ASCIS	or	a	tSCI?
Although several predictors of outcome such as age, gender, and ASIA 
impairment scale have been reported in patients with ASCIS64, only one study 
compared the neurological and functional outcome between patients with tSCI or 
nontraumatic SCI with solely a vascular origin.65 Iseli et al.65 identified that the rate 
of neurological and ambulatory recovery is quite similar in patients with tSCI and 
ASCIS. 
ASCIS and tSCI patients are sometimes grouped while they are considered to 
have the same neurological and functional recovery.66 One could question, however, 
whether it is justified to include SCI patients with different aetiology in the same 
study population
1
Introduction and outline of the thesis
24
References
1. van den Berg ME, Castellote JM, Mahillo-Fernandez I, de Pedro-Cuesta J. Incidence 
of spinal cord injury worldwide: a systematic review. Neuroepidemiology 2010; 34(3): 
184-92; discussion 92.
2. Frisbie JH, Kache A. Increasing survival and changing causes of death in myelopathy 
patients. The	Journal	of	the	American	Paraplegia	Society 1983; 6(3): 51-6.
3. www.spinalcord.uab.edu. Facts and Figures at a Glance. National	Spinal	Cord	 Injury	
Statistical	Center, 2012. 
4. French DD, Campbell RR, Sabharwal S, Nelson AL, Palacios PA, Gavin-Dreschnack 
D. Health care costs for patients with chronic spinal cord injury in the Veterans Health 
Administration. The	journal	of	spinal	cord	medicine 2007; 30(5): 477-81.
5. New PW, Jackson T. The costs and adverse events associated with hospitalization of 
patients with spinal cord injury in Victoria, Australia. Spine	 (Phila	 Pa	 1976) 2010; 
35(7): 796-802.
6. Christie S, Thibault-Halman G, Casha S. Acute pharmacological DVT prophylaxis 
after spinal cord injury. Journal of neurotrauma 2011; 28(8): 1509-14.
7. Thibault-Halman G, Casha S, Singer S, Christie S. Acute management of nutritional 
demands after spinal cord injury. Journal of neurotrauma 2011; 28(8): 1497-507.
8. Furlan JC, Noonan V, Cadotte DW, Fehlings MG. Timing of decompressive surgery 
of spinal cord after traumatic spinal cord injury: an evidence-based examination of pre-
clinical and clinical studies. Journal of neurotrauma 2011; 28(8): 1371-99.
9. Casha S, Christie S. A systematic review of intensive cardiopulmonary management 
after spinal cord injury. Journal of neurotrauma 2011; 28(8): 1479-95.
10. Bydon M, Lin J, Macki M, Gokalsan ZL, Bydon A. The Role of Steroids in Acute 
Spinal Cord Injury. World	neurosurgery 2013.
11. Bracken MB, Shepard MJ, Holford TR, et al. Administration of methylprednisolone for 
24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord 
injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled 
Trial. National Acute Spinal Cord Injury Study. JAMA 1997; 277(20): 1597-604.
12. Burrell HL. I. Fracture of the Spine: A Summary of All the Cases (244) which were 
Treated at the Boston City Hospital from 1864 to 1905. Annals	of	surgery 1905; 42(4): 
481-506.
C
ha
pt
er
 1
1
25
13. Fehlings MG, Vaccaro A, Wilson JR, et al. Early versus delayed decompression for 
traumatic cervical spinal cord injury: results of the Surgical Timing in Acute Spinal 
Cord Injury Study (STASCIS). PloS	one 2012; 7(2): e32037.
14. Rowland JW, Hawryluk GW, Kwon B, Fehlings MG. Current status of acute spinal cord 
injury pathophysiology and emerging therapies: promise on the horizon. Neurosurgical	
focus 2008; 25(5): E2.
15. American Spinal Injury Association: International	Standards	for	Neurological	Classification	
of	Spinal	Cord	Injury,	revised	2002: Chicago, IL; 2002.
16. Burns AS, Ditunno JF. Establishing prognosis and maximizing functional outcomes 
after spinal cord injury: a review of current and future directions in rehabilitation 
management. Spine	(Phila	Pa	1976) 2001; 26(24 Suppl): S137-45.
17. Burns AS, Lee BS, Ditunno JF, Jr., Tessler A. Patient selection for clinical trials: the 
reliability of the early spinal cord injury examination. Journal of neurotrauma 2003; 
20(5): 477-82.
18. Fawcett JW, Curt A, Steeves JD, et al. Guidelines for the conduct of clinical trials for 
spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal 
cord injury and statistical power needed for therapeutic clinical trials. Spinal	Cord 2007; 
45(3): 190-205.
19. Geisler FH, Coleman WP, Grieco G, Poonian D, Sygen Study G. The Sygen multicenter 
acute spinal cord injury study. Spine	(Phila	Pa	1976) 2001; 26(24 Suppl): S87-98.
20. van Middendorp JJ, Hosman AJ, Pouw MH, Group E-SS, Van de Meent H. ASIA 
impairment scale conversion in traumatic SCI: is it related with the ability to walk? A 
descriptive comparison with functional ambulation outcome measures in 273 patients. 
Spinal	Cord 2009; 47(7): 555-60.
21. Steeves JD, Lammertse D, Curt A, et al. Guidelines for the conduct of clinical trials 
for spinal cord injury (SCI) as developed by the ICCP panel: clinical trial outcome 
measures. Spinal	Cord 2007; 45(3): 206-21.
22. Noppe M, Crols R, Andries D, Lowenthal A. Determination in human cerebrospinal 
fluid of glial fibrillary acidic protein, S-100 and myelin basic protein as indices of non-
specific or specific central nervous tissue pathology. ClinChimActa 1986; 155(2): 143-
50.
23. Lamers KJ, van Engelen BG, Gabreels FJ, Hommes OR, Borm GF, Wevers RA. 
Cerebrospinal neuron-specific enolase, S-100 and myelin basic protein in neurological 
disorders. Acta	NeurolScand 1995; 92(3): 247-51.
1
Introduction and outline of the thesis
26
24. Mokuno K, Kiyosawa K, Sugimura K, et al. Prognostic value of cerebrospinal fluid 
neuron-specific enolase and S-100b protein in Guillain-Barre syndrome. Acta 
NeurolScand 1994; 89(1): 27-30.
25. Floyd E, McShane TM. Development and use of biomarkers in oncology drug 
development. ToxicolPathol 2004; 32 Suppl 1: 106-15.
26. Kochanek PM, Berger RP, Bayir H, Wagner AK, Jenkins LW, Clark RS. Biomarkers 
of primary and evolving damage in traumatic and ischemic brain injury: diagnosis, 
prognosis, probing mechanisms, and therapeutic decision making. CurrOpinCrit	Care 
2008; 14(2): 135-41.
27. Rosengren LE, Karlsson JE, Karlsson JO, Persson LI, Wikkelso C. Patients with 
amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels 
of neurofilament protein in CSF. JNeurochem 1996; 67(5): 2013-8.
28. Miller DH. Biomarkers and surrogate outcomes in neurodegenerative disease: lessons 
from multiple sclerosis. NeuroRx 2004; 1(2): 284-94.
29. Kwon BK, Stammers AM, Belanger LM, et al. Cerebrospinal fluid inflammatory 
cytokines and biomarkers of injury severity in acute human spinal cord injury. 
Journal of neurotrauma 2010; 27(4): 669-82.
30. Schaefer DM, Flanders AE, Osterholm JL, Northrup BE. Prognostic significance of 
magnetic resonance imaging in the acute phase of cervical spine injury. JNeurosurg 
1992; 76(2): 218-23.
31. Boldin C, Raith J, Fankhauser F, Haunschmid C, Schwantzer G, Schweighofer F. 
Predicting neurologic recovery in cervical spinal cord injury with postoperative MR 
imaging. Spine	(Phila	Pa	1976) 2006; 31(5): 554-9.
32. Lammertse D, Dungan D, Dreisbach J, et al. Neuroimaging in traumatic spinal cord 
injury: an evidence-based review for clinical practice and research. JSpinal	CordMed 
2007; 30(3): 205-14.
33. Tsuchiya K, Fujikawa A, Honya K, Tateishi H, Nitatori T. Value of diffusion-weighted 
MR imaging in acute cervical cord injury as a predictor of outcome. Neuroradiology 
2006; 48(11): 803-8.
34. Schneider RC, Cherry G, Pantek H. The syndrome of acute central cervical spinal cord 
injury; with special reference to the mechanisms involved in hyperextension injuries of 
cervical spine. JNeurosurg 1954; 11(6): 546-77.
35. Aarabi B, Koltz M, Ibrahimi D. Hyperextension cervical spine injuries and traumatic 
central cord syndrome. NeurosurgFocus 2008; 25(5): E9.
C
ha
pt
er
 1
1
27
36. McKinley W, Santos K, Meade M, Brooke K. Incidence and outcomes of spinal cord 
injury clinical syndromes. JSpinal	CordMed 2007; 30(3): 215-24.
37. Bosch A, Stauffer ES, Nickel VL. Incomplete traumatic quadriplegia. A ten-year review. 
JAMA 1971; 216(3): 473-8.
38. McKinley W, Santos K, Meade M, Brooke K. Incidence and outcomes of spinal cord 
injury clinical syndromes. The	journal	of	spinal	cord	medicine 2007; 30(3): 215-24.
39. Tow AM, Kong KH. Central cord syndrome: functional outcome after rehabilitation. 
Spinal	Cord 1998; 36(3): 156-60.
40. Dvorak MF, Fisher CG, Hoekema J, et al. Factors predicting motor recovery and 
functional outcome after traumatic central cord syndrome: a long-term follow-up. 
Spine	(Phila	Pa	1976) 2005; 30(20): 2303-11.
41. Penrod LE, Hegde SK, Ditunno JF, Jr. Age effect on prognosis for functional recovery 
in acute, traumatic central cord syndrome. ArchPhysMedRehabil 1990; 71(12): 963-8.
42. Roth EJ, Lawler MH, Yarkony GM. Traumatic central cord syndrome: clinical features 
and functional outcomes. ArchPhysMedRehabil 1990; 71(1): 18-23.
43. Merriam WF, Taylor TK, Ruff SJ, McPhail MJ. A reappraisal of acute traumatic central 
cord syndrome. JBone	Joint	SurgBr 1986; 68(5): 708-13.
44. Aito S, D’Andrea M, Werhagen L, et al. Neurological and functional outcome in 
traumatic central cord syndrome. Spinal	Cord 2007; 45(4): 292-7.
45. Ishida Y, Tominaga T. Predictors of neurologic recovery in acute central cervical cord 
injury with only upper extremity impairment. Spine 2002; 27(15): 1652-8.
46. Schneider RC, Thompson JM, Bebin J. The syndrome of acute central cervical spinal 
cord injury. Journal	of	neurology,	neurosurgery,	and	psychiatry 1958; 21(3): 216-27.
47. Eidelberg E. Consequences of spinal cord lesions upon motor function, with special 
reference to locomotor activity. ProgNeurobiol 1981; 17(3): 185-202.
48. Quencer RM, Bunge RP, Egnor M, et al. Acute traumatic central cord syndrome: MRI-
pathological correlations. Neuroradiology 1992; 34(2): 85-94.
49. Levi AD, Tator CH, Bunge RP. Clinical syndromes associated with disproportionate 
weakness of the upper versus the lower extremities after cervical spinal cord injury. 
Neurosurgery 1996; 38(1): 179-83.
50. Peacock WJ, Shrosbree RD, Key AG. A review of 450 stabwounds of the spinal cord. 
SAfrMedJ 1977; 51(26): 961-4.
1
Introduction and outline of the thesis
28
51. Miranda P, Gomez P, Alday R, Kaen A, Ramos A. Brown-Sequard syndrome after blunt 
cervical spine trauma: clinical and radiological correlations. EurSpine J 2007; 16(8): 
1165-70.
52. Koehler PJ, Endtz LJ. The Brown-Sequard syndrome. True or false? ArchNeurol 1986; 
43(9): 921-4.
53. Taylor RG, Gleave JR. Incomplete spinal cord injuries; with Brown-Sequard phenomena. 
JBone	Joint	SurgBr 1957; 39-B(3): 438-50.
54. Roth EJ, Park T, Pang T, Yarkony GM, Lee MY. Traumatic cervical Brown-Sequard 
and Brown-Sequard-plus syndromes: the spectrum of presentations and outcomes. 
Paraplegia 1991; 29(9): 582-9.
55. Maynard FM, Jr., Bracken MB, Creasey G, et al. International Standards for 
Neurological and Functional Classification of Spinal Cord Injury. American Spinal 
Injury Association. Spinal	Cord 1997; 35(5): 266-74.
56. Garcia-Manzanares MD, Belda-Sanchis JI, Giner-Pascual M, Miguel-Leon I, gado-
Calvo M, Sanz JL. Brown-Sequard syndrome associated with Horner’s syndrome after a 
penetrating trauma at the cervicomedullary junction. Spinal	Cord 2000; 38(11): 705-7.
57. Henderson SO, Hoffner RJ. Brown-Sequard syndrome due to isolated blunt trauma. 
JEmergMed 1998; 16(6): 847-50.
58. Epstein BE, Marin EL. An unusual cause of spinal cord injury: case report and 
discussion. AmJOrthop 1999; 28(11): 650-2.
59. Koehler PJ. Charles-Edouard Brown-Sequard (1817-1894). JNeurol 2001; 248(4): 
345-6.
60. Sandson TA, Friedman JH. Spinal cord infarction. Report of 8 cases and review of the 
literature. Medicine 1989; 68(5): 282-92.
61. Cheshire WP, Santos CC, Massey EW, Howard JF, Jr. Spinal cord infarction: etiology 
and outcome. Neurology 1996; 47(2): 321-30.
62. Masson C, Pruvo JP, Meder JF, et al. Spinal cord infarction: clinical and magnetic 
resonance imaging findings and short term outcome. Journal	of	neurology,	neurosurgery,	
and	psychiatry 2004; 75(10): 1431-5.
63. Nedeltchev K, Loher TJ, Stepper F, et al. Long-term outcome of acute spinal cord 
ischemia syndrome. Stroke 2004; 35(2): 560-5.
C
ha
pt
er
 1
1
29
1
Introduction and outline of the thesis
64. Iseli E, Cavigelli A, Dietz V, Curt A. Prognosis and recovery in ischaemic and traumatic 
spinal cord injury: clinical and electrophysiological evaluation. Journal	 of	 neurology,	
neurosurgery,	and	psychiatry 1999; 67(5): 567-71.
65. Wirz M, Zorner B, Rupp R, Dietz V. Outcome after incomplete spinal cord injury: 
central cord versus Brown-Sequard syndrome. Spinal	Cord 2010; 48(5): 407-14.

Chapter 2
Biomarkers in spinal cord injury
M.H. Pouw
A.J.F. Hosman
J.J. van Middendorp
M.M Verbeek 
P.E. Vos
H. van de Meent
Spinal	Cord.	2009	Jul;47(7):519-25.	
32
Abstract
Study	design:	Literature review.
Background:	 In traumatic spinal cord injury (SCI), much effort has been put 
into the evaluation of SCI severity and the prediction of recovery potential. An 
accurate prediction of the initial damage of the spinal cord that differentiates 
between the severities of SCI however, may help physicians in choosing a particular 
neuroprotective treatment in the acute phase. Neurochemical biomarkers may 
possibly fulfil these requirements. The aim of this review was to describe (1) the 
current status of neurochemical biomarkers in SCI; (2) their potential diagnostic 
role in SCI.
Methods: MEDLINE was searched from 1966 to 2008 to identify publications 
concerning biomarkers in traumatic SCI.
Results: The biomarkers S-100β, Neuron-specific enolase, Neurofilament light chain, 
and Glial fibrillary acidic protein are significantly increased in cases of (experimental) 
spinal cord injury. Furthermore, increased serum concentrations of S-100β have 
been correlated with an unfavourable functional outcome. Although biomarkers in 
SCI show promising results, considerations and shortcomings, such as polytrauma, 
haemolysis, extracerebral sources, and poor resuscitation, must be studied in greater 
detail before biomarkers can be utilised in the clinical care of SCI. 
Conclusions: Quantitative standards for determining the extent of SCI during the 
acute phase must be developed and validated. Even though increased concentrations 
of neurochemical biomarkers have been identified in patients with SCI, these do 
not yet provide a sensitive prognostic tool. Considering the limited availability of 
sensitive prognostic tools, neurochemical biomarkers of SCI should be evaluated 
and validated in future clinical trials.
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Introduction
In traumatic spinal cord injury (SCI) much effort has been put into evaluation 
of SCI severity and the prediction of recovery potential. Interventions for the recovery 
of function following SCI include a combination of pharmacological1, surgical2, 
and rehabilitation3 approaches. The benefits of these interventions, however, are not 
univocal in clinical trials. It is assumed that patients with more severe SCI respond 
differently to neuroprotective interventions than patients with less severe SCI.3 
An accurate prediction of the initial damage of the spinal cord that differentiates 
between the different severities of SCI may help physicians in choosing an available 
or experimental neuroprotective intervention in the very acute phase.
Conventional Magnetic Resonance Imaging (MRI) is currently the best 
imaging modality for evaluating traumatic SCI during the very acute phase.4 
Although several MRI findings such as parenchymal haemorrhage, transection, and 
longer lesion length correlate with less favourable neurological outcomes, findings 
on neurological examinations are most predictive of outcomes.5 Prediction of 
functional outcome by means of the American Spinal Injury Association (ASIA) 
motor scores is considered to be reliable and prognostic in patients with motor 
complete SCI when tested 72 hours after the initial trauma.6, 7 Combining the results 
of MRI and initial neurological examination results in an even better prediction of 
the recovery of motor scores.8, 9 However, early ASIA examinations (e.g., within 72 
hours post-injury) are considered unreliable.6
Therefore, an early accurate diagnostic test with the purpose of indicating 
neuroprotective interventions is preferable. Conventional MRI appears restricted to 
assessing macroscopic changes in the injured spinal cord since it does not adequately 
address axonal injury in the white matter. Since the degree and localisation of 
injured and spared white matter primarily determine functioning after SCI, MRI 
has limited success as a prognostic tool.5 MRI is largely a qualitative measure and 
quantitative standards, in relation to functional SCI outcomes, will need to be 
developed and validated.3 
A new approach for evaluating the primary cord damage in the acute phase 
may be the assessment of biomarker concentrations in the cerebrospinal fluid (CSF). 
Trauma to the spinal cord causes an acute physical injury with neuronal necrosis. 
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This is followed by a secondary axonal degeneration and further degeneration or 
death of nerve cells by either apoptosis or necrosis, processes that may last between 
days and weeks. Since the spinal cord is surrounded by CSF, damage to the spinal 
cord may lead to the release of proteins and metabolites from the nervous tissue into 
the CSF. This process allows for the study of ‘biomarkers’ of spinal cord injury in the 
CSF.10-12 A biomarker is a characteristic that is objectively measured and evaluated 
as an indicator of normal or pathologic processes or pharmacologic responses to a 
therapeutic intervention.13 
Biomarkers of SCI can be approached in two ways: 1) a direct survey of primary 
structural damage using a specific unique marker (or markers) of tissue damage, 
and 2) measure aspects of the cellular, biochemical, or molecular cascades in the 
secondary injury (or repair) response phase.14 An ideal prognostic central nervous 
system (CNS) biochemical marker should have all of the following properties: 
1. central nervous system specificity
2. rapid and significant release into blood or CSF after injury
3. readily obtainable assay results
4. predictability of serious injury from an early sample
5. relationship of marker concentration with the degree of injury
6. inexpensive
7. little variability in diagnosing traumatic SCI15
There has been growing interest in biomarkers as indicators of tissue 
destruction in CNS diseases. Several studies have indicated that monitoring the 
levels of neuron-, myelin- or astroglia-specific proteins in the serum and CSF may 
be a useful approach for evaluating the severity of non-traumatic CNS injury.11, 12, 
16, 17 
Several studies have been published concerning the use of biomarkers in 
CSF and serum of patients with traumatic brain injury (TBI).18-21 A recent review 
discussed the role of biomarkers in TBI.14 In the field of SCI, however, there is no 
review on the value of biomarkers.
The aim of this literature review is to describe the current status of neurochemical 
biomarkers and their potential diagnostic value from either experimental models or 
patient series of acute SCI. This review focuses on the markers that survey direct 
structural damage.
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Methods
Clinical and experimental studies that included biomarkers investigating 
direct structural damage in serum and/or CSF after a SCI in humans or animals 
were eligible for this review. 
We searched MEDLINE ( PubMed interface), EMBASE, and reference lists of 
the included articles published between 1966 and November 2008. In MEDLINE, 
we used a combination of the following search terms: diagnosis, spinal cord, trauma, 
biomarker, cerebrospinal fluid, and serum. Furthermore, the references of retrieved 
publications were manually checked for additional studies that could potentially 
meet the inclusion criteria.
Results
The search strategy resulted in 250 potentially relevant articles from 
MEDLINE. The search in other databases yielded no additional relevant articles. A 
review of the titles, abstract, and the full text resulted in the inclusion of 18 articles. 
Twelve studies investigated biomarkers in humans22-32 and six studies investigated 
biomarkers in animals.33-38 Relatively few studies have been performed in which 
biomarkers in serum and/or CSF after SCI were investigated. For those that have 
been conducted, S-100β and neuron-specific enolase (NSE) have especially received 
attention. An overview is shown in Table 1 and 2.
Biomarkers in animal studies after spinal cord injury
S-100β 
S-100β is a calcium binding protein localised predominantly in astroglial and 
Schwann cells.39 In a model using Sprague-Dawley rats with SCI (induced by a 
weight-drop device), significantly increased serum and CSF levels of S-100β were 
observed compared to the control group without SCI at 6 hours after the induced 
SCI.37 Another model using Sprague-Dawley rats identified a significant increase of 
2
Biom
arkers in spinal cord injury
36
S-100β serum concentrations after a SCI or a plexus avulsion injury compared to a 
control group.34 
Neuron-specific	enolase
NSE is a glycolytic enzyme predominantly localised in the cytoplasm of neurons 
and cells of neuroendocrine lineage.40 Loy et al.37 assessed NSE serum and CSF 
levels in a rat model using a weight-drop device to simulate SCI. Compared to the 
control group, NSE levels in serum and CSF were significantly increased at 6 hours 
after the induced SCI. The NSE levels in the two graded injured groups did not 
significantly differ. Another study simulating ischemic SCI using thoracoabdominal 
aortic cross-clamping in 10 dogs identified significantly elevated NSE levels in CSF 
during clamping and reperfusion.35  
Time-dependency	of	biomarkers
Cao et al.38 evaluated the relationship between the protein levels of NSE and 
S-100β in serum and CSF and the severity of acute SCI in an animal model. Eighty 
Sprague-Dawley rats were divided into four groups: control group, mild SCI group, 
moderate SCI group, and severe SCI group. Graded SCI was provided using a 
weight-drop model from different heights. Serum and CSF samples were collected 
at different time points. Concentrations of NSE and S-100β were significantly 
(p<0.05) increased at 2 hours after the SCI and reached maximum levels at 6 hours. 
The NSE and S-100β levels in the moderate and severe SCI groups were significantly 
higher (p<0.05) than the NSE and S-100β levels in the mild SCI group. At 24 hours 
after injury, NSE and S-100β levels in the serum and CSF were still significantly 
higher than those in the control group. However, after 24 hours, the graded SCI 
groups did not differ significantly. 
It is hypothesized that the peak in the concentration of NSE and S-100β 
after 6 hours  reflects mechanical disruption of the spinal cord. Furthermore, the 
concentration of NSE and S-100β, is positively correlated with the grade of the 
SCI. This study indicates that NSE and S-100β alterations are time-dependent 
and positively correlated with the severity of the trauma. Although the correlations 
between neurophysiological findings and/or radiographic abnormalities and 
changes of biomarkers after trauma were not assessed, this study suggests that both 
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biomarkers reflect neuronal and glial damage induced during the acute phase of 
SCI.
Nerve	root	injury
Although a nerve root compression is not a CNS injury, the role of biomarkers 
in nerve root injury is addressed. From previous studies, it is known that a breakdown 
of the blood-nerve barrier occurs in compressed nerve roots.41 This may result in a 
detectable elevation of biomarkers in CSF.
In a pig model investigating biomarkers after experimental nerve root injury, 
unilateral compression of the nerve root of S1 was obtained by means of an ameroid 
constrictor.33 Compared to the control group, pigs with an experimental nerve 
root injury had elevated NFL levels in CSF one week after the induced injury.33 
Another pig model also investigated several biomarkers in CSF in an experimental 
nerve root injury model of S1.36 Twenty pigs were divided into four groups: 1) 
slow-onset mechanical compression with an ameroid constrictor; 2) harvested 
autologous nucleus pulposus applied to the nerve root; 3) mechanical compression 
plus harvested autologous nucleus pulposus; 4) sham operation. Significantly 
increased concentrations of Neurofilament protein (NFL) in CSF after mechanical 
compression on spinal nerve roots were identified compared to the nucleus pulposus 
group and sham group after one week.36 The results of these studies indicate that 
compression of nerve roots can induce a significant increase in NFL, indicating 
nerve tissue damage.33, 36
Biomarkers in patients after spinal cord injury
S-100β
In patients with thoracic and thoracoabdominal aortic aneurysms, surgical 
treatment may be associated with a significant risk of perioperative morbidity, 
including paraplegia. Several studies investigated the concentrations of S-100β in 
serum and CSF during and after thoracic endovascular stent grafting. Van Dongen 
et al.22, 23 identified elevated CSF concentrations of S-100β in 19 patients undergoing 
thoracoabdominal aortic aneurysm (TAAA) surgery. The highest concentrations of 
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S-100β were found in CSF samples taken 5 minutes after reperfusion. The authors 
suggest that the increased CSF S-100β after unclamping of the aorta indicates that 
there is a continuous release of S-100β from ischemic neural tissue.22-24 Another 
study re-evaluated the potential impact of S-100β in serum and CSF in 13 patients 
undergoing TAAA surgery. Six hours after unclamping, significantly elevated 
(p<0.001) CSF concentrations of S-100β were identified in two patients with 
ischemic SCI.32 Significantly elevated serum and CSF concentrations of S-100β 6 
hours after unclamping have also been identified in another study.42 Brunnekreef et 
al.24 evaluated S-100β CSF concentrations in eight patients who underwent TAAA 
surgery. However, there was no significant increase in S-100β CSF concentrations. It 
was suggested that an increased concentration of S-100β in CSF is a marker of spinal 
cord ischemia.22-24 In addition, the release of the biomarkers S-100β, neurofilament 
light chain protein (NFL), and Glial fibrillary acidic protein (GFAP) in CSF was 
investigated in another study in which 39 patients underwent TAAA surgery.33 
GFAP is a filament protein localised predominantly in astroglial cells.43 NFL is a 
structural protein of neurons and it is predominantly localised in the axons.44 In this 
study, CSF concentrations of S-100β, NFL, and GFAP were significantly increased 
in five patients (p<0.05) with ischemic spinal cord injury compared to patients 
without spinal cord injury.31
Furthermore, the predictive potential of S-100β concentrations in serum 
has been analysed in patients with spinal cord compression caused by epidural 
empyema and spinal metastasis.29, 30 Clinical outcome was considered favourable in 
cases of motor score improvement and preservation or retrieval of walking ability, 
whereas no improvement or further neurologic deterioration without restoration 
of gait function was regarded to be unfavourable. Motor function was based on 
the strongest muscle group in the lower extremities using the 0 to 5 rating system. 
Patients with epidural empyema and persistently increased S-100β levels for a 
minimum of three days after operative decompression had unfavourable functional 
outcome (p<0.003) as measured by motor function.30 Patients with spinal metastasis 
and persistently increased S-100β levels for a minimum of 10 days after operative 
decompression had unfavourable functional outcome (p<0.0001), as measured by 
motor function.29  As motor scores are not equal to a direct functional ambulation 
outcome measurement45, patients with increased S-100β levels in these studies have 
unfavorable motor function, not unfavourable functional outcome. 
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Traumatic	spinal	cord	injury
Guéz et al.27 conducted, to our knowledge, the only study that investigated 
biomarkers in patients with traumatic SCI. In this prospective study, six patients 
with traumatic SCI and 17 patients with a severe whiplash injury were compared to 
a control group of 24 neurologically healthy individuals. All individuals underwent 
a lumbar puncture. CSF concentrations of NFL and GFAP were analysed. Non-
significantly increased concentrations of NFL and GFAP were identified in CSF of 
all SCI patients. 
Myelin	basic	protein
Myelin Basic Protein (MBP) is a protein produced by oligodendrocytes and is 
the major constituent of the myelin sheath of axons.46, 47 No study has specifically 
investigated the role of MBP in traumatic SCI; however, a single study retrospectively 
identified higher CSF concentrations of MBP in patients with tropical spastic 
paraparesis compared to CSF of patients with non-neurological diseases.26
Tau
 Tau, a protein localised primarily in neurons and especially in axonal 
compartments48, has been correlated with outcome in patients with TBI.49 Alterations 
of CSF Tau levels were evaluated in a study with 28 patients undergoing aortic 
surgery. However, compared to the group without any neurologic complications, 
Tau levels were not significantly elevated in patients with postoperative SCI.28
Nerve	root	injury
The pathophysiologic mechanisms of disc herniation are not fully understood, 
however herniated discs are believed to have direct mechanical effects on the nerve 
root. Brisby et al.25 assessed biomarkers in 15 patients with disc herniation who 
underwent surgery due to a lumbar disc herniation. Increased CSF concentrations 
of NFL and S-100β were identified compared to a control group. Furthermore, 
patients with less than 3 months’ duration of symptoms before surgery had 
significantly higher levels of NFL than  patients with more than 3 months duration 
(p<0.05). This may be consistent with a release of NFL from the damaged nerve 
of the compressed nerve root during the acute phase. The lower level of NFL in 
patients with long-standing chronic pain may have been caused by atrophy of the 
nerve root, which results in a lesser release of NFL.25
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Table 1: 
Included animal studies
Study Year Biomarker 
investigated
CSF/
Serum
Details of study (sub) groups Results
Skouen 
et al.
1999 S-100β, NFL, 
NSE, and 
GFAP
CSF 18 pigs underwent an 
experimental nerve root injury 
and 18 pigs were used as sham 
operated animals 
Control: 5 pigs without nerve 
root injury
At 1 week after the experimental 
nerve root injury, NFL 
concentrations were elevated 
(p<0.001). Non-significant 
differences of S-100β, NSE, 
and GFAP concentrations were 
identified after the induced nerve 
root injury.
Ma et al. 2001 S-100β Serum 40 Sprague-Dawley rats in a 
weight-drop model and 66 
Sprague- 
Dawley rats with induced lumbar 
plexus avulsion injury  
Control: 28 Sprague-Dawley rats 
without SCI or plexus injury
At 3, 12, and 72 hours after 
SCI, increased levels of S-100β 
(p<0.05) were identified.
Nagy  
et al.
2002 NSE CSF 10 dogs who underwent 
thoracoabdominal cross-clamping
At 55 minutes of clamping, 
increased levels of NSE were 
identified (p<0.05).
Cornefjord 
et al.
2004 S-100β, NFL, 
NSE, and 
GFAP
CSF 20 pigs were divided in 
four groups (n=5 each): 1) 
experimental nerve root injury, 
2) autologous nucleus pulposus 
application, 3) experimental 
nerve root injury and nucleus 
pulposus application 
Control: 4) sham operation
At 1 week after the experimental 
nerve root injury, NFL 
concentrations were elevated 
(p<0.01). Non-significant 
differences of S-100β, NSE, 
and GFAP concentrations were 
identified after the induced nerve 
root injury
Loy et al. 2005 S-100β and 
NSE
Serum 34 Sprague-Dawley rats in a 
weight-drop model 
Control: 6 Sprague-Dawley rats 
without SCI
At 6 hours after SCI, increased 
levels of S-100β (p<0.05)and 
NSE (p<0.001) were identified. 
Cao et al. 2008 S-100β and 
NSE
Both 60 Sprague-Dawley rats in a 
weight-drop model  
Control: 20 Sprague-Dawley rats 
without SCI
At 2 hours after the force-
defined SCI, serum and CSF 
concentrations were elevated 
(p<0.05).
Abbreviations: NFL, Neurofilament protein; NSE, Neuron-specific enolase; GFAP, Glial fibrillary acidic protein; CSF, 
cerebrospinal fluid; SCI, spinal cord injury
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Table 2: 
Included human studies
Study Year Biomarker 
investigated
CSF/
Serum
Details of study (sub) groups Results
Van 
Dongen 
et al.
1998 S-100β Both 8 patients who underwent 
elective TAAA surgery
Non-significantly elevated 
S-100β CSF concentrations. 
Serum concentrations were not 
elevated.
Van 
Dongen 
et al. 
1999 S-100β CSF 19 patients who underwent 
elective TAAA surgery
Non-significantly elevated 
S-100β concentrations
Brisby et al. 1999 S-100β 
and NSE
CSF 15 patients who underwent 
surgery due to a  
lumbar disc herniation 
Control: 7 patients without 
lumbar disc herniation
Concentrations of NFL 
(p<0.01) and S-100β (p<0.05) 
were elevated in patients with 
lumbar disc herniation. NSE 
and GFAP concentrations were 
non-significantly elevated.
Kunihara 
et al.
2001 S-100β Both 23 patients who underwent 
thoracic aorta or TAAA surgery
At 6 hours after surgery, 
increased levels of S-100β 
(p<0.01) were identified in four 
patients with post-operative 
SCI.
Ohta  
et al.
2002 MBP Both 36 patients with tropical spastic 
paraparesis 
Control: 45 patients with non-
neurological diseases and 70 
healthy subjects
Elevated CSF MBP 
concentrations were identified 
in patients with tropical spastic 
paraparesis (p<0.001). Non-
significantly elevated serum 
MBP concentrations were 
detected.
Guez et al. 2003 GFAP  
and NFL
CSF 6 patients with traumatic SCI and 
17 patients with a whiplash injury  
Control: 24 neurologically healthy 
individuals
Non-significantly elevated 
levels of NFL and GFAP were 
identified in all SCI patients.
Shiiya et al. 2004 Tau and 
S-100β
CSF 28 patients who underwent 
elective prosthetic replacement 
of the descending thoracic aorta 
or TAAA
Non-significantly elevated 
levels of Tau. At 6 hours 
after surgery, elevated levels 
of S-100β (p<0.05) were 
identified in three patients with 
post-operative SCI. 
Marquardt 
et al.
2004 S-100β Serum 11 patients with spinal epidural 
empyema; S-100β 
measurements were correlated 
with clinical outcome
Patients with increased levels 
for a minimum of 3 days 
had unfavourable outcome 
(p<0.003).
Marquardt 
et al.
2004 S-100β Serum 34 patients with paresis due 
to spinal metastasis; S-100β 
measurements were correlated 
with clinical outcome
Patients with increased levels 
for a minimum of 10 days 
had unfavourable outcome 
(p<0.0001).
>>
2
Biom
arkers in spinal cord injury
42
Brunnekreef 
et al.
2007 S-100β CSF 8 patients who underwent 
elective TAAA surgery
Non-significantly increased 
levels of S-100β were detected.
Winnerkvist 
et al.
2007 GFAP, NFL, 
and S-100β
CSF 39 patients who underwent 
elective TAAA surgery
At 24 hours after surgery, 
increased levels of S-100β 
(p<0.05), NFL (p<0.05), 
and GFAP (p<0.001) were 
identified in five patients with 
post-operative SCI.
Khaladj 
et al.
2008 S-100β Both 13 patients who underwent 
elective TAAA surgery
At 6 hours after surgery, 
increased levels of S-100β 
(p<0.001) were identified 
in two patients with post-
operative SCI.
Abbreviations: NFL, Neurofilament protein; NSE, Neuron-specific enolase; GFAP, Glial fibrillary acidic protein; MBP, 
Myelin basic protein; CSF, cerebrospinal fluid; SCI, spinal cord injury; TAAA, thoracoabdominal aortic aneurysm
Discussion
In contrast to the large number of reports on biomarkers in structural brain 
damage, only few studies investigated the role of biomarkers in patients with SCI. 
Although studies investigating biomarkers in TBI and SCI are promising, several 
considerations must be kept in mind before utilising them in the clinical care of 
SCI.  
Most biomarker assays are not widely available in a standard clinical chemistry 
lab since these are “specialty analyses” and are, therefore, only available in designated 
laboratories. However, standardised commercial assays for S-100ß and NSE are 
available. Commercial assays are also available for Tau, GFAP, and MBP. There 
is no commercial assay for NFL. It is expected that faster techniques will cause 
neurochemical biomarkers to be more readily obtainable; however, at this stage, 
most biomarker assays must be performed in designated laboratories.
The studies of Ohta et al.26 and Guez et al.27 showed that biomarker 
concentrations are not elevated in neurological healthy subjects. In contrast, other 
studies showed that biomarker levels in CSF can be elevated in patients without 
spinal cord injury.22, 27, 31, 32 For example, patients with a period of aortic clamping 
and patients with a whiplash trauma may have elevated biomarker levels in CSF 
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without neurologic deficits. It is possible that these patients have a subclinical 
injury of the spinal cord with absent neurological deficits. For instance, in the aortic 
clamping group, there may have been ischemic spinal cord damage to some extent 
with concomitant elevation of biomarkers, but without neurological deficits.22, 31, 32 
This means that there is a “false positive” range of biomarker elevations. Considering 
the absence of neurologic deficits as the “gold standard” for the absence of SCI, 
a certain elevation of biomarker concentration should be regarded as normal. 
Furthermore,  NSE and S-100ß serum levels can become artificially elevated 
after polytrauma, haemolysis, and poor resuscitation.13, 37, 50, 51 The role of NSE 
and S-100ß in polytraumatised patients as a marker of nervous tissue damage is, 
therefore, questionable since increased serum levels of NSE and S-100ß are also 
identified in critically ill patients without brain injury. Traumatized fat, muscle, 
bone marrow, and several abdominal organs have been identified as the source for 
these increased serum levels of NSE and S-100ß in trauma patients without CNS 
injury.50, 51
Increased concentrations of biomarkers S-100ß, NSE, NFL, and GFAP have 
been identified in serum and CSF after SCI, but how these concentrations relate 
to neurological outcome remains unclear. Only two studies identified patients as 
having an unfavourable motor function in cases of persistently increased serum 
levels of S-100ß.29, 30 The studies of Marquardt et al.29, 30 identified that a longer 
period of persistently elevated S-100ß concentrations in serum was significantly 
related to lower extremity muscle power outcome. 
To our knowledge, only one study investigated biomarkers in traumatic SCI.27 
This study, however, has several limitations. For example, this study included only 
six SCI patients, the lumbar puncture was performed with a range of 1-21 days after 
the initial trauma, no statistical analysis was performed, and concentrations were 
not correlated to neurologic deficit or functional outcome. Although this study is 
the first to suggest the possibility of quantifying the degree of nerve cell damage after 
traumatic SCI, no definitive conclusions can be drawn about the diagnostic role of 
biomarkers in traumatic SCI patients.
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Conclusion
 Although several studies identified increased concentrations of 
neurochemical biomarkers, most studies identified these biomarkers in patients 
at risk for ischemic SCI during and after TAAA surgery. To date, only one study 
investigating biomarkers in traumatic SCI has been performed. Moreover, none of 
the available human studies correlated the concentrations of biomarkers to adequate 
measures of neurological outcome. Therefore, care must be taken to control for 
several clinical variables in order to ensure accurate results and prevent invalid 
conclusions. 
Considering the limited availability of sensitive prognostic modalities for the 
evaluation of traumatic SCI, it is our opinion that further clinical trials in SCI 
are necessary to evaluate the applicability of biomarkers as a diagnostic tool in 
patients with traumatic SCI. We are currently performing a multicentre study to 
investigate the diagnostic role of neurochemical biomarkers in traumatic SCI within 
the consortium of the European Multicentre Study on Human Spinal Cord Injury 
(EM-SCI; www.emsci.org). 
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Abstract
Study	design:	Prospective cohort study.
Background: To characterize the cerebrospinal fluid (CSF) concentrations of glial 
fibrillary acidic protein (GFAP), neuron specific enolase (NSE), S-100β, tau, and 
neurofilament heavy chain (NFH) within 24 hours of an acute traumatic spinal 
cord injury (SCI), and to correlate these concentrations with the baseline severity 
of neurologic impairment as graded by the American Spinal Injury Association 
impairment scale (AIS). 
Methods: A lumbar puncture was performed to obtain CSF from sixteen acute 
traumatic SCI patients within 24 hours post-injury. Neurological examinations 
were performed within 24 hours of injury and again at 6 or 12 months post-injury. 
The correlations between the CSF concentrations and initial AIS were calculated by 
using Pearson correlation coefficients. In addition, an independent student t-test 
was used to test for differences in CSF concentrations between patients of different 
AIS grades.
Results: The CSF NSE concentrations were significantly correlated with the baseline 
neurologic impairment being either “motor complete” (AIS A,B) or “motor 
incomplete”(AIS C,D) (r=0.520, p<0.05). The mean S-100β concentration in 
motor complete patients was significantly higher compared with motor incomplete 
patients; 377.2 μg/l(SD ± 523 μg/l) vs 57.1 μg/l(SD ± 56 μg/l) (p<0.05) respectively. 
Lastly, the mean NFH concentration in motor complete patients was significantly 
higher compared with motor incomplete patient, 11813 ng/l(SD ± 16195 ng/l) vs 
1446.8 ng/l(SD ± 1533 ng/l), (p<0.05), respectively.  
Conclusions: In this study we identified differences in the structural CSF biomarkers 
NSE, S-100β and NFH between motor complete and motor incomplete SCI 
patients. Our data showed no clear differences in any of the protein concentrations 
between the different AIS grades.
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Introduction
In traumatic spinal cord injury (SCI) much effort has been put into the evaluation 
of SCI severity and the prediction of neurologic recovery. Interventions intended to 
improve neurologic function following SCI include pharmacological1, surgical2, and 
rehabilitation3 approaches. Unequivocally demonstrating the neurologic efficacy of 
these interventions in clinical trials has, to date, been challenging. Contributing 
to this difficulty has been the considerable variability in spontaneous neurologic 
recovery that occurs amongst SCI patients of the same AIS grade. Measures to better 
stratify injury severity and precisely predict eventual neurologic recovery would be 
extremely valuable in the evaluation of novel pharmacologic or surgical interventions 
for acute SCI.4, 5 
Following a traumatic SCI, the initial severity of neurologic impairment is 
the best predictor of long-term neurologic outcome.6 The assessment of neurologic 
impairment in accordance with the International Standards for Neurological 
Classification of Spinal Cord Injury (ISNCSCI)   is considered to be most reliable 
and prognostic when conducted 72 hours after the initial trauma.7 Prior to the 
72 hour post-injury mark, several factors such as spinal shock, medical instability, 
or concomitant injuries affect the reliability of the neurological examination.8 
Furthermore, even with a reliable baseline neurologic examination performed acutely 
after injury, the extent of spontaneous recovery amongst SCI patients with the same 
ASIA impairment scale (AIS) grade is extremely variable.4 This variability in natural 
recovery forces investigators to enrol large numbers of patients into clinical trials of 
acute SCI therapies. Therefore, an accurate diagnostic-prognostic test which more 
precisely predicts neurologic outcome would greatly facilitate the conduct of such 
clinical trials.9 
A new approach for evaluating the extent of spinal cord damage in the acute 
phase is the measurement of specific neural proteins within the cerebrospinal fluid 
(CSF).10 Trauma to the spinal cord causes an acute disruption of the spinal cord 
parenchyma. This is followed by a secondary axonal degeneration and further 
degeneration or death of nerve cells by either apoptosis or necrosis, processes that 
may last from days to weeks. Since the spinal cord is surrounded by CSF, damage 
to the spinal cord releases proteins and metabolites from the nervous tissue into the 
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CSF. This process allows for the study of ‘biomarkers’ in the CSF.10-13 Although, 
several studies have been published concerning the use of biomarkers in CSF of 
patients with traumatic brain injury, only few studies exist in the field of SCI.10 The 
potential of this approach in traumatic SCI was recently demonstrated by using 
the CSF concentration of several inflammatory cytokines and structural proteins 
such as S-100β, tau and glial fibrillary acidic protein (GFAP) in patients within 24 
hours post-injury.9 However, several other promising markers like neuron specific 
enolase (NSE) and neurofilament heavy chain (NFH) have not prospectively been 
investigated in SCI patients within 24 hours post-injury.10
Therefore, the main purpose of the current study was to determine if the 24 
hour post-injury CSF concentrations of a number of structural markers (GFAP, 
NSE, S-100β, tau, and NFH) correlated with the baseline AIS grade of patients 
with an acute traumatic SCI. We also sought to establish the relationship between 
these proteins and neurologic recovery.
Materials and Methods
Patients
Two level 1 trauma centers (Nijmegen, the Netherlands and Vancouver, 
Canada) prospectively recruited patients with complete or incomplete traumatic 
SCI between 2007 and 2011. Patients were recruited based on the following 
inclusion criteria: 18 years or older; blunt SCI between C2 and T12; presentation 
and operative decompression and/or stabilization within 24 hours of injury; and 
the ability to undergo a valid, reliable neurological examination according to the 
ISNCSCI.14 Patients were excluded if they had concomitant major trauma to the 
chest, pelvis, and/or extremities requiring immediate invasive intervention, or if 
they suffered from pre-existent neurodegenerative disorders. Furthermore, eye 
opening and verbal response according to the Glasgow Coma Scale had to be 4 and 
6, respectively.  All patients provided informed consent (third-party assent was not 
allowed).
All patient underwent a neurological assessment according to the ISNCSCI 
by a certified physician or study nurse having at least 1 year of experience in 
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examining patients with SCI. They were classified as:  AIS grade A (No motor or 
sensory function preservation in the sacral segments S4-S5), AIS grade B (Sensory 
but not motor function preservation below the neurological level of injury (NLI) 
and includes the sacral segments S4-S5), AIS grade C (Motor function preservation 
below the NLI, and more than half of key muscles below the NLI have a muscle 
grade less than 3) or AIS grade D (Motor function preservation below the NLI, and 
at least half of key muscles below the NLI have a muscle grade of 3 or more).14 
The study protocols were approved by the respective local ethics committees 
and were registered within the Dutch or American clinical trial registries (trialregister.
nl identifier NTR1381, clinicaltrials.gov identifier NCT00135278).
Analyses
CSF samples were obtained under supervision of the spine surgeon. Using 
strict aseptic technique in laterally positioned patients, lumbar punctures were 
performed at L3-L4 or L4-L5, and a 3-5 ml sample of CSF was obtained in a 
polypropylene tube. In Vancouver, the lumbar puncture was followed by insertion of 
intrathecal catheter (PERIFIX® Custom Epidural Anesthesia Kit; B. Braun Medical 
Inc., Bethlehem, PA). Samples were drawn from this catheter using a strict sterile 
technique every 6-8 hours. The first samples from those patients, punctured within 
24 hours post-injury, were included in this analysis. Within 1 hour of acquisition, 
samples were centrifuged at 3000 rpm for 5 minutes and the supernatant was 
immediately stored at - 80 °C until analyzed.
For the biochemical analysis, we used previously described sandwich ELISAs 
for following CNS-specific proteins: NFH, tau, GFAP, S-100β, and NSE.15-19
Levels of NFHp35 were determined using a modified version of the 
sandwich ELISA. In summary, the microtiter plates were coated with mouse anti-
phosphorylated NFHp35 antibodies (SMI35; Sternberger Monoclonals) and 
subsequently incubated with bovine NFHp35 standard (ICN, Burlingame, CA) or 
CSF samples, polyclonal rabbit anti-NFHp35 antibody (Affiniti Research Products, 
Exeter, UK), and with polyclonal peroxidase-labeled goat anti-rabbit antibodies 
(Jackson, Immunoresearch, Westgrove, PA). Tetramethyl-benzidin (TMB) was used 
as a substrate in the peroxidase reaction, and absorbance was read at 450 nm. Tris-
buffered saline (pH 8.9) was used as a washing and dilution buffer. The detection 
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limit of the assay was calculated as the mean plus 3 SD of the zero standard signal 
from 34 measurements, and was determined to be 17 ng/L. Mean recovery of the 
assay was 91.2% (n = 14). The intra-assay variation coefficient (VC) was 8.3% at a 
concentration of 71 ng/L (n = 12), 22.5% at a concentration of 38 ng/L (n = 12), 
and 2.8% at a concentration of 423 ng/L (n = 12). The interassay VC was 18% at a 
concentration of 35 ng/L (n = 18).20 
Both NSE and S-100β concentrations were analyzed in an immunoluminometric 
assay (Byk Sangtec, Dietzenbach, Germany) by using the Liaison automated analyzer 
(Byk Sangtec). The assays were linear up to 200μg/L (NSE) and 30 μg/L (S-100β). 
The interassay variation coefficients were <5.3 % (NSE) and <11% (S-100β). CSF 
GFAP was measured by using a homemade sandwich ELISA21, 22 (linear up to 250 
μg/L; interassay variation coefficient <14%).  CSF tau was measured by using the 
Innotest hTau assay (Innogenetics, Gent, Belgium; linearity up to 1,200 pg/L; 
interassay variation coefficient <6.0%).
The reference CSF concentration ranges were: NSE <17.5 μg/L, Tau <300 
ng/l, GFAP <1.5 μg/l, S-100β <3.3 μg/l and NFH <115 ng/l. The reference ranges 
for the above structural biomarkers in CSF were determined by analysis of CSF in 
patients who were examined for a neurological disorder, but were diagnosed with 
either a systemic disease without neurological manifestations (e.g. with tension-type 
headache or depression). As additional requirements, all routine analyses (e.g. cell 
count, glucose, lactate, total protein, blood pigments, oligoclonal IgG bands) had to 
be in the normal range for each patient to be regarded as control.16, 18, 20, 21, 23
Neurological	outcomes
Neurological examinations were conducted according to the ISCNSCI 
standards.24 All patients with an acute phase neurological examination (within the 
first 24 hours after the injury) were included for the analysis. In addition, chronic 
phase (6 or 12 months) measurements had to be performed in each patient.25 On 
the basis of the ASIA sensory and motor scores, the level of injury and AIS grade 
were determined. 
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Statistical	Analysis
Statistical analyses were performed using SPSS 15.0 for windows. Data were 
presented as mean (SD) unless stated otherwise. We tested for a correlation between 
CSF concentrations and age as well by calculating Pearson correlation coefficients. 
Spearman’s rank or Pearson’s correlations test were also calculated between the CSF 
concentrations and initial motor complete (AIS A and B) or incomplete SCI patients 
(AIS C and D). An independent student t-test was used to test for differences in 
CSF concentrations between patients of different AIS grades. The AIS grades were 
considered as the gold standard for SCI severity. In addition, the initial mean CSF 
concentrations were compared between the different AIS grades 6 or 12 months 
post-injury.
Results
A total of 23 patients who were admitted to one of the trauma centers following 
blunt traumatic SCI were considered. Seven patients were excluded, three because 
the time of injury to CSF sampling was >24 hours, two because the 6 or 12 months 
post-injury neurological assessments were missing, and two because their CSF 
samples were grossly contaminated with blood. A total of sixteen patients were thus 
included. In one of these 16 patients (case 13), there was an insufficient amount of 
CSF obtained to measure the NFH concentration; the measurement of the other 
CSF proteins in this patient were included in the overall analysis of the other CSF 
proteins.
Ten patients were male and the mean age of the included patients was 46 years 
(range, 18-84). The mechanism of injury was a fall from height in the majority 
of the patients. The AIS grades were A (n=7), B (n=2), C (n=4), and D (n=3). 
In addition, the mean time of injury to CSF sampling was 14 hours (range, 3-24 
hours). See table 1.
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For each patient, the CSF concentrations of NSE, S-100β, GFAP, NFH, and 
Tau are listed in table 1. These concentrations are stratified by the baseline level 
of neurologic impairment (AIS A, B, C, or D) in table 2. As shown in table 2, 
the concentrations of all of the proteins are generally highest in the most severely 
injured (AIS A), and then tend to decrease in each of the less severe AIS grades. The 
only exception was NFH, where the mean concentration was 11,636 ng/l in the AIS 
A and 12,431 ng/l in the AIS B patients (although it should be acknowledges that 
there were only 2 patients with AIS B injuries).     
The mean NSE concentration in motor complete patients (AIS A and B) was 
significantly higher compared with motor incomplete patients (AIS C and D); 83.7 
μg/l (SD ± 75 μg/l) vs 25.3 μg/l (SD ± 17 μg/l) (p<0.05) respectively. In addition, 
the mean S-100β  concentration in motor complete patients was significantly higher 
compared with motor incomplete patients; 377.2 μg/l (SD ± 523 μg/l) vs 57.1 
μg/l (SD ± 56 μg/l) (p<0.05) respectively. Lastly, the mean NFH concentration in 
motor complete patients was significantly higher compared with motor incomplete 
patient, 11813 ng/l (SD ± 16195 ng/l) vs 1446.8 ng/l (SD ± 1533 ng/l), (p<0.05), 
respectively. 
When comparing the mean CSF concentrations by AIS grade within 24 hours 
post-injury, the mean concentrations of all the biomarkers were lower when the AIS 
grade was less severe (i.e. AIS C and D). Although CSF concentrations were the 
lowest in the AIS C and D patients, only the NSE and S-100β differed significantly 
(p<0.05) between AIS A and AIS C or D patients. In addition, only S-100β and 
NFH concentrations differed significantly (p<0.05) between AIS B and AIS C 
patients. Lastly, the GFAP and S-100β concentrations were lower (p<0.05) in AIS 
D patients compared to AIS C patients (table 2). 
No significant differences in CSF concentrations were observed between males 
and females, nor was there a significant correlation between CSF concentrations and 
age. Only the NSE concentrations had a significant correlation with patients being 
motor complete or incomplete (r=0.520, p<0.05) within 24 hours post-injury. 
When comparing the correlation between the time of injury to CSF sampling and 
the biomarker concentrations in all the 16 subjects, no significant correlations were 
indentified. However, in the 7 AIS A patients, statistically significant correlations 
were identified between the time post-injury when the CSF samples were obtained 
and the CSF concentrations for  NSE (r=0.897, p<0.05), S-100β (r=0.863, p<0.05) 
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and NFH (r=0.782, p<0.05). 
Lastly, the concentrations of S-100β ,GFAP and Tau  were lower in AIS A 
patients who improved in their AIS grade as compared to AIS A patients who 
remained AIS A. Interestingly, GFAP and Tau concentrations in AIS A patients 
who remained AIS A at follow-up, were 9.6 and 2.5 times higher, respectively, 
compared to the GFAP and Tau concentrations in AIS A patients who neurologically 
‘converted’ to an AIS B. See table 3.
Table 2: 
Mean cerebrospinal fluid concentrations of structural biomarkers per American 
spinal Injury Association impairment scale in 16 patients within 24 hours post-injury
 
NSE  (μg/l) S-100β (μg/l) GFAP (μg/l) NFH (ng/l) Tau (ng/l)
AIS vac 
grade mean (SD) mean (SD) mean (SD) mean (SD) mean (SD)
A (n=7) 85.4 (86.2) 426.1 (590.8) 4506.4 (9095.9) 11636.3 (17767.5) 583.6 (805.8)
B (n=2) 77.7 (9.4) 206 (128.7) 579 (275.7) 12431.5 (14253.2) 405.5 (30.4)
C (n=4) 32.9 (18.5)a 88.7 (54.2)a,c 326.2 (389.5) 2352 (1800.1)*,c 254.3 (101.4)
D (n=3) 15.1 (11.5)b 14.9 (20)d 66 (110)d 541.7 (419.5)d 292 (151.8)
Abbrevations: AIS vac, ASIA impairment scale within 24 hours post-injury;  NSE, neuron specific enolase; 
GFAP, glial fibrillary acidic protein; NFH, neurofilament heavy chain; SD, standard deviation
 * Note: absent NFH measurement in one AIS C patient
 a Statistical significant difference (p<0.05) between AIS A and AIS C patients
 b Statistical significant difference (p<0.05) between AIS A and AIS D patients
 c Statistical significant difference (p<0.05) between AIS B and AIS C patients
 d Statistical significant difference (p<0.05) between AIS B and AIS D patients.
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Table 3: 
Mean cerebrospinal fluid concentrations of structural biomarkers per improvement in 
the American Spinal Injury Association impairment scale in 16 patients after 6 or 12 
months post-injury
 
NSE  (μg/l) S-100β (μg/l) GFAP (μg/l) NFH (ng/l) Tau (ng/l)
AIS improvement mean mean mean mean mean
A → A (n=5) 71.8 437.8 6056.9 6846.8 706
A → B (n=2) 119.5 397 630.1 23610 277.5
B → C (n=1) 84.3 297 384.0 22510 427
B → D (n=1) 71 115 773.9 2353 384
C → C (n=1) 12.2 21.2 42.1 597 152
C → D (n=3) 39.8 111.2 420.9 3229.5* 288.3
D → D (n=2) 19.7 20.7 98 661.5 348
D → E (n=1) 5.9 3.2 2.2 302 181
Abbrevations: AIS ch, ASIA impairment scale after 6 or 12 months post-injury;  NSE, neuron specific enolase; 
GFAP, glial fibrillary acidic protein; NFH, neurofilament heavy chain; NA, not applicable
 * Note: absent NFH measurement in one AIS C patient
Discussion
In this study, when stratifying patients as motor complete (AIS A+B) versus 
motor incomplete (AIS C+D), there were significant differences in NSE, S-100β, 
and NFH concentrations within the CSF. With the small numbers of patients in 
this analysis, there was not a significant difference in any of the proteins when 
comparing between the individual AIS grades.
The CSF concentrations of all of the proteins examined were elevated in the 
SCI patients as compared to uninjured controls irrespective of the AIS severity. 
This suggests (not surprisingly) that trauma to the spinal cord causes a release of 
proteins from the cord into the CSF. Our objective was to determine if the CSF 
concentration of these proteins differed according to injury severity. With the small 
number of patients in each AIS grade (A n=7, B n=2, C n=4, and D n=3) and the 
different time points of CSF collection (ranging from 3 to 24 hours post-injury), 
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there were no significant differences between each AIS grade for any of the proteins 
tested. This was in contrast to the single-center study of Kwon et al. in which there 
were significant differences between AIS grades in the 24 hour post-injury CSF 
concentrations for a number of different markers, including tau, S-100β, GFAP, 
IL-6, IL-8, and MCP-1.9  In our current study, when stratifying patients as motor 
complete (AIS A+B) versus motor incomplete (AIS C+D), there were significant 
differences in CSF concentrations of NSE, S-100β, and NFH. 
Aside from the small numbers of patients, a possible explanation for the 
variability in CSF concentrations and the inability to distinguish different injury 
severities was the variability with which the CSF was collected in this particularly 
study – ranging from 3 hours to 24 hours post-injury, with  the mean time of injury 
to CSF sampling of 14 hours. Given the complex and dynamic pathology of SCI, 
it can be expected that levels of SCI biomarkers evident within the CSF will be 
time dependent26 as shown previously by Kwon et al.9 For instance, S-100β and 
NSE reach peak levels at 6 hours post-injury and are not detectable after 24 hours 
in rats.10, 27 This has also been identified in patients at risk of a ischemic SCI during 
endovascular stent grafting where S-100β peak at 6 hours post-injury.10 GFAP on 
the other hand has the tendency to reach peak levels after 24 hours.28, 29 To date, we 
are not aware of published studies that have reported  NFH concentrations in the 
CSF of human SCI  patients. A recent study, however, used 25 swines in a model 
that mimics blast-induced traumatic brain injury. The study identified significantly 
increased CSF NFH concentrations at 6 hours post-injury compared to pre-injury 
levels. Remarkably, the NFH decreased again to a level that differed non-significantly 
compared to pre-injury levels after 24 hours.30 Our data also showed the influence 
of the time of sampling against the concentrations of NSE, GFAP and NFH in the 
7 AIS A patients. 
In our previous review10, we showed that structural biomarkers were not a 
sensitive prognostic tool according to the then available studies. However, a 
recent study showed the potential of cerebrospinal fluid biomarkers.9 In the 
study, a biochemical model was created that utilized the levels of Interleukin-8, 
S-100β, and GFAP at 24 hours post-injury to classify AIS grade and to predict 
segmental motor recovery in 20 cervical SCI patients. The model predicted the 
observed AIS grade in 89% of the SCI patients. In addition, segmental motor 
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recovery in the upper extremities at 6 months post-injury was predicted with either 
the CSF concentrations IL-8, S-100β and GFAP, or the initial AIS grade. The 
biochemical model was comparable to (if not slightly better than) the initial AIS 
grade at predicting segmental motor recovery. Although these are promising results, 
validation of the ability for such biomarkers to distinguish injury severity requires 
testing in an independent cohort of patients.
 Although our data showed no significant differences in S-100β, Tau, 
GFAP and NFH concentrations between all the different AIS grades, the mean 
CSF concentrations tend to suggest that the more severely a SCI patient is injured, 
as determined by the AIS grade, the higher the concentrations of a structural 
biomarker. The GFAP and Tau concentrations in table 3 also reflect what may be a 
functional ‘ceiling effect’ with the AIS grading system. Conceptually, if the spinal 
cord is traumatically injured to a degree that produces a functionally ‘complete’ AIS 
A injury, doubling the mechanical severity of injury may increase the biological 
extent of injury, but would still result in the identical injury grading according to 
the AIS. This increased biological extent of injury, however, may be reflected in 
the CSF concentrations of structural biomarkers such as Tau and GFAP. However, 
there is also a considerable variability in the concentrations among the most severely 
damaged spinal cords, i.e. the AIS A patients. A possible explanation for this variety, 
may be the time that the different samples were obtained. Our  data showed that 
this variability in timing significantly influenced the NFH, NSE and S-100β 
concentrations in AIS A patients. 
Our results should be interpreted in the context of specific study limitations. 
We presented the study results of 16 SCI patients. As we used strict inclusion criteria, 
the interpretation of our results is limited by the small sample size patient numbers. 
The less severely injured SCI patients who improved in their AIS grade seemed 
to have lower biomarker concentrations, however, the great variability and small 
numbers severely limits the conclusions drawn from our analysis. In addition, our 
study population limits us from using a biochemical model with statistical power 
as proposed by a previous study.5 Also, our study protocol was not standardized 
for several putative confounders such as treatment regimens and blood pressure 
augmentation. The method of obtaining CSF differed between the two centers. As 
the purpose of this study was to analyze CSF samples obtained within 24 hours, 
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we believe that this has not influenced our results. However, the time between the 
injury  and CSF sampling differed considerably amongst the patients in our study, 
ranging from 3 hours to 24 hours, and our  data showed that this variability in timing 
significantly influenced the NFH, NSE and S-100β concentrations. Future studies 
therefore should perform CSF sampling on predetermined time intervals. Lastly, 
although the AIS is a recognizable benchmark for the baseline neurologic assessment 
of the acute SCI patient, the AIS is a questionable outcome measurement, since it 
does not address the functional capabilities.31
As previously mentioned, the diagnostic capabilities of the currently available 
biomarkers will not exceed that of the initial neurological assessments, so long 
as they are compared to these neurological assessments as the comparative gold 
standard.5 Future studies are needed to determine whether structural biomarkers 
could be used as diagnostic markers in those SCI patients where a valid baseline 
neurological assessment cannot be obtained, or if they could better predict long-
term outcome than this initial neurological evaluation.
 
Conclusion
In this study of 16 SCI patients, the structural CSF biomarkers NSE, 
S-100β and NFH appeared to correspond with patients having a motor complete 
or incomplete SCI. Our data showed no clear differences in any of the protein 
concentrations between the different AIS grades.
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Abstract
Study	design: Prospective cohort study and literature review.
Objectives:	Only few studies have been published about diffusion-weighted imaging 
(DWI) within 24 hours of traumatic spinal cord injury (tSCI). The purpose of this 
study was to compare the imaging findings from conventional magnetic resonance 
imaging (MRI) and DWI in seven tSCI patients with findings in the existing 
literature.
Methods:	Seven patients with tSCI at neurologic levels C2-T10 were examined with 
conventional MRI and DWI within 24 hours post-injury. DWI was obtained with 
a b-factor of 1000 s/mm2.  American Spinal Injury Association (ASIA) scores and 
Spinal Cord Independence Measurement (SCIM) II item 12 after 12 months were 
collected. In addition, MEDLINE was searched from 1995 to 2010 to identify 
clinical tSCI studies reporting on MRI, DWI, and ADC maps within 24 hours 
post-injury to perform a meta-analysis. Images obtained with a b-factor of 1000 s/
mm2 were compared with lower b-factors. Differences were calculated using χ2 tests.
Results:	 No associations were identified between the images of the seven tSCI 
patients and ASIA or SCIM II scores. Eighteen SCI patients (11 from the retrieved 
publications) were included in the meta-analysis. The detection rates of hyperintense 
signals on T2-weighted and DW imaging did not show significant differences at 
94% and 72%, respectively. In addition, there were no significant differences in 
detection rates or diffusion abnormalities between subjects in whom DW images 
were obtained with a maximum b-factor of 1000 or <1000 s/mm2. 
Conclusion:	 Our analysis suggests that T2-weighted and DW imaging have 
comparable detection rates for spinal cord damage in tSCI patients within 24 hours 
post-injury. 
C
ha
pt
er
 4
4
71
Introduction
In traumatic spinal cord injury (tSCI), much effort has been placed on 
evaluating SCI severity to predict recovery potential. However, an increasing number 
of SCI studies have begun shifting their research focus from care to cure.1–3 It is 
assumed that patients with more severe SCI respond differently to neuroprotective 
interventions than do patients with less severe SCI. An accurate prediction of the 
initial damage of the spinal cord that more exactly differentiates between the severity 
of SCI may help physicians in choosing neuroprotective interventions in the acute 
phase.
Conventional magnetic resonance imaging (MRI) is currently the best 
imaging modality for evaluating tSCI during the acute phase.4 Standard clinical 
MRI sequences effectively identify spinal cord compression, edema and hemorrhage 
in the spinal cord. In addition, the presence of large intraparenchymal hemorrhages 
is a well-known predictor of poor outcome following tSCI.5 Conventional MR 
sequences, however, do not provide enough information about the integrity of the 
critical, long white-matter long tracts responsible for the observed functional deficits 
after SCI. Previous studies have established that diffusion-weighted imaging (DWI) 
may have diagnostic value for SCI.6–8 DWI evaluates the free Brownian motion 
of water molecules in vivo. Spinal cord white-matter tracts are well organized in 
the craniocaudal direction, so diffusion is anisotropically oriented, with a higher 
apparent diffusion coefficient (ADC) along the fibers than transversely. DWI, 
therefore, can be used to evaluate the integrity of white-matter tracts in the spinal 
cord, and has the potential to provide information beyond the anatomic or spatial 
data provided by conventional MRI techniques. To illustrate, Shanmuganathan et 
al.8 identified decreased ADC values throughout the cervical spinal cord of SCI 
patients which were not seen on conventional MRI. The authors concluded that 
these abnormalities were greatest at the cord injury site and may reflect injury 
severity.8
Currently, the neurological examination is the most sensitive tool in 
predicting outcomes after the initial damage of the spinal cord in SCIpatients.9 The 
neurological examination based on the American Spinal Injury Association (ASIA) 
scores is considered to be reliable and prognostic in patients who are tested 72 h 
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after the initial trauma.10 Within 72 h post-injury, several factors, such as spinal 
shock, medical instability, concomitant brain injury or coma, affect the reliability of 
the neurological examination.11 
In the therapeutic management of tSCI patients, the optimal timing of 
decompressive surgery remains controversial. A recent study stated that surgical 
decompression (within 24 h post-injury) should be considered a part of the 
neuroprotective management of any tSCI patient.12 
The purpose of this study was (1) to compare the detection rates for spinal 
cord damage on conventional MR and DWI within 24 h postinjury; (2) to compare 
different b-factors used for DWI of the spinal cord; and (3) to compare the results 
with previously published data.
Materials and Methods
Study	population
For this study, we used data that were prospectively collected from tSCI patients. 
Data were collected from patients primarily referred to the Emergency Department 
of our Level 1 trauma center between March 2008 and August 2009. Patients ≥ 
18 years of age were included in our diagnostic trauma protocol. All patients were 
examined with conventional MRI and DWI within 24 hours post-injury. The ADC 
maps were also generated from the DWI. Neurological assessments and functional 
outcomes in this database were collected at five time points: during the acute phase 
(i.e., within the first 15 days post injury), and at one, three, six and twelve months 
after the injury. Clinical assessments were conducted by trained neurological and 
rehabilitation physicians who had at least one year experience in examining patients 
with SCI.
The study protocol was approved by the local ethics committee, and written, 
informed consent was obtained from all subjects. See also www.trialregister.nl, study 
ID: NTR1381.
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Imaging
MRI studies were performed on a Siemens Avanto 1.5-T. magnet using a spine 
array coil (Erlangen, Germany). Sagittal T1-W SE (spin echo time) MR images (TR/
TE (time of repetition/time of echo) 550/10ms, 3mm slice thickness), T2-W TSE 
(turbo spin echo time) MR images (TR/TE 4800/102ms, 3mm slice thickness), 
true inversion recovery magnitude (TIRM) images (TR/TE/time of inversion (TI) 
1650/15/860ms, 3.5mm slice thickness) and axial T2-W TSE MR images (TR/
TE 1500/123 ms, 3mm slice thickness) were acquired in all patients. In addition, 
sagittal T2-weighted gradient-echo sequences were performed to identify possible 
hemorrhages in the spinal cord. DWI was performed in a sagittal plane in all 
patients using multi-shot echo planar imaging (EPI) with the following parameters: 
field of view (FOV) 280_280mm2 or 350_350mm2; slice thickness 3mm; TR/
TE 200/89; number of b-factors 2; and number of signal averages (NSA) 10. The 
minimum and maximum b-factors were 0 and 1000 smm–2, respectively. Diffusion 
encoding gradients were played out sequentially along all three principal axes on 
a per-pixel basis. ADC maps were generated from the DWI on a pixel-by-pixel 
basis with software supplied by the manufacturer. The ADC values of the lesion 
in the cord were measured by visual assessment by drawing small ROIs (regions 
of interests) on the ADC maps with T2-weighted images as a reference. The ROI 
analysis is considered to be a reliable method for measurements of lesions in MRI.13 
To minimize the influence of small movements during scanning of T2-weighted 
images and DWI, image registration was performed. We set the size and location 
of the ROIs so as to include only the lesion, and averaged three measurements. The 
images were evaluated for all subjects by an experienced neuroradiologist (AMvdV) 
who was blinded for the patients’ clinical status. The sagittal T2-weighted and 
DWimages were graded as normal, hyperintense or hypointense. The sagittal ADC 
maps were graded as normal, decreased or increased diffusion.
Neurological	outcome
Neurological examinations were conducted according to the ASIA standards.14 
This requires the SCI patient to demonstrate his/her residual strength in 10 muscle 
groups in the arms and legs, and to report their sensation to pin-prick and light 
touch throughout the body, including the peri-anal region. On the basis of the 
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ASIA sensory and motor scores, the neurological level of injury (NLI) and ASIA 
impairment scale (AIS) were determined. For the analysis, only patients with an AIS 
A-D, an NLI between C2 and T10, and completely conducted examinations within 
15 days post-injury (acute phase) and 12 months post-injury were included. 
Functional	outcome
The Spinal Cord Independence Measurement (SCIM) II is an instrument that 
focuses on performing everyday tasks, and captures the disability, as well as the 
impact of disability, on the patient’s overall medical condition and comfort.15 The 
SCIM II consists of three main categories, namely, 1) self-care, 2) respiration and 
sphincter management, and 3) mobility.16 As independent ambulation is a high 
priority for recovery among SCI patients17, the chronic phase scores from item 
12 of the SCIM II (indoor mobility) were collected in each patient. This SCIM 
mobility item has a range of 0-8. The indoor mobility is scored as: (0) requires 
total assistance; (1) needs an electric wheelchair or partial  assistance to operate 
manual wheelchair; (2) moves independently in a manual wheelchair; (3) requires 
supervision while walking (with or without devices); (4) walks with a walking frame 
or crutches (swing); (5) walks with crutches or two canes (reciprocal walking); (6) 
walks with one cane; (7) needs leg orthosis only; and (8) walks without aid.
Retrieval	of	publications
A MEDLINE (PubMed interface) search was performed to compile a reference 
list of articles published between 1995 and March 2010. The search strategy used 
both key words and the following MeSH terms: spinal cord injuries; traumatic spinal 
cord injury; Magnetic Resonance Imaging; and Diffusion Magnetic Resonance 
Imaging. The abstracts and references from all identified articles were also examined 
for importance, relevance, and overlap by two reviewers (MHP, AMvdV). 
All clinical studies reporting on MRI and DWI in subjects with a tSCI 
were eligible for analysis. The findings of this study were compared with those in 
published series. Case reports were also included. Only studies or case reports in 
which the sagittal imaging was performed ≤ 24 hours post-injury were included. 
Studies that failed to report the interval between injury and MR imaging and the 
DWI technique used, were excluded. The qualitative and quantitative ADC analysis 
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of the spinal cord lesions was included. The ADCs of these studies were also graded 
as normal, decreased, or increased diffusion. 
Statistics
Descriptive statistics on age, gender, and AIS were used to provide general 
information about the study population. As only patients with spinal cord damage 
were included for the meta-analysis (i.e., an abnormal neurological examination 
being the gold standard), the detection percentage for spinal cord damage was 
calculated for T2-weighted images and DW-images. By applying the qualitative 
interpretation of the ADC maps, we also evaluated any differences in possible 
diffusion abnormalities. 
As the DW images in our study were obtained with EPI using a maximum 
b-factor of 1000 s/mm2, we compared our images with the images from other studies 
that were obtained using a lower b-factor than 1000 s/mm2. The differences in the 
number of patients with hypo- or hyperintensity on T2-weighted images and DW 
images were calculated using a chi square or Fisher’s exact test, as appropriate. The 
differences were considered statistically significant at p < 0.05. Data were analyzed 
using SPSS software (version 16.0, SPSS, Chicago, IL).
Results
A total of 10 patients who were admitted to our trauma center following blunt 
force trauma were included. All of these 10 patients were suspected of having an SCI, 
as assessed by the attending trauma surgeon at admission. Mechanisms of injury 
included motor vehicle accidents (n=4) and falls from heights (n=6). However, two 
patients had a motor and/or sensory deficit that was not attributable to an SCI. In 
addition, one polytraumatized patient (case no. 9) complained of a lower extremity 
sensory deficit at the scene of the accident. As the patient was sedated on arrival 
at our emergency department, a reliable neurological examination could not be 
performed and eventually this patient had no motor or sensory deficit. In these 
three subjects without SCI, the T2-weighted images, DW images, and ADCs were 
all normal. A total of seven SCI subjects were thus included for the analysis, with 
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a mean age of 62 years (range, 32-91 years). Of the 7 SCI patients, the AIS were A 
(n=2), C (n=1), and D (n=4). 
The T2-weighted images showed a hyperintensity in the cord in six of the 
seven tSCI patients. The DW images showed hyperintensities in five of the seven 
tSCI patients. In one patient, both the T2 and DW images were graded as normal. 
None of the images was graded as hypointense. The ADC value (mean ± standard 
deviation) in the hyperintensities of these seven patients was 536 ± 94 x 10-6 
mm2/s. In addition, the gradient echo sequences showed no haemorrhages in the 
spinal cords of these seven tSCI patients. In case no. 8, DW images showed no 
abnormalities. The ADC, however, was only slightly decreased compared to the 
non-injured spinal cord. In addition, comparing the T2-weighted images with the 
b-factor 0 s/mm2  value of the DWI showed no discrepancies in the appearance of 
the abnormal signals.
Although the AIS improved in cases no. 6 (A-C) and 10 (D-E), no clear 
differences or associations were identified between the different ASIA impairment 
scales and/or item 12 of the SCIM and the findings on DWI in any of the seven 
tSCI patients .The only patient with a complete SCI, i.e., AIS grade A, who did not 
improve in AIS grade also had the largest lesion size on the MR and DW images (see 
Figure 1). However, our data of seven patients did not show an association between 
lesion size and neurological or functional outcomes (Table 1).  
MEDLINE	search
Of 32 articles from MEDLINE identified by the predefined key words, four 
studies were recognized as potentially relevant. Two studies were excluded, as one 
did not report the interval between injury and imaging and the other was not 
in English.18, 19 One study  20 and one case report21 could be accepted for further 
analysis after accounting for the inclusion/exclusion criteria. In these reports, a total 
of 11 tSCI patients, who received conventional MRI and DW imaging within 24 
hours post-injury, were included (Table 2). None of the included studies reported 
standardized neurological or functional outcomes. 
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Meta-analysis	
A total of 18 SCI patients (11 subjects from the retrieved publications and 
seven from this study) were included in the meta-analysis. Thirteen subjects were 
male patients and the mean age was 55 years (range, 2-91 years). The mean interval 
between time of injury and imaging was 10.4 hours (range, 1-24 hours). The 
included studies both used a b-factor of less than 1000 s/mm2, 70021 and 42420 s/
mm2, respectively.
In 1/18 patients (6%), both the T2-weighted and DW images were graded 
as normal. In 4/18 (2%) other patients, no abnormalities on the DW images were 
identified, whereas hyperintensity was detected on T2-weighted images. In 13/18 
patients, hyperintensity was observed on T2-weighted and DW images. 
The detection rates of hyperintensities on T2-weighted imaging in subjects 
in whom DW imaging was performed with a maximum b-factor of 1000 s/mm2 
and <1000 s/mm2  were 86% and 100%, respectively (p>0.05). The detection rates 
of hyperintensities on DWI in subjects with a maximum b-factor of 1000 s/mm2 
and <1000 s/mm2  were 71% and 73%, respectively (p>0.05). In addition, the data 
showed no significant differences in decreased diffusion percentages between images 
obtained with a maximum b-factor of 1000 s/mm2 and <1000 s/mm2 . 
Regardless of the b-factor used, the detection rates of signal abnormalities on 
T2-weighted and DW imaging were 94% and 72%, respectively. This difference, 
however, was non-significant (Table 2). 
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Tabel 1: 
Demographic data
Case Age at 
injury
(years)
Sex Cause 
of 
injury
NLI AIS 
vac1
AIS 
ch2
Lesion 
size 
MRI 
(mm)
Lesion 
size 
DWI 
(mm)
T2 findings DWI ADC SCIM 
Item 
12 
ch
1 32 F MVA C2 D D 33,6 6,5 hyperintense hyperintense decreased 8
2 91 M Fall C2 D D 33 5,8 hyperintense hyperintense decreased 6
3 46 M Fall L2 E E NA NA normal normal normal 8
4 49 M MVA C2 C C 18,7 8,8 hyperintense hyperintense decreased 2
5 43 M MVA C6 E E NA NA normal normal normal 8
6 66 M Fall C3 A C 34 6 hyperintense hyperintense decreased 1
7 36 M MVA T9 A A 79,5 9,2 hyperintense hyperintense decreased 2
8 72 M Fall C5 D D 36,5 NA hyperintense normal normal 8
9 65 F Fall C6 E E NA NA normal normal normal 8
10 85 F Fall C5 D E NA NA normal normal normal 7
Abbreviations: MVA, motor vehicle accident; NLI, neurological level of injury; AIS vac, ASIA impairment scale 
within 15 days post-injury; AIS ch, ASIA impairment scale after 12 months; MRI, Magnetic Resonance Imaging; DWI, 
diffusion-weighted imaging; SCIM item 12 ch, Spinal Cord Independence Measure item 12 after 12 months; NA, not 
applicable.
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Table 2:
Images from patients with traumatic spinal cord injury obtained within 24 hours post-injury.
Study Case 
no. 
In 
study
Gen-
der
Age
(years)
Interval 
between 
imaging 
and 
onset of 
SCI (h)
DWI 
technique
Maximum 
b-factor
Slice 
thickness 
(mm)
Location Lesion 
ADC  
value
( x 10-6 
mm2/s)
MRI 
findings 
on 
T2-W 
images
DWI
Current 
study
1 F 32 1 Multi-shot 
EPI
1000 3 cervical 657 + +
2 M 91 15 Multi-shot 
EPI
1000 3 cervical 534 + +
4 M 49 4.15 Multi-shot 
EPI
1000 3 cervical 393 + +
6 M 66 2.5 Multi-shot 
EPI
1000 3 cervical 550 + +
7 M 36 7.5 Multi-shot 
EPI
1000 3 thoracic 441 + +
8 M 72 19 Multi-shot 
EPI
1000 3 cervical 588 + -
10 F 85 3 Multi-shot 
EPI
1000 3 cervical 590 - -
21 1 M 51 2 Single-shot 
EPI
700 6 cervical 660 + +
20 2 M 26 9 SSFSE 424 5 cervical 2100 + +
3 F 64 11 SSFSE 424 5 cervical 2220 + +
4 M 20 11 SSFSE 424 5 cervical 1590 + +
5 M 40 24 SSFSE 424 5 cervical 370 + -
6 M 81 3 SSFSE 424 5 cervical 450 + -
8 F 74 12 SSFSE 424 5 cervical 1830 + +
9 F 86 24 SSFSE 424 5 cervical 1920 + +
12 M 54 2 SSFSE 424 5 cervical 2420 + -
13 M 56 4 SSFSE 424 5 cervical 1180 + +
  14 M 2 6 SSFSE 424 5 cervical 1220 + +
Abbreviations: EPI, echo planar imaging, +, hyperintense image; -, no abnormalities detected; SSFSE, single-shot fast 
spin echo.
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Figure 1: Images of case no. 7. (a) Sagittal T2-weighted imaging of an unstable fracture at the level of Th12 with 
a compression of the lower thoracic spinal cord. (b) There is a hyperintense lesion on the DW image. (c)  
The hyperintensity on the DW images is hypointense at the corresponding level on the ADC map.
Discussion
In this study, the imaging findings from T2-weighted imaging and DW 
imaging were analyzed in seven subjects with tSCI, and further compared with 
results previously published in the literature. Our qualitative data analysis suggests 
that T2-weighted and DW images have a comparable detection rate for spinal cord 
damage in patients with tSCI within 24 hours post-injury. 
Although it is hypothesized that DWI may be more sensitive in detecting signal 
abnormalities than conventional MRI in patients with traumatic SCI during the 
acute phase (i.e., within 24 hours post-injury), our combined data do not suggest 
this. No significant differences in detection rates between T2-weighted imaging and 
DWI in tSCI patients were identified. A maximum b-factor of 1000 s/mm2  did not 
lead to higher detection rates or differences in diffusion abnormalities compared 
to lower b-factors. In addition, a study comparing a b-factor of 1000 s/mm2  in 
the detection of ischemic stroke showed that a higher b-factor of 3000 s/mm2  had 
no impact on the diagnosis of acute infarction. However compared to 1000 s/
mm2,  the b-factor of 3000 s/mm2  improved the gray-white matter differentiation 
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on ADC maps and the visual assessment of decreased diffusion.22 Lower b-factors 
would require shorter scanning time, an important factor in acute SCI setting. In 
practice, a b-factor of 1000 mm/s2 has been accepted to be reliable in DW imaging 
of the spinal cord. There is no clear benefit for choosing a b-factor of 1000 mm/
s2 compared with lower b-factors in the detection of traumatic SCI. However, 
the quality of DWI images is improved with a b-factor of 1000 mm/s2 which is 
important for measurements.
In 2006, the National institute on Disability and Rehabilitation Research 
Spinal Cord Injury Measures Meeting made several recommendations about 
neuroimaging techniques that are applied in SCI patients. The commission stated 
that future DWI research should be focused on 1) the correlation between lesion 
size and clinical status, and 2) the refinement of clinical and prognostic capabilities 
in close correlation with improvements in field strength and software.9 In our own 
series, six of the seven SCI patients had a hyperintensity on T2-weighted images 
and five of the seven SCI patients had a hyperintensity on the DW images with 
decreased ADC values. With these numbers any correlation between clinical status 
and neuroimaging lacks statistical power. To date, only two studies have evaluated 
the correlation between DW images and clinical status.18, 20 Tsuchiya et al.20, 
however, did not perform neurological assessments according to a standardized 
classification, such as the ASIA standards. Therefore, it is not clear whether the 
presence of hyperintensity on T2-weighted images and DW images might be 
associated with an incomplete or complete neurologic injury. For example, large and 
small regions of hyperintensity may be present in both an incomplete and a complete 
neurological injury.23 In addition, this study20 failed to use a standardized functional 
outcome scale, such as the SCIM, or functional independence measure items24, 
but rather, divided the functional outcome into a poor or fair outcome. In view 
of these methodological limitations, one might conclude that restricted diffusion 
is predictive of an unfavorable prognosis. The study by Shen et al.18 conducted 
neurological examinations according to the ASIA standards, and these investigators 
showed that there was no correlation between DWI and neurological outcome in 
their study population of five patients.18 Remarkably, the study concluded that 
future DWI may provide important information complementary to conventional 
MRI, and allow for a better prognostic evaluation of recovery.18 
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The study by Marcel et al.25 showed that, in some cases, the high signal on 
DWI in spinal cord lesions was associated with an increased signal on ADC, which 
means elevated diffusion. This can be explained by the T2 shine-through effect 26. In 
addition, the acute phase in this meta-analyis was considered to be within 24 hours 
post-injury. This time interval itself may be inadequate to investigate the correlation 
between images and neurological and functional outcomes using a qualitative 
interpretation. To illustrate, there is evidence that water accumulation in spinal cord 
parenchyma occurs as early as two hours post-injury after SCI.27, 28 This secondary 
injury mechanism may therefore be the reason that we were not able to identify 
any qualitative differences between T2-weighted and DW images, because this early 
edema can also be detected on T2-weighted images. Although we were not able 
to identify any differences between T2-weighted images and DWI within a time 
interval of 24 hours post-injury, a recent study showed a higher sensitivity for the 
detection of early pathological changes after contusive SCI using DWI, compared 
to conventional MRI in 40 rabbits.6 In addition, differences in ADC values between 
lesions in the mild, moderate, and severe injury group were identified within a range 
of 30 minutes to 24 hours post-injury.6 
Although our study used multi-shot EPI, the other studies used single-shot 
EPI21 and  single-shot fast spin echo (SSFSE).20 Multi-shot EPI has been proven 
to be less sensitive to geometric and susceptibility distortions than single-shot EPI, 
and provides better resolution and less blurring than single-shot EPI.29 In addition, 
multi-shot EPI was rated superior to SSFSE in one study.29 
Some limitations of this study warrant consideration. Our small study 
population of 18 patients limits any valid conclusions. The qualitative interpretation 
of the data is also a limitation of this study. Since no standardized ADC values exist, 
to date, and different imaging techniques and b-factors were used in the included 
studies,20,21 this qualitative data interpretation was chosen. Although we choose a 
qualitative interpretation, the different imaging techniques in this meta-analysis 
limit the clinical implications of our conclusions. With this interpretation, all ages 
were also included, although it is hypothesized that the ADC is higher in the aging 
spinal cord.30 Since ADC values can be correlated with histologic parameters, that 
is, axonal loss,31,32 future studies with standard imaging techniques should focus on 
the correlation between standardized neurological and/or functional outcomes and 
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quantitative data, such as the ADC or lesion size.
Two problems may exist for future MRI/DWI studies. First, due to the limited 
availability of MR imaging, obtaining MR/DW images from tSCI patients within 24 
hours post-injury is a logistic pitfall in most hospitals. Valuable time-to-intervention 
may be lost when waiting for these images. Second, the current technique is also 
limited. All data from the included images were performed on 1.5-T clinical 
scanners. When one considers the issue of spatial resolution and the desire to image 
a patient’s spinal cord with a resolution that approaches in vitro cord imaging, the 
problem of insufficient signal becomes clear.33 It may be that the 1.5-T scanners do 
not offer the high signal and image quality that would allow DWI of the spinal cord 
to be widely and routinely implemented. As our data suggest that DWI with the 
current 1.5-T scanners does not clearly improve the detection rate within 24 hours 
post-injury, future studies should implement newer acquisition techniques34 with 
the use of higher field strengths (3-T or higher), and should ideally be performed in 
large multicenter networks to investigate the prognostic capabilities of DWI in SCI. 
Conclusion
Our qualitative analysis suggests that T2-weighted and DW imaging have 
comparable detection rates for spinal cord damage in 18 tSCI patients within 
24 hours post-injury. Future DWI studies in spinal cord injury should focus on 
the correlation between standardized neurological and functional outcomes and 
quantitative data such as the ADC and lesion size, to evaluate the prognostic 
capabilities of this technique.  
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Abstract
Study	design: Systematic review.
Background:	To review currently applied TCCS diagnostic criteria and quantitative 
data regarding the ‘disproportionate weakness’ between the upper and lower 
extremities described in original studies reporting on TCCS subjects.
Methods:	 A MEDLINE (1966 to 2008) literature search was conducted. The 
descriptors applied to define TCCS were extracted from all included articles. We 
included original studies that reported on the differences in motor score (based on 
the Medical Research Council scale) between the total upper extremity motor score 
(UEMS) and the total lower extremity motor score (LEMS), in a minimum of five 
TCCS patients at the time of hospital admission. The mean difference between 
the total UEMS and the total LEMS of the patients included in each study was 
calculated. Case reports were excluded.
Results:	None of the identified studies on TCCS patients reported inclusion and/or 
exclusion criteria using a quantified difference between the UEMS and LEMS. Out 
of 30 retrieved studies, we identified seven different clinical descriptors that have 
been applied as TCCS diagnostic criteria. Nine studies reporting on a total of 312 
TCCS patients were eligible for analysis. The mean total UEMS was 10.5 motor 
points lower than the mean total LEMS.
Conclusions:	There is no consensus on the diagnostic criteria for TCCS. Nevertheless, 
this review revealed an average of 10 motor points between the UEMS and LEMS 
as a possible TCCS diagnostic criterion. However, further discussion by an expert 
panel will be required to establish definitive diagnostic criteria.
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Introduction
Traumatic central cord syndrome (TCCS) is a clinical diagnosis that was first 
described by Schneider et al. in 1954.1 TCCS is characterized by 1) a disproportionate 
impairment (weakness and reduced function) of the upper limbs as compared with 
the lower limbs, 2) neurogenic bladder dysfunction, and 3) varying degrees of sensory 
loss at and below the level of the lesion.1 A TCCS is considered the most prevalent 
incomplete spinal cord injury (SCI) syndrome, accounting for approximately 9% of 
all traumatic SCI’s.2, 3 In TCCS patients, recovery of a certain degree of ambulation, 
participation in daily life activities, bowel and bladder function has been reported to 
be favorable in several studies.2-10
TCCS also occurs frequently in elderly subjects due to rather minor spine 
trauma (hyperextension injury) based on underlying cervical spondylosis. The 
pathophysiological mechanisms inducing the TCCS are probably multi-modal. One 
hypothesis is that a spinal cord compression occurs between bony spurs anteriorly 
and buckling of the ligamentum flavum posteriorly.1, 11 This cord compression may 
cause direct damage of neural structures located in the central gray matter and/or 
attenuation of the segmental blood supply. These mechanisms affect the cervical 
enlargement at the levels of the alpha motor neurons supplying predominantly hand 
muscles and to a lesser extent fibers of the corticospinal tracts (CST). Such a pattern 
of injury that spares the descending CST’s but damages the alpha motor neurons 
is assumed to result in a syndrome of disproportionate arm and leg weakness.12 An 
alternative hypothesis is that the TCCS results from an injury to the CST’s. The 
CST tends to produce relatively greater dysfunction in the hand and arms than in 
the legs, as the main function of the CST is to support fine motor movements in the 
distal musculature, especially of the upper limbs.13, 14 
Since the introduction of the TCCS diagnostic criteria more than 5 decades 
ago, it has been one of the most frequently cited definitions of an incomplete SCI 
syndrome.3 However, the TCCS lacks uniform and broadly accepted diagnostic 
criteria. In other words, the diagnosis of TCCS is based on non-specific criteria and 
interpretation of physical examination. Therefore the utility of currently applied 
TCCS diagnostic criteria can be considered as limited. 
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The primary objective of this review was to investigate the current literature 
on applied TCCS diagnostic criteria. The secondary objective was to analyze the 
quantitative differences between the total UEMS’s and LEMS’s described in these 
original studies.
Methods
Retrieval	of	publications
All clinical studies reporting on TCCS were eligible for this review. Case-
reports were excluded in this review. 
A MEDLINE(PubMed interface) search was performed to compile a reference 
list of articles published between 1966 and November 2008 identified by the 
following key words: spinal cord injury, central cord syndrome, cruciate paralysis, 
incomplete SCI, spinal cord syndromes, ASIA motor score, LEMS, UEMS, and 
cervical spondylosis. Furthermore, the retrieved list of references was manually 
checked for additional studies potentially meeting the inclusion criteria. 
Analysis	of	applied	TCCS	diagnostic	criteria	
All retrieved original studies reporting on TCCS patients, irrespective of 
whether the total UEMS and LEMS were reported, were analyzed with regard to 
the TCCS diagnostic criteria applied. All descriptors used to define the TCCS were 
extracted from the included articles.  
Analysis	of	scores	
In order to calculate the mean difference between the total UEMS and 
total LEMS, we included only original studies that reported on the total UEMS 
and total LEMS (based on the Medical Research Council scale), for a minimum 
of 5 TCCS patients, upon their admission to the hospital. Each study’s reported 
difference between the total UEMS and LEMS in TCCS patients was recorded to 
identify which difference in motor loss the authors regarded as a ‘disproportionate 
impairment of the upper limbs as compared with the lower limbs’. To calculate 
these ‘disproportionate’ differences, the mean differences between the total UEMS 
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and LEMS were multiplied by the number of patients reported in each study. These 
numbers were added and divided by the total number of pooled patients. 
Table 1: 
Details of the TCCS diagnostic criteria applied in of 30 retrieved articles.
Diagnostic criteria Number of  
articles included  
for analysis
Number of  
articles excluded 
from analysis
Disproportionate weakness of the UE compared with 
the LE, variable sensory loss, and bladder dysfunction. 39, 13, 23 56, 22, 31, 32, 41
Disproportionate weakness of the UE compared with 
the LE, variable sensory loss, bladder dysfunction and 
associated with sacral sparing. 124 0
Disproportionate weakness of the UE compared with 
the LE and associated with sacral sparing. 111 125
Greater weakness of the UE than the LE and associated 
with sacral sparing. 0 215, 21
Greater weakness of the UE than the LE. 135 37, 29, 30
Symmetric motor impairment of the UE without motor 
weakness in the LE and associated with sacral sparing. 117 0
Symmetric incomplete tetraplegia. 0 127
None given. 233, 38 91, 3-5, 10, 28, 34, 36, 39
Total 9 21
Abbrevations: TCCS, traumatic central cord syndrome; UE, upper extremities; LE, lower extremities.
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Table 2: 
Studies included for analysis
Author Details of study 
 (sub) groups
Design Average ASIA 
motor score at  
admission
Difference 
between 
LEMS and UEMS
Tow et al.10 73 patients Retrospective 
study
UEMS 22.8                                   
LEMS  31.8
9 motor points
Newey et al.15 32 patients Retrospective  
study
UEMS 18                                  
LEMS  33.9                        
15.9 motor points
Collignon et al.16 18 patients Retrospective  
study
UEMS 32                                   
LEMS  42.3
10.3 motor points
Guest et al.17 50 patients Retrospective  
study
UEMS 24.8                                   
LEMS  34.9
10.1 motor points
Ishida et al.6 22  patients Prospective  
study
UEMS 32.2                                   
LEMS  50
17.8 motor points
Dvorak et al.5 70 patients Retrospective review with  
cross-sectional outcome analysis
UEMS 25.9                                   
LEMS  32.7
6.8 motor points
Song et al.18 23 patients Retrospective  
study
UEMS 29.3                                   
LEMS  42.7
13.4 motor points
Miranda et al.19 15 patients Retrospective study UEMS 32.6 
LEMS 41.2
8.6  motor points
Waters et al.20 9 patients Retrospective  
study
UEMS  7.3 
LEMS  18.4
11.1 motor points
Abbrevations: UEMS, upper extremity motor score; LEMS, lower extremity motor score
Results
Out of 177 articles from MEDLINE identified by the predefined key words, 
only 30 studies could be accepted after accounting for the inclusion/exclusion 
criteria. In these 30 articles, seven different clinical descriptors were provided that 
have been applied as criteria to diagnose TCCS (Table 1). 
As the UEMS and LEMS were not reported in TCCS patients, 21 studies1-4, 
7-9, 14, 21-33 were excluded in the analysis of the scores. Out of the 30 retrieved studies, 
nine studies5, 6, 10, 15-20 that reported the UEMS and LEMS at admission were included 
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in our analysis. In two articles6, 15, a scatter diagram6 and a bar graph15 were used to 
determine the UEMS and LEMS. An overview of the studies included for analysis 
is shown in Table 2. Furthermore, no study on TCCS patients was identified that 
reported inclusion and/or exclusion criteria using a quantified difference between 
the UEMS and LEMS.
Differences in motor scores between upper and lower extremities
Guest et al.17 investigated the neurological outcome in 50 patients who 
underwent early (≤ 24 hours after injury) or late (> 24 hours after injury) surgery. 
The pre-operative mean difference between the UEMS and LEMS of these 50 
patients was 10.1 motor points. Another retrospective study15 reported on the long-
term outcome in 32 conservatively treated patients with symptoms consistent with 
the TCCS. Patients were divided by age into 3 groups. In this study, the mean 
difference between the UEMS and LEMS of these three groups was 15.9 motor 
points.15 Tow et al.10 reported the UEMS and LEMS at admission in patients who 
were identified to have greater weakness of the upper than the lower extremities. In 
73 TCCS patients, a mean difference of nine motor points was identified. Another 
retrospective study5 assessed the improvement in ASIA motor score in 70 TCCS 
patients. This study5 identified a mean difference between the UEMS and LEMS of 
6.8 motor points. Waters et al.20 identified a mean difference between the UEMS 
and LEMS of 11.1 motor points in a prospective study reporting on nine patients 
with TCCS. The study by Ishida et al.6 examined neurological recovery in 22 TCCS 
patients. Only patients with an LEMS of 50 were included. The mean difference 
between the UEMS and LEMS in this study was 17.8 motor points.
Three studies16, 18, 19 evaluated the radiological findings in TCCS patients. In 
15 patients, Miranda et al.19 identified a mean difference between the UEMS and 
LEMS of 8.6 motor points. Collignon et al.16 performed a retrospective study of 18 
TCCS patients to assess the presence of intramedullary blood in the spinal cord. The 
mean difference identified between the UEMS and LEMS was 10.3 motor points. 
Another study18 evaluated the value of radiological findings in 23 TCCS patients. 
We identified a mean difference between the UEMS and LEMS of 13.4 motor 
points. 
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Analysis	 	
We calculated the mean difference between the total UEMS and total LEMS 
for the 9 studies depicted in Table 2. This analysis demonstrated that in 312 TCCS 
patients, the mean total UEMS was 10.5 (range 6.8-17.8) motor points lower than 
the mean total LEMS. 
Discussion
In this review, seven different descriptors to define the TCCS were identified 
among 30 retrieved articles. Furthermore, no study on TCCS patients reported 
inclusion and/or exclusion criteria regarding a quantified difference between the 
UEMS and LEMS. Our analysis showed that out of the 312 pooled subjects with 
TCCS, the mean total UEMS was approximately 10 motor points lower than the 
mean total LEMS. 
The currently applied TCCS diagnostic criteria can be interpreted broadly, 
so that patients with incomplete tetraplegia are diagnosed with TCCS and vice 
versa. As quantified, diagnostic criteria for TCCS are lacking, and the incidence of 
TCCS can be expected to increase in SCI patients older than 60 years34. Thus, it is 
necessary to define not only univocal TCCS diagnostic criteria, but also a quantified 
difference between the UEMS and LEMS. 
Quantifying the term ‘disproportionate’ to a specific minimum of motor points 
could lead to a more adequate and reliable TCCS diagnosis. In addition, TCCS 
diagnostic criteria would also be valuable for research purposes. If quantified TCCS 
diagnostic criteria are applied, investigators would be able to stratify and constrain 
the heterogeneity of SCI patient samples. This is important, since TCCS patients 
probably have a favorable recovery pattern compared with incomplete tetraplegia.2-10 
In future SCI trials, analyzing outcome data for TCCS patients as a separate group 
could be important for a more sensitive detection of treatment effects. 
Although Schneider et al.1 reported bladder dysfunction to be a characteristic 
of TCCS, the International Standards for Neurological and Functional Classification 
of Spinal Cord Injury Patients35 did not include the presence of bladder dysfunction 
as a diagnostic criterion for TCCS. Therefore, the analysis of the scores in our review 
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has been focused on the difference between the total UEMS and the total LEMS. 
As a “disproportionate” weakness of the arms with better (or normal) strength 
in the legs can occur in both TCCS and cruciate paralysis36, 37, we also searched for 
articles in which patients with cruciate paralysis were described. Cruciate paralysis is 
characterized by an isolated injury to the cervicomedullary junction that results in 
paralysis of the arms with minimal or absent lower extremity involvement.37, 38 The 
pathophysiology is based on neuroanatomy: the motor tract of the upper extremities 
crosses rostrally in the cervicomedullary junction, whereas that of the lower 
extremities crosses caudally in the superior cervical spinal cord.37, 39, 40 Despite the 
fact that TCCS and cruciate paralysis have been reported separately in the literature, 
it is suggested that both syndromes are expressions of the same mechanism rather 
than two separate entities based on damage to the pyramidal crossing arm fibers.40 
Since the clinical presentations of TCCS and cruciate paralysis are comparable and 
we were only interested in the quantitative details of the difference between the 
upper and lower extremity motor scores, TCCS and cruciate paralysis were grouped 
in our analysis.36
In one of our previous studies41, we decided to define TCCS as a total LEMS 
of 10 or more points higher than the total UEMS. Although no study was identified 
that reported inclusion and/or exclusion criteria using a quantified difference 
between the UEMS and LEMS, Hayes et al.25 described an approach to classify 
patients with incomplete SCI according to SCI syndromes. In this study25, the 
choice was made to diagnose TCCS based on a total LEMS of five or more points 
higher than the total UEMS. However, both proposals were arbitrary and had not 
been validated previously.25, 41
Conclusion
To our knowledge, no study on TCCS patients reported inclusion and/or 
exclusion criteria using a quantified difference between the UEMS and LEMS. In 
addition, seven different clinical descriptors were identified that have been applied 
as criteria to diagnose TCCS. This study is a first attempt to provide a quantified 
approach to determine whether an incomplete SCI can be labeled as TCCS. Our 
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analysis showed that out of the 312 pooled subjects with TCCS, the mean total 
UEMS was approximately 10 motor points lower than the mean total LEMS.
Further discussion by an expert panel will be required to establish definitive 
diagnostic criteria for TCCS.
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Abstract
Study	design:	A questionnaire survey.
Background:	To evaluate the need for the introduction of quantitative diagnostic 
criteria for the traumatic central cord syndrome (TCCS).
Methods:	An invitation to participate in an eight-item online survey questionnaire 
was sent to surgeon members of AOSpine International.
Results:	Out of 3340 invited professionals, 157 surgeons (5%) from 41 countries 
completed the survey. Whereas most of the respondents (75%) described greater 
impairment of the upper extremities than of the lower extremities in their own 
TCCS definitions, symptoms such as sensory deficit (39%) and bladder dysfunctions 
(24%) were reported less frequently. Initially, any difference in motor strength 
between the upper and lower extremities was considered most frequently (23%) as 
a ‘disproportionate’ difference in power. However, after presenting literature review 
findings, the majority of surgeons (61%) considered a proposed difference of at least 
10 points of power (based on the Medical Research Council scale) in favour of the 
lower extremities as an acceptable cutoff criterion for a diagnosis of TCCS. Most of 
the participants (40%) felt that applying a single criterion to the diagnosis of TCCS 
is insufficient for research purposes.
Conclusions:	Various definitions of TCCS were used by physicians involved in the 
spinal trauma care.
The authors consider a difference of at least 10 motor score points between upper and 
lower extremity power a clear diagnostic criterion. For clinical research purposes, this 
diagnostic criterion can be considered as a face valid addendum to the commonly 
applied TCCS definition as introduced by Schneider et al.
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Introduction
In 1954, Schneider and colleagues were the first to describe “a	 syndrome	
that	 suggests	 central	 cervical	 spinal	 cord	 involvement”. This condition is now better 
known as traumatic central cord syndrome (TCCS).1 TCCS is characterized by 1) 
disproportionately	more	motor	impairment	of	the	upper	than	of	the	lower	extremities,	
2)	 bladder	 dysfunction,	 usually	 urinary	 retention,	 and	 3)	 varying	 degrees	 of	 sensory	
loss	 below	 the	 level	 of	 the	 lesion.1 Occurring mainly in elderly patients who have 
sustained a cervical hyperextension injury, TCCS has been reported to be the most 
common spinal cord injury (SCI) syndrome, accounting for approximately 9% of 
all traumatic SCI’s.2-4
Despite its frequency, uniform and globally accepted diagnostic criteria of 
TCCS are lacking. In the first of this two-paper series, we concluded that a variety of 
definitions had been applied in the original studies reporting on TCCS.5 Interestingly, 
none of the referenced studies provided specific neurological or functional eligibility 
criteria. A pragmatic analysis of pooled TCCS patients showed that, based on the 
Medical Research Council scale, the mean difference between strength of the upper 
and lower extremities was 10.5 motor score points in favor of the lower extremities.5
The introduction of quantitative diagnostic criteria allows clinicians to report on 
a more homogeneous, well-defined group of patients suffering TCCS. A minimum 
difference in strength between upper and lower extremities as proposed in part	1 may 
assist in  distinguishing TCCS from other forms of incomplete tetraplegia. From 
one perspective, a diagnostic criterion based on a difference in motor strength alone 
may be seen as over-simplistic and that associated symptoms need consideration. 
Furthermore, the introduction of quantitative diagnostic TCCS criteria may be 
considered unnecessary due to a lack of impact on treatment decision-making.
To investigate the hypothetical tension between 1) the variety of applied 
diagnostic TCCS criteria among physicians, 2) the reduction of diagnostic 
parameters and 3) the clinical relevance of the TCCS diagnosis, we developed a 
questionnaire survey. The primary objective of this survey was to evaluate the need 
for the introduction of quantitative diagnostic criteria of TCCS among physicians 
involved in spinal trauma care and research. The secondary objective was to evaluate 
the face validity of the diagnostic criterion of a minimum difference of 10 motor 
score points between the upper and lower extremity power.5
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Material & Methods
At the annual meeting of the European multicenter study of human SCI (EM-
SCI) network in Prague, Czech on July 3 2009, the results of part	1 of this two-paper 
series were presented and discussed.5 During this session several neurological reports 
of incomplete traumatic tetraplegic patients were also evaluated and discussed. It 
became clear that even among the scientifically active EM-SCI network, a variety of 
interpretations of TCCS existed. This led us to the development of the questions of 
the current study. An interactive pilot questionnaire survey was created and a group 
of 22 participants of the 48th International Spinal Cord Society (ISCoS) annual 
scientific meeting in Florence, October 21-24 2009, were found to participate. 
Based on the answers, comments and suggestions of these 22 participants a 
definitive online survey version was created using Quizmaker ‘09 (Articulate®, New 
York, NY). The survey items and questions are presented in Table	1A. Each question 
was presented on a separate webpage. The ‘browse backward’-option was disabled to 
prevent participants from correcting earlier answers based on additional information 
provided in following questions.
To reach a large number of specialists in spinal trauma care, we contacted 
the secretary of the AOSpine Research Commission. The AOSpine community 
is an established organization with a considerable number of orthopaedic- and 
neurosurgeons actively involved in the diagnosis, treatment and study of SCI. On 
December 10, 2009 an invitation to participate in the online questionnaire survey 
was sent to  AOSpine community members. The website of the online survey was 
closed at December 31 2009. Data concerning physicians’ specialties was extracted 
from the membership databases. Prior to the data analysis, answers to open-ended 
questions were re-coded independently by two reviewers (JJvM, MHP). The data 
were entered into spreadsheets and in Excel (Microsoft®, Office Excel 2003) for 
descriptive analysis.
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Table 1
A: Survey items and questions. B: Survey answers of   
 156 spine specialists 
 (in percentages).
Survey items  
and questions
Possible 
answers
% Yes/ 
Agree
% No/ 
Disagree
% No 
opinion 
Intro Introduction of the survey and explanation of 
research objectives
- -
1 What is your applied definition of the Trauma-
tic Central Cord Syndrome?
Essay See Table 
2.
2 Are you satisfied with this definition for clinical 
purposes and communication?
Yes, No*, 
No opinion
71 20 9
3 From a scientific point of view: Do you agree 
that diagnostic criteria for a TCCS are needed 
for future clinical studies? (To define clear 
eligibility criteria, for instance.)
Agree, Dis-
agree*, No 
opinion
95 4 1
4 If answer question 3 was Agree; Which diag-
nostic item(s) and (cut-off) criteria should then 
be applied for a TCCS?
Essay See text.
Inter-
mezzo 1
Quotation of  TCCS definition as introduced 
by Schneider and colleagues.1
- -
5 What do you consider as a disproportionate 
difference of motor loss? In other words; with 
use of the UEMS and LEMS, how would you 
standardize or quantify this difference.
Essay See Table 
3.
See Table 
3.
Inter-
mezzo 2
Brief summary of the methods & results of 
part 1 including a quotation of proposed 
diagnostic TCCS criterion:5
“Patients can be classified as having a TCCS 
if the total LEMS is 10 or more points higher 
than the total UEMS.”
6 Do you think that a minimum difference of 10 
motor points is an acceptable cut-off criterion 
to differentiate between TCCS and non-TCCS 
patients?
Yes, No*, 
No opinion
61 24 15
7 Do you think this approach is a too much 
simplified one for research purposes?
Yes*, No, 
No opinion
40 36 24
8 Do you agree that TCCS patients have a favo-
rable prognosis with regard to the neurological 
and/or functional recovery compared to non-
TCCS incomplete tetraplegic patients?
Agree,  
Disagree, 
No opinion
76 16 8
Symbols & Abbreviations: *: Selection of this answer was followed by an additional question asking for an additio-
nal explanation or motivation. TCCS: Traumatic Central Cord Syndrome. UEMS: Upper Extremity Motor Score, LEMS: 
Lower Extremity Motor Score. (Both according to the ASIA International Standards for Neurological Classification of 
Spinal Cord Injury.6)
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Table 2:
Descriptive items included in the personal TCCS definitions applied by the 157 survey 
participants
Descriptive item  N % 
Neurological & Functional deficits
Neurological deficit 143 91
- UE’s more affected than LE’s 113 72
- Motor deficit 89 57
- Sensory deficit 61 39
- Level of injury: Cervical or upper Thoracic 45 29
- Sacral sparing: Incomplete SCI 25 16
- Motor deficit more predominant than sensory deficit 1 1
     
Functional deficit of extremities 6 4
 - UE’s more affected than LE’s 5 3
Bladder dysfunction 37 24
Bowel dysfunction 0 -
Other descriptives     
Neuro-anatomy of affected structures spinal cord 31 20
Injury mechanism 29 18
Pre-existent stenotic, spondylotic spinal canal 23 15
Associated spinal column injury 13 8
Age of patients 11 7
Findings discerned from spinal cord imaging 10 6
Prognosis 3 2
Spinal cord ischemia 2 1
Symmetrical neurological deficit 2 1
Abbreviations: UE’s: Upper extremities, LE’s: Lower extremities.
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Figure 1:
Geographical distribution of the 157 survey responders.
Results
Characteristics	of	Responders.
An invitation to participate in the questionnaire survey was sent to 3340 
professionals. Complete responses were received from 156 professionals (5% 
response rate), including 62 (39%) orthopaedic surgeons, 47 (30%) spine surgeons, 
43 (27%) neurosurgeons and 5 (3%) residents orthopaedic surgery. The respondents 
represented 41 countries from all 6 major regions of the world (Figure	 1). Fifty 
(32%) of all respondents were from Europe, and 31% and 22% were from Asia and 
Latin America, respectively. The mean duration of participants’ experience in the 
clinical field of SCI was 9.1 years (range 1-29 years) with 95 surgeons (61%) having 
a minimum of 5 years of experience.
Applied	TCCS	definitions	(Question	1)
A wide variety of answers were given to the question “What	is	your	definition	of	
Traumatic	Central	Cord	Syndrome?” (Table	2). The majority of respondents included 
neurological (91%) and/or functional (4%) impairment in their definition. Most 
of the physicians (75%) described the typical disproportionate upper limb motor 
Number of participants
per continent
Europe 50
Asia 48
Latin America 34
North America 19
Oceania 4
Africa 2 5
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loss. Less than half of the respondents included sensory deficit (39%) or bladder 
dysfunction (24%) as symptoms of  TCCS. Only 36 physicians (23%) described all 
three classical features of the TCCS as defined by Schneider and colleagues.1
Other common patient characteristics were documented as well as neurological 
and functional signs and symptoms associated with TCCS. Approximately 15% of 
respondents described the elderly patient with a pre-existent stenotic, spondylotic 
spinal canal sustaining a hyperextension injury as being at highest risk for TCCS. 
A minority of physicians applied neuro-anatomical explanatory descriptives (20%; 
e.g., “affected	 corticospinal	 tracts” ) and the anticipated findings of spinal cord 
imaging (6%; e.g., “intramedullary	 high-signal	 intensity	 on	 Magnetic	 Resonance	
Imaging	(MRI)”) as essential items in the definition of TCCS (Table	2). 
Need	for	diagnostic	TCCS	criteria	(Questions	2,	3	&	4)
With regard to clinical practice, communication and treatment decision-
making, the majority of  surgeons (71%) considered their own TCCS definition 
satisfactory (Table	 1B). Of the remaining surgeons, 32 (20%) were not satisfied 
with their current definition. Referring to the ‘Schneider definition’, 22 physicians 
(14%) stated that the TCCS definition is an ambiguous one which is lacking in 
precision. Another stated reason for the lack of physician support for the current 
TCCS definition was a perceived lack of clinical relevance and utility (8%).
Even with physicians’ general acceptance of the clinical applicability of the 
TCCS definition (71%), the vast majority of respondents (95%) acknowledged the 
need for diagnostic criteria for research purposes. Physicians of this latter group 
were asked to provide the necessary diagnostic items for inclusion in such criteria. 
Although a wide variety of diagnostic items similar to answers provided in Question	
1 were proposed, none of the respondents suggested a specific cut-off criterion.
Disproportionate	difference	of	motor	loss	(Question	5)
As presented in Table	 3,	 physicians’ interpretation of the disproportionate 
difference of motor loss varied considerably. The interpretations of a disproportionate 
difference in strength as reported by the respondents can be categorized as 1) 
absolute or  2) proportionate difference between the UEMS and LEMS, and 3) a 
threshold difference of the manual muscle test (MMT) grades of the affected key 
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muscles between the upper (i.e. 0-2) and lower extremities (i.e. 3-5).6 Even within 
these approaches a variety of interpretations existed (Table	 3). Remarkably, any 
difference between the strength of the upper and lower extremities in favor of the 
lower extremities (23%) was frequently considered a disproportionate difference. 
Fifty-five physicians (35%) did not report their interpretation of a disproportionate 
difference and another 11 physicians (7%) continued reporting a ‘disproportionate 
difference’ without any further specification.
Diagnostic	TCCS	criterion	&	prognosis	(Questions	6,	7	&	8)
Respondents were asked their opinion of the diagnostic criterion of TCCS as 
proposed in the first of this two-paper series (Intermezzo	2,	Table	1A).5 The majority of 
physicians (61%) considered a minimal difference of 10 motor score points between 
the upper and lower extremities in favor of the lower extremities as an acceptable 
cut-off criterion for research purposes. Of the remaining surgeons, 23 (15%) had 
no opinion and 28 (24%) did not agree with the proposed diagnostic criterion and/
or cut-off level. Thirteen respondents (8%) of this latter group suggested applying 
a minimum difference of less than 10 motor score points between upper and lower 
limb power. In contrast, 4 respondents (3%) suggested a minimum difference of 
greater	than 10 points as a diagnostic criterion.
Physicians were also asked whether they agreed or disagreed that the proposed 
’10 motor score points difference’-approach is too simplistic to accurately identify 
TCCS patients for clinical trials. Where 57 respondents (36%) regarded this a 
valid approach, most respondents (40%) regarded this approach over-simplistic 
(Table	 1B). The latter group suggested that the following areas need also be 
covered by diagnostic criteria : findings of spinal cord imaging (11%); sensory 
deficit (4%); bladder dysfunction (4%); level of injury (3%); sacral sparing (3%); 
neurophysiological parameters (2%) and others. However, as in Question	4, none 
of the respondents suggested a specific cut-off criterion in combination with their 
proposed additional diagnostic item.
Finally, participants were asked their opinion of the prognosis of recovery in 
TCCS patients. Most of the participating surgeons (76%) held the opinion that 
TCCS had a favourable prognosis for neurological and/or functional recovery 
compared with non-TCCS incomplete tetraplegic patients (Table	1B).
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Table 3: 
Categories of interpretations of the disproportionateness1 of the greater motor impairment 
of the upper than of the lower extremities in TCCS patients as reported by the 156 survey 
participants.
Category N  % 
LEMS>UEMS - ≥15 points 5 3
LEMS>UEMS - ≥10 points 3 2
LEMS>UEMS - ≥5 points 3 2
LEMS>UEMS - ≥2 points 7 4
LEMS>UEMS - ≥1 point (ie. any difference) 36 23
     
LEMS>UEMS - ≥50% 3 2
LEMS>UEMS - ≥20% 2 1
LEMS>UEMS - ≥10% 1 1
LEMS>UEMS - ratio (NOS) 4 3
     
LEMS MMS grades 3-5 & UEMS MMS grades 0-2 7 4
Difference between AIS grades of UE’s & LE’s* 5 3
Functional deficits UE’s > LE’s (NOS) 4 3
Other suggestion 10 6
     
No suggestion 55 35
LEMS>UEMS – Disproportionate (NOS) 7 4
No need for diagnostic criteria 5 3
Abbreviations: *: Although this answer was provided, it is theoretically an impossible approach, UEMS: Upper 
Extremity Motor Score, LEMS: Lower Extremity Motor Score. (Both according to the ASIA International Standards for 
Neurological Classification of Spinal Cord Injury.6) NOS: Not otherwise specified, AIS: ASIA Impairment Scale, UE’s: 
Upper extremities, LE’s: Lower extremities.
Discussion
This survey study illustrates that a wide range of TCCS definitions are in 
use among physicians involved in spinal trauma care. Although the majority of 
the respondents apply their own TCCS definitions in clinical applications, most 
physicians agree on the need for more specific diagnostic criteria in the setting 
of research. The majority of physicians considered a difference in motor score of 
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at least 10 points as an acceptable cut-off criterion, however, the majority of the 
respondents also felt that applying a single criterion to the diagnosis of TCCS would 
be insufficiently accurate for clinical research purposes.
In the recent past, the historical paper of Schneider et al.1 has been challenged. 
Not only have the original descriptions of pathogenesis and neuro-anatomical basis 
of TCCS  been criticized,7-11 but optimal treatment of the condition has also been 
reappraised.3, 12-16 The current survey study challenges the ambiguity of the TCCS 
definition as introduced by Schneider and colleagues. Whereas several physicians 
assign a diagnosis of TCCS in SCI patients with only 1 motor score point lower 
in the upper extremities than in the lower extremities, other physicians consider 
subjects with a minimum difference of 15 points as TCCS patients. In part	1 we 
demonstrated that clinical researchers also apply a variety of approaches in assigning 
a diagnosis of TCCS.5 Obviously, a lack of uniform diagnostic criteria in clinical 
studies may limit the translational potential of results. 
In the most recent revision of the International Standards for Neurological 
Classification of Spinal Cord Injury (2002) the CCS is defined as “a	lesion,	occurring	
almost	exclusively	in	the	cervical	region,	that	produces	sacral	sensory	sparing	and	greater	
weakness	 in	the	upper	 limbs	than	in	the	 lower	 limbs.” Interestingly, items from the 
original ‘Schneider definition’ including bladder dysfunction and varying degrees 
of sensory loss have been omitted from this consensus-based definition. Concurrent 
findings of this study showed that the presence of sensory deficit and bladder 
dysfunction were reported as TCCS descriptives by only 39% and 24% respectively 
of this survey’s respondents,. From a practical point of view, distinguishing TCCS 
patients from other incomplete tetraplegics based on specific cut-off criteria for 
bladder dysfunction and varying degrees of sensory loss would be a difficult, if not 
impossible, task. However, since the Schneider definition is the most commonly 
reported definition of TCCS,5 we adhered to this definition by introducing a 
quantitative addendum to the description “disproportionately	more	motor	impairment	
of	the	upper	than	of	the	lower	extremities”.1 Approximately one out of ten respondents 
suggested the introduction of additional diagnostic criteria based on spinal cord 
imaging. Although clinically relevant correlations between acute phase MRI 
findings and neurological outcomes have been reported in SCI patients, no studies 
reporting significant correlation between MRI findings and initial neurological 
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examination results have been published to date.17-20 Nonetheless, as diagnostic 
imaging technology continues to evolve, future modification of SCI syndrome 
definitions may occur.
The clinical relevance of TCCS was questioned in 8% of the responses 
provided by surgeons. Indeed, from a neurological point of view, TCCS can be 
considered as tetraplegia with sparing of the sacral segments. Interestingly, 76% 
of the responding physicians had the opinion that TCCS patients have a better 
outlook than non-TCCS incomplete tetraplegic patients. Although strong evidence 
supporting this common opinion is currently missing, this finding clearly illustrates 
that - in terms of natural history - TCCS is considered a clinically relevant entity by 
the majority of surgeons.21 This finding is supported by a panel of SCI experts from 
the International Campaign for Cures of Spinal Cord Injury Paralysis (ICCP) who 
published four reference works appraising methodological issues for the conduct of 
clinical trials in SCI.22-24 Referring to higher spontaneous rates of overall sensory and 
motor recovery in TCCS, the expert panel considered TCCS subjects “not	being	the	
best	subjects	to	be	included	with	other	types	of	traumatic	SCI	during	a	Phase	1	or	Phase	
2	trial,	as	they	could	increase	the	variability	of	the	outcome	data”.24 To examine the 
hypothesis that TCCS subjects truly have a higher rate of neurological recovery, the 
use of a clear diagnostic criterion may be of great benefit.
To illustrate, in future clinical comparative studies incomplete tetraplegic 
patients may be stratified into three groups: 1) those with equal or less power in 
the lower limbs, 2) those with 1 to 9 points more power in the lower limbs, and 
3) those with 10 points or more power in the lower limbs compared to the upper 
limbs. If multiple studies would show that subjects in group 3 indeed do have higher 
spontaneous rates of overall recovery than those in group 1, then the assumptions 
of the majority of the responding surgeons and the ICCP expert panel would be 
confirmed. This in turn will justify a subsequent evaluation of the possibilities 
to adjust the currently proposed diagnostic criterion into a less conservative one 
(i.e., less than 10 points difference).25 Yet, if the hypothesis would be rejected, then 
the clinical relevance of the TCCS in terms of natural history and acute phase 
treatment-decision making should, again, be reappraised critically.3 These two 
scenarios clearly illustrate the importance of clear and unambiguous definitions for 
patient stratification in SCI research. A face valid, quantitative diagnostic criterion 
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as presented in this two-paper series may facilitate this patient selection.26
Although the majority of surgeons considered a difference of at least 10 points 
of power in favor of the lower extremities as an acceptable cut-off criterion for a 
diagnosis of  TCCS, several limitations to the proposed criterion require consideration. 
A substantial number of physicians (n=36, 23%) initially considered any difference 
of motor strength between the upper and lower extremities as a disproportionate 
difference. Furthermore, 13 respondents (8%) regarded the proposed minimum 
difference of 10 motor score points too high. From a clinical point of view, a 
difference of 1 motor score point between the upper and lower extremities does 
not reflect a ‘clinically significant’ difference in strength between TCCS and other 
incomplete tetraplegic subjects. The same can be said for the ‘proportional difference’ 
approach when applied in subjects with a more severe deficit in the lower limbs 
(e.g., UEMS/LEMS: 40/50 (=20%) compared to 16/20(=20%)). Nonetheless, as 
illustrated in Box	1, clinically evident TCCS subjects - in particular those with lower 
cervical level of injuries - may not be categorized as TCCS subjects by applying our 
proposed criterion. Although we did not find an identical case as presented in Box	1 
in the EM-SCI database (No.	traumatic	SCI	patients	>1000), we acknowledge that 
the proposed criterion is a somewhat conservative one lacking optimal (clinical) 
sensitivity. As outlined earlier, the use of our proposed diagnostic criterion in future 
studies would inevitably result in a selection of more outspoken TCCS patients 
compared to those patients described in studies included for review in part	 1.5 
Moreover, by applying our proposed criterion the proportion of quantitatively 
diagnosed TCCS subjects would be less in future studies. This may increase the risk 
of not detecting significant effects (type II error) in following comparative studies.23 
Hence, future clinical studies comparing the recovery of incomplete tetraplegic and 
TCCS patients should ideally be performed in large multicenter networks.
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Box 1: 
A theoretical case of a patient with traumatic incomplete tetraplegia: Is this a TCCS patient 
or not? (For additional explanation, see text.)
Myotomes Right Left Key muscles
C5 5 5 Elbow flexors
C6 5 5 Wrist extensors
C7 3 3 Elbow extensors
C8 2 2 Finger flexors (distal phalanx dig. III)
T1 1 1 Finger abductor (dig. V)
Total UEMS 32
L2 4 4 Hip flexors
L3 4 4 Knee extensors
L4 4 4 Ankle dorsiflexors
L5 4 4 Long toe extensors
S1 4 4 Ankle plantar flexors
Total LEMS 40
Another aspect that requires consideration is the timing of examination. It 
has been documented that the motor power returns earlier to the lower than to the 
upper limbs in TCCS patients.3 This means that the difference of motor strength 
between the upper and lower limbs increases during the initial phase of recovery. 
To illustrate, whereas the difference in power between the upper and lower limbs 
may be 8 points 24 hours post-injury (Box	1), this difference may be increased to 
10 or even more points one week after the injury. To improve the applicability of 
the proposed cut-off criterion for (acute) TCCS, we therefore suggest to extend the 
scientific applicability of the diagnostic criterion to the first 2 weeks post-injury.27 
Those patients who show both a difference of less than 10 points of power between 
C
ha
pt
er
 5
.2
5
119
the upper and lower extremities at the initial examination and this typical pattern 
of early (≤2 weeks) recovery – resulting in a difference of at least 10 points - may 
still be classified as TCCS subjects. We acknowledge that this standardization of 
timing is somewhat arbitrary. However, this indicative time frame may result in an 
increased sensitivity of the diagnostic criterion and also an improved homogeneity 
of future TCCS study populations. To gain more insight in the initial recovery 
patterns of incomplete tetraplegics and TCCS subjects, further descriptive studies 
are warranted.
In this survey a substantial number of surgeons described the elderly patient 
with a pre-existent stenotic, spondylotic spinal canal sustaining a hyperextension 
injury as being at highest risk for TCCS.1, 28 Several reports proposed the benefit of 
surgical treatment in elderly TCCS patients with a pre-existent degenerative cervical 
spine for the prevention of late neurological deterioration or progressive chronic 
myelopathy.2, 29, 30 This suggestion may shed a new light on the earlier mentioned 
clinical relevance of TCCS in the elderly. Nevertheless, no study evaluating the 
differences in pre-existent degenerative changes of the cervical spine and late onset 
neurological deterioration between elderly patients with incomplete tetraplegia and 
TCCS has been published to date. Also from this point of view well-conducted 
clinical studies comparing the recovery of incomplete tetraplegic and TCCS patients 
are warranted.
The main strength of this survey study is the large number of participating spine 
specialists from all over the world. Although the response rate was low, the sample 
size is relatively large. A possible explanation for the low response rate may be that 
not all AOSpine members are involved in spinal trauma care. Another limitation of 
the power of this survey’s finding is the absence of rehabilitation specialists. Although 
the ISCoS secretary was contacted at an early stage, the digital infrastructure of this 
organisation did not allow us to reach a large number of rehabilitation specialists. 
Nonetheless, a number of rehabilitation specialists were involved in development 
of the questionnaire and study design. Following previous questionnaire surveys 
in the field of SCI and spinal surgery, this survey study reinforces the notion that, 
by gathering experts’ opinions, a clear insight can be obtained into controversial 
issues.31-33 International scientific organizations like the AOSpine and ISCoS can 
play an important facilitating role in such important scientifically and clinically 
orientated collaborative research initiatives.
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Conclusion
This survey study found that a wide range of definitions of  TCCS exists among 
physicians involved in spinal trauma care. Although the majority of respondents 
expressed their desire to apply their own TCCS definitions in a clinical setting, most 
physicians agreed upon the need for more specific diagnostic criteria for scientific 
purposes. Based on the results of this two-paper series, the authors consider a 
difference of at least 10 motor score points between the upper and lower extremities 
a clear diagnostic criterion. Applying this additional diagnostic criterion in future 
SCI studies may result in more clearly defined patient samples and improved 
translational potential of results.
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Abstract
Study	design: Prospective multicenter cohort study.
 
Objectives:	To compare the neurological recovery and functional outcomes 
between traumatic central cord syndrome (TCCS) patients and motor incomplete 
tetraplegic patients.
Methods:	In 248 traumatic motor incomplete tetraplegics, initial phase (0–15 days) 
American Spinal Injury Association (ASIA) impairment grading, upper and lower 
extremity motor scores (UEMS and LEMS), upper and lower sensory scores and 
chronic phase (6 or 12 months) neurological outcomes were analyzed. In addition, 
chronic phase self-care and indoor mobility Spinal Cord Independence Measure 
(SCIM) items were studied. Tetraplegics were subdivided into three groups: (1) 
non-TCCS group (UEMS≥LEMS), (2) intermediate-TCCS group (UEMS=(1–9 
points)<LEMS) and (3) TCCS group (UEMS=(≥10 points)<LEMS). Student’s 
t-tests and w2-tests were applied.
Results:	A total of 89 non-TCCS subjects (AIS D, n=28), 62 int-TCCS (AIS D, 
n=43) and 97 TCCS (AIS D, n=80) subjects were analysed. Although minimal 
significant differences in chronic phase LEMS and UEMS outcomes were identified 
between TCCS and non-TCCS patients after stratification by the AIS grade, our 
data showed no significant differences in functional upper and lower extremity 
outcomes at 6 or 12 months post-injury.
Conclusion:	The AIS grading system, and not the diagnosis TCCS, continues to be 
the best available prognostic parameter for neurological and functional outcomes 
in motor incomplete tetraplegics. The authors recommend that for future outcome 
studies in motor incomplete tetraplegia, patients should not be selected based on, or 
stratified by, the diagnosis TCCS.
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Introduction
The traumatic central cord syndrome (TCCS) is a clinical diagnosis that was 
first described by Schneider et al. in 1954.1 The TCCS is characterized by: 1) a 
disproportionate impairment (weakness and reduced function) of the upper limbs 
compared with the lower limbs, 2) neurogenic bladder dysfunction, and 3) varying 
degrees of sensory loss at and below the level of lesion.1 Out of these three clinical 
characteristics, the first is generally considered to be the most typical and important 
one.2, 3 
It has been hypothesized that TCCS patients have a favourable recovery 
pattern compared to other motor incomplete tetraplegics.4-7 Although several 
studies have compared TCCS with other spinal cord injury syndromes, such 
as the Brown-Séquard Syndrome4, 8, 9, no study has compared the neurological 
and functional recovery between TCCS and other motor incomplete tetraplegic 
patients. The assumed superior recovery of TCCS patients has also been expressed 
by an international panel of SCI experts convened by the International Campaign 
for Cures of Spinal Cord Injury Paralysis (ICCP).10 
In the first two parts2, 3 of this three-paper series, we demonstrated that a 
wide variety of definitions of TCCS are employed among both researchers and 
physicians. In part 1, a pragmatic analysis of 312 pooled TCCS subjects included in 
previous studies showed that the average difference in motor strength between the 
upper extremity motor score (UEMS) and the lower extremity motor score (LEMS) 
was 10.5 points based on the Medical Research Council Scale (MRC).2 In part 2, 
a questionnaire survey among  physicians showed that the majority of physicians 
considered this difference in motor score of at least 10 points as an acceptable cut-
off criterion for scientific purposes. Nonetheless, there were a number of physicians 
who favoured assigning the diagnosis TCCS in SCI patients with 1-9 motor points 
difference between the UEMS and LEMS.3 
The introduction of the diagnostic TCCS criterion in part 2 of this three-
paper series, ie. ‘a minimal difference of 10 motor score points between the upper 
and lower extremities, in favor of the lower extremities’, enabled us to investigate 
the hypothesized differences in recovery patterns between subgroups of motor 
incomplete tetraplegics with use of a face valid and reproducible criterion. The 
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objective of this study therefore was to compare the neurological recovery and 
functional outcomes between motor incomplete tetraplegic patients with 1) equal 
or less motor strength in the lower extremities (non-TCCS), 2) 1 to 9 motor points 
more in the lower extremities (intermediate TCCS), and 3) 10 motor points or 
more in the lower extremities compared to the upper extremities (TCCS).
Materials and Methods
Eighteen European SCI centres prospectively collected clinical data of complete 
and incomplete traumatic SCI patients between 2002 and 2009. Patients referred to 
one of the 18 SCI centers were enrolled consecutively into the European Multicenter 
Study on Human Spinal Cord Injury (EM-SCI; www.emsci.org) database. The data 
are gathered to establish a multicenter basis for future therapeutic interventions 
in human spinal cord injury. Data within the EM-SCI are collected at five time 
intervals: at the initial phase (ie. within the first 15 days post injury) and 1, 3, 6 and 
12 months after the injury. Clinical assessments in the EM-SCI are conducted by 
trained neurological and rehabilitation physicians having at least 1-year experience 
in examining patients with SCI. The study protocols were approved by the local 
ethics committees and the subjects gave their informed consent before entering the 
study protocol.
Study population
Patients were included in the study if they had a motor incomplete traumatic 
tetraplegia (C2-T1) injury (ASIA Impairment Scale (AIS) C or D)11 assessed within 
the first two weeks post-injury. The motor incomplete tetraplegia were subdivided 
into three study groups: 1) patients with equal or less MRC points in the LEMS 
compared to the UEMS (non-TCCS group), 2) patients with 1 to 9 points more 
in the LEMS compared to the UEMS (intermediate or int-TCCS group), and 3) 
patients with 10 points or more in the LEMS compared to the UEMS (TCCS 
group).3 
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Patients with a severe cognitive impairment, peripheral nerve lesion, incomplete 
database record, non-traumatic spinal cord lesion, polyneuropathy, or craniocerebral 
injury were not included. Accompanying polyneuropathy independent of SCI was 
excluded by medical history and by means of measuring the ulnar and tibial nerve 
conduction velocity. 
Neurological examination
Neurological examinations were conducted according to the International 
Standards for the Neurological Classification of Spinal Cord Injury (ISNCSCI) 
and the extent of incomplete tetraplegia was graded by ASIA Impairment Scale 
(AIS).12 Only patients with completely conducted neurological examinations within 
the first two weeks post-injury were included for analysis. The scores of the UEMS 
and the LEMS were calculated. Each of the two motor score subscales consist of a 
total of 5 bilateral key muscles innervated by myotomes C5-T1 (UEMS) and L2-
S1 (LEMS).12 To evaluate the sensory scores of the upper and lower extremities we 
subdivided and calculated the light touch and pin-prick scores into upper scores 
(dermatomes C4-T1) and lower scores (dermatomes L1-S4-5). The level of injury 
and AIS were determined based on the ASIA protocol. 
Functional outcomes
The Spinal Cord Independence Measure (SCIM) is an instrument that focuses 
on performing everyday tasks, and captures the disability as well as the impact of 
disability on the patient’s overall medical condition and comfort.13 The SCIM II14, 
15 consists of three main categories, namely, 1) self-care, 2) respiration and sphincter 
management, and 3) mobility. The functional outcomes in the chronic phase 
focused on the self-care items that test upper extremity function (SCIM II items 1, 
2a, 3a, and 4) and ambulation using the mobility indoors (SCIM II item 12). This 
approach of testing ambulation by using mobility indoors, has been applied in a 
previous study.16 
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In addition, the SCIM scores of items 1, 2a, 3a, 4, and 12 were converted to 
dichotomous outcomes, i.e. able to perform the function independently or not. 
Patients who needed fully assisted oral feeding, a gastrostomy, parenteral feeding or 
were able to eat  food but unable to hold a cup, were scored as dependent “feeding” 
group (SCIM II item 1). Patients who required total or partial assistance in upper-
body bathing, were scored as dependent “upper-body bathing” group (SCIM II 
item 2a). Patients who required total or partial assistance in upper-body dressing, 
were scored as dependent “upper-body dressing” group (SCIM II item 3a). Patients 
who required total assistance, performed only one task or performed some tasks 
using adaptive devices but needed help to put on/take off devices, were scored 
as dependent “grooming” group (SCIM II item 4). Patients who required total 
assistance for their mobility, partial assistance to operate a manual wheelchair, a 
manual wheelchair without assistance or supervision while walking, were grouped 
and scored as dependent “mobility indoors” group (SCIM II item 12). 
Statistics
Descriptive statistics on age, gender, and AIS were used to provide general 
information about the study population. Analyses on AIS, gender (χ2 analysis), and 
age (student’s t-test) were performed to identify possible differences between the 
three study groups.
We performed three main analyses on the study groups (see figure 1). The first 
analysis was performed to demonstrate neurological impairment of motor incomplete 
tetraplegics as assessed within the first 2 weeks post-injury (‘initial descriptive 
analysis’). The second analysis was performed to demonstrate any differences between 
initial neurological findings (<15 days post-injury) and neurological and functional 
outcomes (6 or 12 months post-injury) in incomplete tetraplegic patients (‘outcome 
analysis’). Finally, those patients with a complete set of follow-up measurements 
(1, 3, and 6 or 12 months) were analysed to demonstrate the neurological recovery 
over time (’longitudinal analysis’). In both the “outcome analysis” and “longitudinal 
analysis”, 6-months follow-up measurements were used for analysis in patients with 
missing chronic phase (12 months) follow-up measurements.17, 18
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Differences in mean ASIA scores between the three study groups were calculated 
using student’s t-tests. The differences in the number of patients who were capable 
of performing the SCIM II items 1, 2a, 3a, or 4 independently were calculated using 
chi-square or Fisher’s exact tests as appropriate between the three study groups. The 
differences were considered statistically significant at p<0.05. Spearman correlation 
coefficients (SCC) were calculated for comparisons between 6 and 12 months 
UEMS and LEMS outcomes in the “outcome analysis”. In addition, the agreement 
between the 6 and 12 months outcomes of the dichotomous SCIM scores were 
calculated using kappa statistic (κ). Data were analysed using SPSS software (version 
16.0, SPSS, Chicago, IL).
Results
Among the 1733 traumatic SCI patients within the EM-SCI database, 248 
(14%) met the study inclusion criteria, see figure 1. Of the 248 patients, there 
were 89 (36%) non-TCCS patients, 62 (25%) int-TCCS and 97 (39%) TCCS 
patients. The patient characteristics of each study group are presented in table 1. 
The non-TCCS group consisted of a significantly higher proportion of AIS grade C 
patients compared to patients in both the int-TCCS and TCCS groups (p<0.001). 
Conversely, the int-TCCS and TCCS group consisted of a significantly higher 
proportion of AIS grade D patients compared to patients in the non-TCCS group 
(p<0.001). Since the number of subjects with an AIS grade C and D appeared not 
to be equally distributed within the three study groups, we decided to stratify each 
study group by the AIS grading system in all of the three main analyses. Thus, in 
each of the three study groups two additional subgroups, consisting of AIS grade 
C and D patients, were evaluated. No significant differences in age were identified 
between the subgroups after stratification by the AIS grading system. In addition, 
the analysis within every subgroup showed no differences in age between AIS grade 
C and AIS grade D patients.
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Initial descriptive analysis
The neurological measurements assessed within the first 2 weeks post-injury 
were available in 248 motor incomplete tetraplegics. In the majority of the patients 
(72%) the NLI was situated at level C4 or C5 (see table 2). Only four motor 
incomplete tetraplegics (2%) had a NLI caudal to level C6. Table 2 clearly illustrates 
that stratification by the AIS grading system has a bigger impact on the mean UEMS 
at each NLI compared to the categorization by the TCCS descriptors. Nonetheless, 
compared to non-TCCS subjects, TCCS subjects had lower UEMS’s at each NLI 
within both the AIS grade C and D strata. A clear association between a more caudal 
NLI and higher UEMS scores was not identified. Because of the small sample sizes, 
some of the descriptive associations were not tested statistically..
Table 3 covers the initial neurological subscores of the motor incomplete 
tetraplegics. Compared to the mean UEMS of 22.2 in TCCS subjects, the initial 
UEMS in non-TCCS and int-TCCS groups, was significantly higher (25.9 (p=0.032) 
and (28.8 (p=0.001), respectively). Compared to the mean LEMS of 40.6 in TCCS 
subjects, the initial LEMS in non-TCCS and int-TCCS groups, was significantly 
lower (11.2 (p<0.001) and 33.0 (p<0.001), respectively). The differences in UEMS 
and LEMS hold true also after stratification by the AIS grading system.
With regard to the initial upper extremity sensory scores, no statistically 
significant differences were observed between the three study groups (see table 
3). Compared to AIS grade C non-TCCS patients, AIS grade C TCCS subjects 
had significantly higher pin-prick scores for the lower extremities (p<0.05). This 
difference was not observed in the light touch sensation scores in AIS grade C 
patients. Compared to AIS grade D non-TCCS patients, AIS grade D TCCS 
subjects had significantly higher pin-prick and light touch scores for the lower 
extremities (p<0.05). 
Outcome analysis
 
A complete record of 12 months post-injury neurological and functional 
measurements was available in 121 patients (49%). In 21 patients (9%) with 
C
ha
pt
er
 5
.3
5
133
absent 12 months post-injury neurological and/or functional measurements, 
6-months follow-up measurements were available and used for analysis. The detailed 
distribution of available 6 and 12 months UEMS/LEMS measurements among 
the 142 motor tetraplegics are presented in webtable 1. Strong and significant 
correlations (p<0.001) were observed between 6 and 12 months UEMS (SCC: 
0.92), LEMS (SCC:0.89) and SCIM (κ:0.64-0.88) outcome measures in 102 
patients with complete 6 and 12 month measurements.
Upper	extremities	
Compared to the initial UEMS, the chronic phase UEMS improved 
considerably in all of the three study groups (see table 4). After stratification by the 
AIS grading system, the mean improvement of non-TCCS patients with an AIS 
grade C was 16 motor points. Compared to these non-TCCS patients, int-TCCS 
and TCCS patients with an AIS grade C had a significantly greater improvement of 
motor points in 6 or 12 months (25.2 (p<0.01) and 29.7 (p<0.001), respectively). 
In addition, with a mean improvement of 20.1 versus 10.0 motor points, AIS grade 
D TCCS patients gained significantly (p<0.001) more motor points than non-
TCCS AIS grade D patients. 
Except for a significant difference in AIS grade D patients (p=0.033), no 
significant differences were observed in the UEMS between the three study groups 
after 6 or 12 months (see table 4). However, when the AIS grade C and D strata were 
compared within each of the three study groups clear differences in neurological 
outcomes were found. On average, AIS grade C patients had approximately 10 
upper extremity motor points less in the chronic phase than AIS grade D patients.
 
Lower	extremities
As for the upper extremities, the LEMS also improved considerably over time 
in the three subgroups, especially in the non-TCCS patients (see table 5). After 
stratification by the AIS grading system, the mean improvement of non-TCCS 
patients with an AIS grade C was 26.1 motor points. Compared to these non-
TCCS patients, int-TCCS and TCCS patients with an AIS grade C had a non-
significantly different improvement of motor points in 6 or 12 months (26.2 and 
19.6, respectively). In addition, the mean improvement of non-TCCS patients with 
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an AIS grade D was 20.1 motor points. Compared to the non-TCCS patients, int-
TCCS and TCCS patients with an AIS grade D gained significantly less motor points 
in 6 or 12 months (9.8 (p<0.001) and 5.2 (p<0.001) motor points, respectively). 
However, after 6 or 12 months, non-TCCS patients had a significantly worse 
(p<0.001) LEMS compared to TCCS patients in the total subgroup. Nonetheless, 
after stratification by the AIS grading system, no differences were found between 
the AIS grade C patients of the three study groups. However, a significant mean 
difference of 3.2 motor points (p<0.001) was observed between AIS grade D non-
TCCS (LEMS: 45.4) and AIS grade D TCCS (LEMS: 48.6) patients.
 
Functional	outcomes
No clear differences were observed between the three study groups for upper-
extremity function. Although AIS grade C patients were more dependent in 
assistance in self-care components compared to AIS grade D patients within each of 
the three study groups, no significant differences were observed (see table 4).
For the ambulation outcomes, the non-TCCS group showed a significantly 
greater proportion of patients (p<0.001) unable to ambulate independently compared 
to the TCCS group. However, this statistical relation completely disappeared after 
stratification by the AIS grading system. While the majority of AIS grade D patients 
(>93%) were able to walk independently after 6 months post injury, approximately 
half of the AIS grade C patients were able to do so (see table 5).
Longitudinal analysis
A complete record of 12 months post-injury neurological and functional 
measurements was available in 95 patients (28%). In 16 patients (7%) with 
absent 12 months post-injury measurements, 6-months follow-up measurements 
were available and used for analysis. The detailed distribution of available 6 and 
12 months UEMS/LEMS measurements among the 111 motor tetraplegics are 
presented in webtable 2. In figure 2, the mean UEMS of each (stratified) study 
group is plotted against the timing of the follow-up assessment. After stratification 
by the AIS grading system, the three study groups are typically ordered from the 
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non-TCCS group with relatively high initial mean UEMS’s to the TCCS group 
with relatively low initial mean UEMS’s. It is only after 6 months to 1 year when 
neurological outcomes of the three study groups approach each other. Figure 2 also 
demonstrates that the relation between the AIS grades and neurological outcomes 
appears to be stronger than the relation between the three study groups (TCCS, int-
TCCS and non-TCCS) and neurological outcomes.
In figure 3, the mean LEMS of each (stratified) study group is plotted against 
the timing of the follow-up assessment. In contrast to figure 2, the three study 
groups are now typically ordered from the TCCS group with relatively high initial 
mean LEMS’s to the non-TCCS with relatively low initial mean LEMS’s. At three 
months post injury, the largest proportion of the total motor recovery was regained.
Neither in the mean UEMS, nor in the mean LEMS, were differences in 
recovery patterns found between the three study groups. 
 
Discussion
In contrast to the general assumption that TCCS patients have a favourable 
neurological and functional outcome compared with other motor incomplete 
tetraplegics, this study demonstrates that the neurological and functional outcomes 
in motor incomplete tetraplegia cannot be simply attributed to the presence or 
absence of TCCS. 
We found that the severity of the initial neurological deficit, as expressed by 
the AIS, has a stronger impact on the prognosis of neurological and functional 
outcomes than categorization into TCCS or not. The presented data confirm that 
TCCS subjects are likely to have a less severe neurological deficit and therefore 
are often categorized as AIS grade D patients on admission.4, 19-21  These findings 
show that most differences between TCCS and non-TCCS patients dissolve when 
stratified by AIS grade. While TCCS patients showed significantly higher rates of 
upper extremity motor strength recovery compared to non-TCCS patients, non-
TCCS patients showed significantly higher rates of lower extremity motor strength 
recovery. These differences can be easily explained by ceiling effects in neurological 
recovery after traumatic SCI. Based on our results, we recommend that future 
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outcome studies in patients with a traumatic motor incomplete tetraplegia use 
a stratification based on the AIS grading rather than the presence or absence of 
TCCS.10
In tetraplegic patients, recovery of arm and hand function is regarded as the 
most important clinical outcome.22 Although AIS grade D TCCS patients had 
significantly lower UEMS outcomes when compared to AIS grade D non-TCCS 
patients, no significant differences in the functional upper extremity independence 
were found between the two groups. Vice versa, whereas AIS grade D TCCS 
patients had significantly higher LEMS outcomes when compared to AIS grade 
D non-TCCS patients, no significant difference in independent ambulation was 
found between the two groups. Therefore, the clinical relevance of the only two 
identified statistical differences in outcomes between the non-TCCS and TCCS 
patient groups - after stratification by AIS grade - is minimal.
In 1996, Waters et al.23 suggested that the recovery of strength in TCCS 
patients is comparable to that of other motor incomplete tetraplegic patients. They 
concluded, however, that a lower proportion of the 9 TCCS patients were able to 
walk at least 150 feet compared to non-TCCS patients. The authors’ explanation 
for this unexpected finding was that the residual upper extremity weakness in TCCS 
patients restricted the use of assisted devices such as canes and crutches and therefore 
limited the ability to walk.23 In contrast, we found no differences in independent 
ambulation outcomes between TCCS patients and non-TCCS patients when 
stratified by AIS grades. The residual upper extremity weakness in TCCS patients 
therefore does not appear to have a negative influence on ambulation outcomes. In 
fact, the lower extremity strength outcomes in TCCS patients are comparable to, or 
even slightly better than in, non-TCCS patients.
Our results should be interpreted in the context of specific study limitations. 
Firstly, several putative confounders such as treatment regimens, including 
administration of methylprednisolone, blood pressure augmentation and urgent 
spinal cord decompression, are not standardized within the EM-SCI consortium. 
Secondly, co-morbidities, rehabilitation programs, and walking aids have not been 
registered in detail within the EM-SCI database. Thirdly, the small sample sizes in 
the three study groups resulted in limited statistical power of the analyses. Fourthly, 
as our study population was not corrected for other SCI syndromes, these other 
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syndromes could have been absorbed into either TCCS, non-TCCS or both. Hayes 
et al.19 reported that many SCI patients defy a clear-cut classification because of a 
mixed presentation of two or more SCI syndromes. It remains unclear what the 
influence of the other SCI syndromes is on the neurological and functional outcome. 
However, the second most common SCI syndrome, the Brown-Séquard syndrome4, 
showed a similar neurological and functional outcome when compared with other 
incomplete SCI patients.9, 24 Finally, although the use of dichotomized SCIM 
outcome measures could reduce the sensitivity of the analysis and has not yet been 
validated, the clinical relevance and utility of this method has been demonstrated in 
previous studies.16, 25 
The strength of this study is that, to our knowledge, it is the first one that 
stratified TCCS patients by applying a quantitative and reproducible TCCS 
diagnostic criterion. Until now the diagnosis of TCCS was based on non-specific 
criteria and subjective interpretation of the neurological examination.1, 11 In earlier 
publications (part 1 and 2), we proposed a minimum of 10 motor points in favour 
of the lower extremities to diagnose TCCS for research purposes.2, 3 However, among 
physicians, two points of discussion originated along with the introduction of this 
diagnostic criterion.
Firstly, a minimum difference of 10 motor points was considered to be too 
high to diagnose TCCS in patients with a lower cervical level of injury. As an 
interesting additional demographic finding, the current study found that motor 
incomplete tetraplegics with a lower cervical level of injury are rare. Out of 248 
patients, only four were diagnosed with a motor incomplete SCI at the NLI C7-T1. 
Therefore, the hypothesized limited (clinical) sensitivity of the TCCS criterion in 
patients with a lower cervical level of injury, as discussed in part 2, did not result in 
an underestimation of the number of TCCS subjects.
Secondly, a substantial number of physicians considered any (≥1 motor points) 
difference between upper and lower extremity strength as an appropriate criterion 
to diagnose patients with TCCS. Although a minimum of 10 motor points was 
supported by the majority of the physicians in part 2, we decided to evaluate the 
outcomes of the so-called intermediate TCCS patient group as well.3 Nevertheless, as 
no apparent clinically relevant differences in neurological and functional outcomes 
were found between the non-TCCS and TCCS study groups after stratification by 
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AIS grade C or D, investigation of the intermediate TCCS study group was not 
relevant.
In fact, the current study also challenges the scientific relevance of the applied 
diagnostic TCCS criterion itself. One should realize, however, that without the 
introduction of a face valid, quantitative and reproducible diagnostic TCCS 
criterion, we probably would not have been able to postulate and support the 
conclusions of this study. This three-paper series is unique in its kind because it 
evaluates, analyses and challenges the reproducibility and prognostic relevance of a 
commonly diagnosed SCI syndrome.4 This project clearly demonstrates that there is 
a need to revisit the scientific and clinical value of previously introduced concepts in 
SCI by applying a systematic and sound methodological approach.
Conclusion
The AIS grading system, and not the diagnosis TCCS, continues to be the 
most important prognostic parameter for neurological and functional outcomes in 
motor incomplete tetraplegics. Based on this study, in which a quantitative TCCS 
diagnostic criterion was applied, we recommend that for future outcome studies 
in traumatic motor incomplete tetraplegia, patients should not be stratified by the 
presence or absence of TCCS, but rather by the severity of the initial injury as 
quantified by the AIS grading system.
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Abstract
Study	design: Prospective multi-center cohort study.
Background:	 To compare the neurological and functional recovery between 
tetraplegic Brown-Séquard plus syndrome (BSPS) and incomplete tetraplegia (non-
BSPS).
Methods:	BSPS was defined as a traumatic incomplete spinal cord injury (SCI) with 
ipsilateral weakness and contralateral loss of pinprick sensation at neurologic levels 
C2–T1. Acute (0–15 days) and chronic phase (6 or 12 months) were assessed for the 
American Spinal Injury Association (ASIA) sensory scores, upper extremity motor 
scores and lower extremity motor scores. Furthermore, chronic phase scores of all 
Spinal Cord Independence Measure (SCIM) II items were analyzed. Differences 
in neurological and functional outcome between BSPS patients and non-BSPS 
patients were calculated using Student’s t-tests and Wilcoxon signed rank tests.
Results:	Out of 148 tetraplegic patients, 30 were diagnosed with BSPS. Patients with 
an ASIA impairment scale (AIS) B were significantly (P<0.001) more identified in 
non-BSPS patients (25%) compared with BSPS patients (3%), respectively. After 
12 months, the median scores for sphincter management of the bladder for both 
BSPS and non-BSPS patients were 15. Both 25 and 75% quartile median scores 
were 15 for BSPS patients and 12 and 15 for non-BSPS patients (P<0.02). Except 
for the difference in bladder function, no significant differences were identified in 
other SCIM II subitems and ASIA motor or sensory scores between BSPS and non-
BSPS patients when stratified for injury severity by excluding AIS B patients.
Conclusion:	Compared with incomplete tetraplegic patients, patients with cervical 
BSPS have a similar neurological and functional outcome when matched for the 
AIS.
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Introduction
The Brown-Séquard syndrome (BSS) is a syndrome consisting of ipsilateral 
upper motor neuron paralysis (hemiplegia) and loss of proprioception with 
contralateral pain and temperature sensation deficits.1 Common causes of BSS 
include penetrating trauma, syringomyelia, spinal neoplasms, disc herniation, spinal 
cord herniation, viral myelitis, or blunt injury.2-4
Most descriptions of a BSS, however, are less pure forms of the syndrome4, 
5, therefore a derivative has been introduced with the term Brown-Séquard-plus 
syndrome (BSPS).4, 6 BSPS is a spinal cord injury (SCI) with bilateral involvement of 
upper and/or lower extremities and is defined as an incomplete SCI syndrome with 
ipsilateral weakness and contralateral loss of pinprick and temperature sensation.4-6 
According to the International Standards for Neurological and Functional 
Classification of Spinal Cord Injury Patients, BSS is a syndrome that produces 
relatively greater ipsilateral proprioceptive and motor loss and contralateral loss 
of sensitivity to pain and temperature.7 The definition for BSS of the American 
Spinal Injury Association (ASIA) standards is essentially the same as BSPS concept 
and therefore leads to SCI patients being classified as BSS instead of BSPS. For 
example, several case reports8-10 described patients with BSS, however, the reported 
neurological examinations were not descriptions of the ‘classic’ BSS.1 According to 
Koehler et al.4, BSS should not be used in incomplete SCI patients with bilateral 
involvement of upper and/or lower extremities. 
The clinical and scientific relevance of incomplete tetraplegic patients being 
labeled as the not ‘classic’ BSS or BSPS therefore can be questioned. The reason 
for defining BSPS may be based on the assumption that patients with BSPS act 
differently than other incomplete tetraplegic patients with regard to neurological and 
functional outcome. To date however, there is no clear evidence for this assumption 
in the literature. 
The purpose of this study therefore is to compare the neurological and functional 
recovery between the tetraplegic BSPS and incomplete tetraplegic patients. 
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Materials and Methods
A total of 17 SCI centers prospectively collected information from complete 
and incomplete traumatic SCI patients between spring 2002 and summer 2008. 
Data in the European Multicenter Study on Human Spinal Cord Injury (EM-SCI; 
www.emsci.org) are assessed to establish a multi-center basis for future therapeutic 
interventions in human spinal cord injury. Data in the EM-SCI are collected at four 
time intervals: 1, 3, 6 and 12 months after the injury. Clinical assessments in the 
EM-SCI are conducted by certificated neurological and rehabilitation physicians 
having at least 1-year experience in examining patients with SCI.
Study population
Patients were included in the study if they had an incomplete traumatic SCI 
injury (ASIA impairment scale B, C or D)7 at neurologic levels C2-T1. The BSPS 
was defined as an incomplete syndrome with ipsilateral weakness and contralateral 
loss of pinprick sensation.4-6 Differences of >0 between left and right ASIA total 
motor and total sensory scores were considered asymmetric left-right neurological 
deficits. 
As we were only interested in the neurological and functional recovery of BSPS 
patients, ‘classic’ BSS patients were excluded. The definition that was used for a BSS: 
A syndrome consisting of ipsilateral upper motor neuron paralysis (hemiplegia) and 
loss of proprioception with contralateral pain sensation deficit.1 Patients with a 
severe cognitive impairment, peripheral nerve lesion, incomplete database record, 
non-traumatic spinal cord lesion, polyneuropathy, or craniocerebral injury were not 
included in the EM-SCI database. In patients where chronic phase (12 months) 
follow-up measurements were not recorded, the 6-months follow-up measurements 
were used for analysis.
The study protocols were approved by the local ethics committees and the 
subjects gave their informed consent before entering the study.
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Neurological outcomes
Neurological examinations were conducted according to the ASIA standards.11 
All patients with completely conducted acute phase examinations (within the first 
15 days after the injury), that is, the upper extremity motor score (UEMS), the lower 
extremity motor score (LEMS), ASIA pin prick score, and ASIA light touch scores 
were included for the analysis. On the basis of the ASIA sensory and motor scores, 
the neurological level of injury (NLI) and ASIA impairment scale (AIS) grade were 
defined. The acute phase and chronic phase were assessed for the total UEMS, the 
total LEMS, total ASIA pin prick scores, and total ASIA light touch scores in each 
patient during follow-up.
Functional outcomes
The Spinal Cord Independence Measure (SCIM) is an instrument that focuses 
on performing everyday tasks, and captures the disability as well as the impact of 
disability on the patient’s overall medical condition and comfort.12 The SCIM II13 
consists of three main categories, namely, 1) self-care, 2) respiration and sphincter 
management, and 3) mobility. The chronic phase were assessed for self-care (SCIM 
II items 1-4), respiration and sphincter management (SCIM II items 5-8), mobility 
in room and toilet (SCIM II items 9-11), and mobility indoors and outdoors (SCIM 
II items 12-16) in each patient during follow-up. 
Statistics
Descriptive statistics on age, gender, and AIS were used to provide general 
information of the study population. Subanalysis on NLI, AIS (χ2 analysis), and 
age (student’s t-test) was performed to identify possible differences between BSPS 
patients and other incomplete tetraplegia (non-BSPS patients).
The mean ASIA scores were calculated for the acute phase and chronic phase. The 
median SCIM II scores were calculated for the chronic phase. Differences in ASIA 
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scores and SCIM II scores between BSPS patients and non-BSPS patients were 
calculated using student’s t-tests and Wilcoxon signed rank tests, respectively. The 
differences were considered statistically significant at p < 0.05. Data were analyzed 
using SPSS software (version 16.0, SPSS, Chicago, IL).
Results
Among the 1365 traumatic SCI patients within the EM-SCI database, 228 
(17%) met the study criteria (see Figure 1). Follow-up SCIM II measurements and 
ASIA motor and sensory scores were available in 148 (65%) patients. The mean 
patient age at time of injury was 48 years (range: 15-88) and 23% were females. 
Acute phase AIS grades were B (n=31, 21%), C (n=47, 32%) and D (n=70, 47%). 
See table 1. 
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Table 1: 
Demographic Data of 148 patients
Characteristics BSPS non-BSPS
Subjects (no.) 30 118
Age, y, mean ± SD 47 ± 17 49 ± 19
Male (no.) 23 91
Left sided (no.) 14 37
NLI (no. and percentage)
C2 2 (7%) 3 (3%)
C3 0 12 (10%)
C4 14 (47%) 42 (36%)
C5 11 (37%) 43 (36%)
C6 3 (10%) 14 (12%)
C7 0 3 (3%)
C8 0 1 (1%)
T1 0 0
AIS (no. and percentage)
B 1 (3%) 30 (25%)
C 8 (27%) 39 (33%)
  D 21 (70%) 49 (42%)
Abbrevations: BSPS; Brown-Séquard-plus syndrome, non-BSPS; incomplete tetraplegia, NLI; neurological level of 
injury, AIS; ASIA impairment scale
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Figure 1:
Flowchart of patients in the EM-SCI database with subjects of patients eligible and included 
for analysis. Period of inclusion: January 2002 – October 2008 
Abbreviations: SCI; spinal cord injury, ASIA; American Spinal Injury Association, AIS; ASIA impairment scale, FU; 
follow-up 
Patients with 12 months 
FU measurements: 
n=125
Patients without 6 and 12 
months FU measurements: 
n=80
Patients with only 6 
months FU measurements:  
n=23
Analyzed patients:   
n=148
Included for 
analysis:
n=228
Eligible patients
for analysis:
n=877
Traumatic SCI patients: 
n=1365
Exclusion criteria:
1. AIS A: n=341
2. Paraplegia: n=147
No complete ASIA  
measurements at  
admission: n=649
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Fifty-two (4%) SCI patients were identified to have the BSPS. Of these 52 
BSPS patients, 7 (14%) subjects had 6 months and 23 (44%) subjects had 12 
months follow-up SCIM II measurements and ASIA motor and sensory scores. 
Non-BSPS was identified in 176 (13%) SCI patients. Of these 176 non-BSPS 
patients, 16 (9%) subjects had 6 months and 102 (58%) subjects had 12 months 
follow-up SCIM II measurements and ASIA motor and sensory scores. No SCI 
patient was identified to have a BSS (table 1).    
The range in difference in left and right ASIA total motor score at baseline and 
follow-up was 1-30 (mean 11.4; SD 9.8) and 0-25 (mean 4.0; SD 10.4), respectively. 
The range in difference in left and right ASIA pin prick scores at baseline and follow-
up was 1-24 (mean 8.4; SD 7.9) and 0-41 (mean 10.4; SD 5.6), respectively. 
Sub analysis identified no differences for age, NLI, AIS C, and AIS D between 
BSPS and non-BSPS patients. However, motor complete SCI’s (AIS B) were 
significantly (p<0.001) more identified in non-BSPS patients (n=30) compared 
with BSPS patients (n=1).    
In BSPS patients, the following subitems during the chronic phase showed 
significant differences compared with non-BSPS patients: bathing (upper body), 
grooming, sphincter management (bladder and bowel), use of toilet, mobility 
indoors, mobility for moderate distances, mobility outdoors, and transfers from 
wheelchair to car (table 2). In addition, BSPS patients had higher mean LEMS’s 
during the acute and chronic phase compared with non-BSPS patients (table 3).
Compared to 30 non-BSPS patients, only 1 BSPS patient was identified to 
have an AIS B (table 1). Therefore, after excluding AIS B subjects we repeated our 
analysis’s. Sub analysis identified no differences for the age, the AIS and the NLI 
between BSPS and non-BSPS patients. Except for sphincter management of the 
bladder (p<0.02), no significant differences in the other SCIM II subitems and 
ASIA motor or sensory scores were identified between 29 BSPS patients and 88 
non-BSPS patients. After 12 months, the median scores for sphincter management 
of the bladder for both BSPS and non-BSPS patients were 15. The 25% and 75% 
quartile median scores were both 15 for BSPS patients and 12 and 15 for non-BSPS 
patients.  
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Table 2: 
The SCIM scores in 30 cervical BSPS patients compared to 118 cervical non-BSPS patients 
after 12 months
BSPS non-
BSPS
SCIM II subitems Maximal 
score
Median Percentiles 
(25-75%)
Median Percentiles 
(25-75%)
P 
values
Self-Care
Feeding 4 4 (3-4) 4 (3-4) 0.108
Bathing (upper body) 3 3a (3-3) 3 (1-3) 0.008
Bathing (lower body) 3 3 (2-3) 3 (1-3) 0.067
Dressing (upper body) 3 3 (2-3) 3 (1-3) 0.312
Dressing (lower body) 3 3 (2-3) 3 (1-3) 0.103
Grooming 4 4a (4-4) 4 (3-4) 0.039
Respiration and  
sphinter management
Respiration  10 constantb constant 10 (10-10) 0.474
Sphincter management (bladder) 15 15a (15-15) 15 (4-15) 0.003
Sphincter management (bowel) 10 10a (10-10) 10 (5-10) 0.011
Use of toilet 5 5 (3.25-5) 4.5 (0-5) 0.039
Mobility (room and toilet)
Motion in bed and sore prevention 6 6 (6-6) 6 (2.75-6) 0.197
Transfers: bed-wheelchair 2 2 (2-2) 2 (1-2) 0.106
Transfers: wheelchair-toilet-tub 2 2 (2-2) 2 (1-2) 0.059
Mobility (indoors and outdoors)
Mobility indoors 8 8a (7-8) 8 (2-8) 0.015
Mobility for moderate distances 8 8 (7-8) 6 (2-8) 0.007
Mobility outdoors 8 8 (6.5-8) 5 (1-8) 0.005
Stair management 3 3 (2-3) 2 (0-3) 0.166
Transfers: wheelchair-car 3 3a (2.75-3) 3 (1-3) 0.034
Abbrevations: SCIM II; Spinal Cord Independence Measure II, BSPS; Brown-Séquard-plus syndrome, non-BSPS; 
incomplete tetraplegia
The numbers in bold indicate significant differences
a Statistically significant difference was seen although the median scores were equal  
b All patients had the maximal score
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Table 3: 
The ASIA scores in 30 cervical BSPS patients compared to 108 cervical non-BSPS patients
   
BSPS
 
non-BSPS
 
BSPS
 
non-BSPS
 
   
acute
 
acute
   
chronic
 
chronic
  
ASIA 
scores
Maximal 
score
Mean 95% 
CI
Mean 95% 
CI
P 
values
Mean 95% 
CI
Mean 95% 
CI
P 
values
Total 
UEMS
50 24.2 20.5-
27.8
22.8 20.4-
25.3
0.603 42.4 39.9-
44.9
38.7 36.7-
40.8
0.095
Total 
LEMS
50 29.0 23.1-
34.9
19.3 15.9-
22.8
0.012 43.2 38.7-
47.6
35.2 32.0-
38.4
0.021
Total 
Pin-Prick 
scores
112 67.8 58.2-
77.5
65.1 59.6-
70.6
0.649 79.5 72.3-
86.6
77.6 72.2-
82.9
0.733
Total 
Light-
Touch 
scores
112 83.0 74.5-
91.4
74.6 70.5-
78.7
0.072 90.1 83.3-
96.8
85.9 82.0-
89.9
0.339
Abbrevations: BSPS; Brown-Séquard-plus syndrome, non-BSPS; incomplete tetraplegia, UEMS; upper extremity 
motor score, LEMS; lower extremity motor score, 95% CI; 95% confidence interval 
The numbers in bold indicate significant differences
Discussion
In this study, we compared the differences in neurological and functional 
recovery between tetraplegic BSPS and non-BSPS patients and identified that 
patients with BSPS or non-BSPS have a similar neurological and functional recovery 
when matched for the AIS. 
Our results showed a favourable recovery of bathing of the upper body, 
grooming, sphincter management, use of toilet, mobility indoors and outdoors 
(SCIM II items 12-14 and item 16), and the LEMS in BSPS patients compared 
to other incomplete tetraplegic patients. All these significant differences became 
nonsignificant when the groups were stratified for injury severity by excluding 
patients with AIS B. However, sphincter management of the bladder appeared to be 
significantly better in BSPS patients after exclusion of the AIS B subjects. 
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This study demonstrates that the favourable neurological and functional 
recovery in patients with BSPS is predominantly determined by injury severity. In 
other words, compared with BSPS patients, more non-BSPS patients had an AIS 
B. As patients with an AIS B generally have a neurological and functional recovery 
to a much lesser degree than patients with an AIS C and AIS D14, 15, BSPS patients 
in this study could be expected to have a relatively better recovery than non-BSPS 
patients. Therefore, compared with incomplete tetraplegic patients, BSPS patients 
do not have a better, but a similar neurological and functional recovery if corrected 
for the injury severity (AIS). 
Although no study was identified that investigated the functional and 
neurological recovery between cervical BSPS and incomplete tetraplegia, 2 
studies reported on the functional recovery in BSPS patients.6, 16 McKinley et al.16 
retrospectively reviewed and compared the functional outcomes in patients with 
SCI syndromes during inpatient rehabilitation. This study16 used the BSS definition 
of the International Standards7 which is essentially the same as the BSPS concept. 
Mckinley et al.16 reported on 30 BSPS patients and concluded that cervical BSPS 
patients seemed to achieve higher functional improvements by discharge compared 
to patients with the traumatic central cord syndrome.16 Roth et al.6 retrospectively 
reviewed the functional outcomes in BSPS patients and concluded that BSPS patients 
generally have a good prognosis for neurological and functional improvement.6 
BSPS patients in this study remained to have a better bladder function 
compared to non-BSPS patients after 12 months. We have no valid explanation why 
BSPS patients have a better bladder function. Two studies support the finding that 
BSPS patients have good bladder function after rehabilitation.6, 16 Mckinley et al.16 
indentified that BSPS patients had the highest levels of independence in bladder 
function compared to other SCI syndromes. Roth et al.6 showed that 89% of the 
33 BSPS patients had independent bladder function at discharge. We consider the 
significant, though small, difference in bladder function scores between BSPS and 
non-BSPS patients in this study to be of little clinical relevance. 
Complete hemisection with the classic clinical features of pure BSS17, 18 
is rare. This could be a reason that most descriptions of BSS are descriptions of 
BSPS. In this study, all patients with left-right asymmetric neurological deficits 
were recognized as BSPS and no patient was identified to have BSS. As quantified 
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criteria for BSS and BSPS are lacking, the diagnosis of BSS and BSPS is based 
on non-specific criteria and interpretation of physical examination. In addition, 
classifying the SCI syndromes by means of the current International Standards for 
Neurological and Functional Classification of Spinal Cord Injury Patients7 is known 
to be challenging.19 The utility of currently applied BSS and BSPS diagnostic criteria 
therefore can be considered as limited. 
Since our data showed that the neurological and functional recovery in 
tetraplegic BSPS patients is comparable to that of other incomplete tetraplegic 
patients, classifying patients according to the currently used BSS7 or BSPS definitions6 
appears to be clinically irrelevant. However, we suggest that the term relatively in the 
current BSS definition7 should be abandoned and replaced by specific diagnostic 
criteria. An univocal quantified definition should result in a clear-cut classification 
for BSS. In addition, we believe that it is not necessary to define the BSPS as a 
separate SCI syndrome apart from BSS. 
Some limitations of this study warrant consideration. Several putative 
confounders such as treatment regimens, co morbidities, rehabilitation programs, 
and walking aids have not been registered within the EM-SCI database. 
Furthermore, we presented the results from the second version of the SCIM, which 
is in use in the centers of the EM-SCI. However, a third version of the SCIM has 
been validated recently.20 The third version includes a new item (transfer ground-
wheelchair) and the scoring of various subitems has been slightly modified, but the 
scores for the overall categories (self-care, respiration and sphincter management, 
and mobility) are unchanged. We believe that the results of our study are supposed 
to be independent of the SCIM version that was used, although the refinement of 
scaling of some subitems might result in the description of more nuances during 
functional recovery. 
Conclusion
When matched for injury severity, cervical BSPS patients appeared to have 
a similar neurological and functional recovery compared to patients with an 
incomplete tetraplegia. 
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Abstract
Study	design:	Retrospective cohort study.
Background:	 To compare the neurological outcome between paraplegic patients 
with acute spinal cord ischaemia syndrome (ASCIS) or traumatic spinal cord injury 
(tSCI) and to investigate the influence of SCI aetiology on the total Spinal Cord 
Independence Measure (SCIM)-II score.
Methods:	 Initial (0–40 days) and chronic-phase (6–12 months) American Spinal 
Injury Association (ASIA) sensory scores, lower extremity motor score (LEMS) and 
chronic-phase total SCIM-II scores were analysed. Differences between ASCIS and 
tSCI patients were calculated using Student’s t-tests and Wilcoxon signed-rank tests. 
To assess which variables give rise to the prediction of total SCIM-II score, a multiple 
linear regression analysis was used. These predictor variables included complete 
(ASIA impairment scale A) or incomplete SCI (AIS B, C, and D), aetiology, age 
and gender.
Results:	Out of 93 included patients, 20 ASCIS and 73 tSCI patients were identified. 
In the complete SCI group, the initial pinprick scores were higher (p<0.05) in 
ASCIS patients compared with tSCI patients, 37.9 (95% Confidence Interval (CI), 
23.3–52.5) and 27.3 (95% CI, 24.1–30.4), respectively.
No other relevant differences in neurological outcome were identified between 
ASCIS and tSCI patients; however, the total SCIM-II scores were higher (p<0.05) 
in tSCI patients after 12 months. Using the linear regression analysis, we were able 
to predict 31.4% of the variability. The aetiology was not significant in this model.
Conclusion:	The neurological outcome was independent of the diagnosis ASCIS or 
tSCI. Furthermore, the diagnosis ASCIS or tSCI was not a significant predictor for 
total SCIM II scores after 12 months.
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Introduction
In patients with spinal cord injury (SCI), the clinical diagnosis of ‘acute spinal 
cord ischaemia syndrome’ (ASCIS) is rare. Although the incidence is not precisely 
known, it probably accounts for 5–8% of all acute myelopathies.1 Most of these 
spinal cord infarctions are located in the thoracic or thoracolumbar spinal cord.2-4 
Although several predictors of outcome, such as age, gender and  American 
Spinal Injury Association (ASIA) impairment scale, have been reported in patients 
with ASCIS,4 only one study compared the neurological and functional outcome 
between patients with traumatic spinal cord injury (tSCI) or non-traumatic SCI 
with a solely vascular origin.5 Iseli et al.5 identified that the rate of neurological and 
ambulatory recovery is quite similar in patients with tSCI and ASCIS. This study, 
however, is limited, as it compared tetraplegic patients with paraplegic patients and 
used a regression analysis without including the predictor variable aetiology. 
Future interventions for the recovery of function following SCI probably 
include a combination of pharmacological,6 surgical7 and rehabilitation8 approaches. 
Therefore, it is important to investigate the effect of these in a homogenous group 
of patients with SCI. ASCIS and tSCI patients are sometimes grouped as they 
are considered to have the same neurological and functional recovery.9 One could 
question, however, whether it is justified to include SCI patients with a different 
aetiology in the same study population. 
Therefore, the objective of this study was to compare the neurological outcome 
between paraplegic patients with ASCIS or tSCI. In addition, the influence of the 
diagnosis of ASCIS or tSCI on functional outcome was investigated. Our hypothesis 
is that ASCIS patients have a less favourable neurological outcome and are a negative 
predictor for functional outcome when compared with tSCI patients.
Materials and methods
For this study, we used outcome data from complete and incomplete SCI 
patients between January 2000 and July 2009 that were collected in a Level 1 
trauma centre with a spinal care unit. Patients referred to this SCI centre enrol 
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consecutively into this ‘Hamburg database’. Data in this database are collected at 
several time intervals: during first admission after injury, during the subacute phase 
(3–5 months), the chronic phase (6–12 months) and at each follow-up appointment 
and/or hospitalization afterwards. Therefore, most patients remain life-long ‘clients’ 
of this spinal cord injury centre. Clinical assessments in this database are conducted 
by certificated neurological and rehabilitation physicians having at least 1-year 
experience in examining patients with SCI.
Study	population
Data from the Hamburg database were used for this retrospective study. 
Paraplegic patients were included in the study if they had an ischaemic or tSCI 
at neurological levels T2–T11. The ASCIS was based on (1) an acute neurological 
deficit attributable to a non-traumatic spinal cord lesion, (2) spinal CT and/or 
MRI findings that were typical for ischaemic lesion and/or excluded an alternative 
diagnosis, such as extrinsic or intrinsic cord compression. Other possible causes 
were further ruled out with CSF examinations.4,10 First neurological assessment had 
to be made within 40 days after the initial injury (initial phase). In patients in whom 
chronic-phase (≥12 months) follow-up measurements were not recorded, the 6- to 
12-month follow-up measurements were used for analysis. 
Patients with a severe cognitive impairment, peripheral nerve lesion, incomplete 
database record, polyneuropathy or cranio-cerebral injury were not included in 
the study. Patients with a possible cauda equina syndrome were excluded from the 
analysis as the cauda equina has been associated with a favourable prognosis.11 
Therefore, injuries at and below the neurological level T12 were grouped and 
excluded from the analysis. Frequent causes of polyneuropathy were excluded by 
recording the history of patients.
Neurological	outcomes
Neurological examinations were conducted according to ASIA standards.12 All 
paraplegic patients with completely conducted first-phase examinations (≤40 days 
after injury), that is, the lower extremity motor score (LEMS) and ASIA impairment 
scale, were included for the analysis. To assess the pinprick and light touch scores 
in paraplegic patients, dermatomes T2-S4–5 were assessed. The maximum score of 
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the sensory scores in these dermatomes T2-S4–5 is 80 points. Spinal cord injuries 
were divided into complete (ASIA impairment scale A) and incomplete (ASIA 
impairment scale B, C and D) lesions. The neurological level of injury (NLI) and 
AIS grade were determined on the basis of the ASIA sensory and motor scores. The 
initial phase, chronic phase and difference between initial and chronic phases were 
assessed for the pinprick scores, light touch scores and LEMS in each patient.
Functional	outcomes
The Spinal Cord Independence Measure (SCIM) is an instrument that focuses 
on performing everyday tasks, and captures the disability and impact of disability on 
the patient’s overall medical condition and comfort.13 The SCIM-II14 consists of three 
main categories, namely, (1) self-care, (2) respiration and sphincter management and 
(3) mobility. The chronic-phase total SCIM-II scores were assessed in each patient.
Statistics
Descriptive statistics on age, gender and AIS were used to provide general 
information of the study population. Subanalysis on complete/incomplete SCI, 
gender (χ2 analysis or Fisher’s exact test as appropriate) and age (student’s t-test) was 
performed to identify possible differences between ASCIS and tSCI patients. 
The mean pinprick scores, light touch scores and LEMS were calculated for the 
initial phase, chronic phase and for the difference between initial and chronic phase. 
The median SCIM-II scores were calculated for the chronic phase. Differences in 
pinprick scores, light touch scores, LEMS and total SCIM-II scores between ASCIS 
patients and tSCI patients were calculated using Student’s t-tests andWilcoxon 
signed-rank tests, respectively. 
To assess the variables that give rise to the prediction of functional outcome 
or total SCIM-II score, a multiple linear regression analysis was used to explain the 
total SCIM-II variability. The predictor variables included the initial-phase complete 
or incomplete SCI, aetiology, age at injury and gender. This analysis was performed 
to assess the role of the predictor aetiology (ASCIS or tSCI) and was not performed 
to identify the most suitable model for explaining total SCIM-II variability.
The differences were considered statistically significant at p<0.05. Data were 
analysed using SPSS software (version 16.0, SPSS, Chicago, IL, USA).
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Results
Among the 461 paraplegic patients within the database, 376 (82%) met the 
study criteria. One-year-follow-up SCIM-II measurements and ASIA motor and 
sensory scores were available in 93 (25%) patients (see Figure 1). The mean age 
at the time of injury in ASCIS patients was 60 years (range: 41–73) and in tSCI 
patients was 34 years (range: 14–80). The mean interval from the onset of the 
paraplegia to admission was 18 and 13 days (p<0.05) and the mean length of stay 
was 145- and 144 days (p<0.05) in ASCIS and tSCI patients, respectively. The mean 
chronic-phase assessments in ASCIS and tSCI patients were 643 and 1226 days 
after injury (p<0.05), respectively. In total, 40% of ASCIS patients and 82% of tSCI 
patients were male. The male–female ratio in ASCIS and tSCI patients was 0.7 and 
4.6, respectively. Initial phase AIS grades in ASCIS patients were A (n=10, 50%), B 
(n=2, 10%) and C (n=8, 40%). In tSCI patients, the initial phase AIS grades were 
A (n=61, 83.6%), B (n=7, 9.6%), C (n=3, 4.1%) and D (n=2, 2.7 %). Sub-analysis 
showed differences between ASCIS patients and tSCI patients for age (p<0.0001), 
complete SCI (p<0.01) and gender (p<0.0001).
In addition, the mean age of female subjects in the study population was higher 
(p<0.05) than the mean age of male subjects, 48 years and 36 years, respectively 
(See Table 1).
In total, 24 (6%) SCI patients were identified to have ASCIS. Of these 24 
ASCIS patients, 12 (50%) had 6- to <12-months follow-up and 8 (33%) had 
≥12-months follow-up SCIM-II measurements and ASIA motor and sensory scores. 
The origin of ASICS was idiopathic (n=7), aortic dissections (n=6), aortic aneurysm 
repair (n=3), embolism (n=3) and arteriovenous fistulae (n=1).
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Figure 1: 
Flowchart of patients in the Hamburg database with subjects eligible and included 
for analysis. Period of inclusion: January 2000 – July 2009
Abbreviations: SCI; spinal cord injury, ASIA; American Spinal Injury Association, ASIA, AIS; ASIA 
impairment scale, FU; follow-up 
Patients with ≥12 months 
FU measurements: 
n=71
Patients with only 6 to12 
months FU measurements:  
n=22
Analyzed patients:   
n=93
Included for analysis:
n=376
Eligible paraplegic patients 
for analysis:
n=461
Exclusion criteria:
1. Craniocerebral injury 
and/or cognitive  
impairment  n=26
2. NLI ≤ T12: n=59
Patients without 6 to 12 
months or ≥12 months FU 
measurements: n=283
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Table 1: 
Demographic data of 93 patients
Characteristics ASCIS tSCI
Subjects (no.) 20 73
Age, y, mean ± SD 60 ± 9 34 ± 15
Male (no. and percentage) 8 (40%) 60 (82%)
AIS (no. and percentage)
A 10 (50%) 61 (83,6%)
B 2 (10%) 7 (9,6%)
C 8 (40%) 3 (4,1%)
D 0 (0%) 2 (2,7%)
Neurological level of injury (no. and percentage)
Th2 1 (5%) 1 (1,4%)
Th3 0 2 (2,7%)
Th4 2 (10%) 13 (17,8%)
Th5 2 (10%) 11 (15,1%)
Th6 0 8 (11,0%)
Th7 2 (10%) 1 (1,4%)
Th8 1 (5%) 7 (9,6%)
Th9 3 (15%) 11 (15,1%)
Th10 5 (25%) 12 (16,4%)
  Th11 4 (20%) 7 (9,6%)
Abbrevations: ASCIS; acute spinal cord ischemia syndrome, tSCI; traumatic spinal cord injury, AIS; ASIA impairment 
scale
In total, 352 (94%) SCI patients were identified as tSCI patients. Of these 
352 tSCI patients, 14 (4%) had 6- to <12-months follow-up and 59 (17%) had 
≥12-months follow-up SCIM-II measurements and ASIA motor and sensory scores. 
As the number of subjects with a complete SCI (ASIA impairment scale A) 
was not equally distributed among ASCIS and tSCI, the outcome data of SCIM-
II scores and ASIA motor and sensory scores were stratified in the data processing 
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according to complete (ASIA impairment scale A) and incomplete SCI (AIS B, C 
and D). In the complete SCI group (n=71), 10 subjects had ASCIS and 71 subjects 
had tSCI. In the incomplete SCI group (n=22), 10 subjects had ASCIS and 12 had 
tSCI. 
Subanalysis in the complete and incomplete SCI group demonstrated a higher 
mean age in ASCIS patients, 58 and 61 years, respectively, compared with tSCI 
patients, 34 and 33 years, respectively (p<0.0001). More ASCIS patients were 
female (p<0.05) compared with tSCI patients in both the complete and incomplete 
SCI group.
Neurological	outcome
Complete	SCI. The LEMS and pinprick scores differed significantly between 
ASCIS and tSCI patients. The mean score in ASCIS patients was 0.8 (95% CI, -0.6 
to 2.2) and 0.03 (95% CI, -0.03 to 0.1) in tSCI patients. The mean pinprick scores 
in ASCIS patients and tSCI patients were 37.9 (95% CI, 23.3–52.5) and 27.3 
(95% CI, 24.1–30.4), respectively. However, after 12 months, no differences were 
identified in ASIA motor and sensory scores (See Table 2).
Incomplete	SCI. No differences were identified in the motor and sensory scores 
between ASCIS and tSCI patients during the initial and chronic phase (See Table 
2).
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Functional	outcome
The median SCIM-II scores were significantly higher (p<0.05) in tSCI patients 
compared with ASCIS patients in both complete and incomplete SCI subjects (Table 
2). Using the linear regression analysis, we were able to predict 31.4% (adjusted R2 
of 0.314) of the variability in total SCIM-II scores. Using the enter method, the 
following model emerged (F4, 137-17.122, p<0.0001). All predictor variables were 
significant in this model, except for the aetiology (Table 3). In other words, the 
diagnosis of ASCIS or tSCI was not a significant predictor for the variability in total 
SCIM-II scores after 12 months post injury.
Table 3: 
Regression results for predicting total SCIM II score after 12 months
Predictor variable β P values
Age at injury -0.403 ≤ 0.0001
Female gender -0.233 0.002
Incomplete SCI 0.361 ≤ 0.0001
Aetiology1
 
0.049 0.572
Abbrevations: SCIM II; Spinal Cord Independence Measure II, SCI; spinal cord injury.     
1 Aetiology of the spinal cord injury was traumatic or ischemic
Discussion
In this study, we identified that the neurological outcome was independent 
of the diagnosis ASCIS or tSCI. In the regression analysis, the variable aetiology 
(ASCIS or tSCI) is not a significant predictor for the variability in total SCIM-II 
scores after 12 months. Although we found a slightly higher initial phase LEMS 
in ASCIS patients compared with tSCI patients in the complete SCI group, this 
difference is not of clinical relevance. In addition, higher initial phase pinprick 
scores were found in ASCIS patients. 
Iseli et al.5 identified higher pinprick scores in tSCI patients (n=39) compared 
with ASCIS patients (n=28). The study, however, provided no data about the NLI. 
As paraplegic and tetraplegic patients were compared, the initial NLI could have 
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influenced the pinprick scores in favour of tSCI patients. In addition, 10 of the 28 
ASCIS patients were lost to follow-up after 6 months. Although the authors state 
that the initial complete–incomplete ratio was similar (P>0.05), the study did not 
explain to what extent this nonsignificant ratio was influenced by the lost-to-follow-
up patients.5 A lack of stratification for the AIS in the study5 could have influenced 
the neurological outcome.8 
Our data showed no differences in motor and sensory scores after 12 months. 
It seems, therefore, that these initial-phase differences are of minimal clinical 
relevance. The ASCIS patients in our study were older compared with tSCI patients. 
This supports the suggestion that patients with non-traumatic SCI have a higher 
average age.5,15 We further identified that neurological outcome is independent of 
and functional outcome is dependent on age. The motor and sensory scores were 
not different after 12 months, although ASCIS patients were significantly older. 
Furlan et al.16 also identified that the potential of neurological outcome is not 
negatively influenced by older age in tSCI patients. Both older and younger patients 
with tSCI improved neurologically within the first year after injury; however, older 
age was associated with greater disability, as assessed using FIM.16 We assume that 
the ageing patient has more comorbidity, less functional reserves and/or learning 
abilities, which could imply less efficiency in the rehabilitation process and thus less 
functional recovery.
Considering the functional outcome, our model explained 31.4% of the 
variability in the total SCIM-II score. The regression analysis showed a poor fit; 
however, the purpose of this study was not to identify the most suitable model, 
but to check the role of the predictor ASCIS or tSCI. In this model, we included 
the variable complete/incomplete SCI, as this is a strong covariate for functional 
outcome.8 The predictor variable gender was included, as this is believed to be a 
predictor for functional outcome.4 In our study, the female gender indeed was 
identified to be an independent predictor of poor functional outcome in patients 
with ASCIS. However, in this study female subjects were significantly older than 
male subjects and age could therefore have caused this negative effect of the female 
gender. The age of the patients furthermore was included in our model, as older age 
is believed to be a negative predictor.16,17 
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The results in our study confirm the suggestion5,18 that these two patient groups 
with pathophysiologically different causes for a SCI have a similar  neurological 
outcome. We identified two studies that compared the neurological outcome 
between ASCIS and tSCI patients. Catz et al.18 assessed the neurological recovery 
and how this recovery was affected by age, gender, NLI, decade of admission to 
rehabilitation and initial Frankel grade following non-traumatic spinal cord lesions. 
The study identified that the odds of recovery following tSCI were not significantly 
different from those of vascular lesions. Although the study18 confirmed the results of 
our study with regard to neurological outcome, comparisons were difficult to make 
as the neurological examinations were not conducted according to ASIA standards. 
The other study5 compared the prognostic factors and functional recovery between 
patients with either ischaemia or tSCI and concluded that the neurological deficits 
and rate of recovery were comparable in ASCIS and tSCI patients. The study5 used 
a stepwise multiple regression analysis for the prediction of ambulatory capacity. 
Of the variables (age,  electrophysiological recordings and ASIA motor and sensory 
scores), the best prediction of outcome of ambulatory capacity was achieved by the 
combination of the total motor score and tibial somatosensory evoked potentials. 
The study, however, did not address aetiology as a predictor in the regression 
analysis.5
Our study limited the study population to paraplegic patients, as ASCIS 
occurs mostly in the midthoracic spinal cord.2,3 For instance, Salvador de la Barrera 
et al. 19 had 35 paraplegic subjects in their study population of 36 ASCIS patients. 
Another study5 had 79% of the NLI located in the thoracic or lumbosacral region. 
Steeves et al. 8 further suggested that the baseline NLI is a very strong covariate 
on the neurological or functional outcome. As the incidence of tetraplegic ASCIS 
patients is probably low and we wanted to reduce the heterogeneity of comparing 
tetraplegics with paraplegics, we choose to limit our study population to paraplegic 
patients.
Our results should be interpreted in the context of specific study limitations. 
First, we used a time frame of 0–40 days after the initial SCI as the initial phase. 
Scivoletto et al. 17 identified that a longer time from lesion to admission did influence 
the neurological recovery negatively because of the ceiling effect. The interval in 
their study, however, had a mean of 56.9 days. 17 In our study, all examinations 
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were within the first 40 days and no differences were identified between ASCIS and 
tSCI patients. The mean chronic-phase assessments, however, differed significantly. 
Although the variation in time points was not analysed in this study, the effect 
on neurological and functional outcomes is believed to be minimal. 20 Second, the 
small patient numbers in this study limit the reliability of our results. Third, it 
has been suggested that patients with an ischaemic myelopathy of idiopathic origin 
have a more favourable outcome.4 In this study, the idiopathic cause for ASCIS still 
made up 35%. Although the seven subjects had an extensive diagnostic workup, 
these patients were diagnosed with ASCIS simply by exclusion of other disorders. 
10 However, in 7–36% of ASCIS patients, the cause for the spinal cord infarction 
remains undefined. 4
Conclusion
In this study, the neurological outcome according to the ASIA standards 
appeared to be independent of the diagnosis ASCIS or tSCI. Furthermore, our 
results suggest that the diagnosis of ASCIS or tSCI is not a significant predictor for 
functional outcome according to the total SCIM-II scores after 12 months.
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Summary and general discussion
Life expectancies of patients with spinal cord injury (SCI) have increased over 
the years and are expected to increase with the current emergency medical services, 
surgical procedures, antibiotics, improved rehabilitation policies and services. The 
search for a “cure” of SCI unfortunately has yet to produce a convincingly efficacious 
treatment that substantially improves neurologic function in SCI patients. However, 
it is assumed that an early, i.e. within 24 hours post-injury, decompression of the 
spinal column and spinal cord is beneficial in SCI patients.
In chapter 1, we emphasized that the severity of SCI needs to be addressed 
more accurately for future clinical research purposes. We questioned 2 issues 
regarding SCI severity, the primary injury to the spinal cord and the SCI syndromes. 
The neurological examination according to the American Spinal Injury Association 
(ASIA) scores is considered to be reliable when tested 72 hours after the initial 
trauma. Considering that the first day post-injury is the most important time-
interval for neuroprotective interventions, the neurological examination appears to 
be limited as a prognostic tool. It is assumed that patients with more severe SCI 
respond differently to neuroprotective interventions than patients with less severe 
SCI. An accurate prediction of the initial damage of the spinal cord that more 
exactly differentiates between the severity of SCI may help physicians in choosing 
an available or experimental treatment modality in the first 24 hours post-injury. 
Besides determining the severity of the injury to the spinal cord, future SCI 
studies will also have to stratify and constrain the heterogeneity of samples for more 
sensitive detection of treatment effects. In this perspective, SCI syndromes are often 
considered to be different entities from other SCI’s. Despite the various applications, 
the usefulness of syndrome classification is currently limited by imprecise and 
variable definitions of the syndromes. In addition, patients with SCI syndromes 
are sometimes excluded because they are believed to increase the heterogeneity of 
the study populations. The international panel of SCI experts convened by the 
International Campaign for Cures of Spinal Cord Injury Paralysis for instance, 
concluded that traumatic central cord patients might be treated differently than 
other motor incomplete traumatic SCI patients in clinical trials, as the different 
recovery pattern could increase the variability of the outcome data. 
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In chapter 2, we reviewed the current status of neurochemical biomarkers 
and their potential diagnostic value from either experimental models or patient 
series of acute SCI. This chapter focused on 1) the current status of neurochemical 
biomarkers in SCI and 2) their potential diagnostic role in SCI. Several studies 
showed that the biomarkers S-100β, Neuron-specific enolase (NSE), Neurofilament 
light chain, and Glial fibrillary acidic protein (GFAP) are significantly increased 
in cases of (experimental) spinal cord injury. Considering the shortcomings of the 
ASIA standards within the first 24 hours post-injury as addressed in chapter 1, 
quantitative standards to determine the extent of the SCI must be developed and 
validated. Based on the results we concluded that neurochemical biomarkers of SCI 
should be evaluated and validated in future clinical trials.
 In chapter 3, we described the cerebrospinal fluid (CSF) concentrations 
of  GFAP, NSE, S-100β, tau and neurofilament high chain (NFH) and its relation 
with the ASIA impairment (AIS) grade severity in 16 traumatic SCI (tSCI) patients. 
Our study suggests that trauma to the spinal cord causes a release of proteins from 
the cord into the CSF. All CSF concentrations are elevated irrespective of the 
AIS severity. In addition, NSE, S-100β and NFH  concentrations were elevated 
in patients having a motor complete SCI compared with patients with a motor 
incomplete SCI. Our data, however, showed no significant differences between the 
S-100β, Tau, GFAP and NFH concentrations in the most severely (AIS A) and less 
severely (AIS D) injured SCI patients. 
Also, the data clearly showed the wide range of the values with low 
concentrations in AIS A patients and high concentrations in AIS D patients. This 
could be attributed to the small study population in this study and also the different 
time intervals that the CSF samples were obtained post-injury. Although a previous 
study clearly showed significant differences between the CSF concentrations of Tau, 
S-100β and GFAP at 24 hours post-injury in AIS A, B and C patients, our results 
showed no significant differences between AIS grade A and B or between AIS grade 
C and D. 
A possible explanation for the variability in CSF concentrations is that the 
mean time of injury to CSF sampling of 14 hours. The results of the STASCIS trial 
showed that a surgical decompression within 24 hours post-injury in SCI patients 
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is associated with improved neurological outcome. This encourages the need for a 
more accurate prediction of SCI severity within these 24 hours post-injury. This 
time-span, however, may either be too short or too long for some biomarkers to 
reach peak levels in the CSF to provide a reliable correlation with injury severity 
after SCI. 
Our data also showed the influence of the time of sampling against the 
concentrations of NSE, GFAP and NFH in the 7 AIS A patients. This issue has 
also been discussed in a recent paper, which showed that all CSF concentrations 
were time dependent. Given the complex and dynamic pathology of SCI, it can 
be expected that levels of SCI biomarkers evident within the CSF will be time 
dependent.
Although our data showed no significant differences in  S-100β, Tau, GFAP 
and NFH concentrations between all the different AIS grades, the mean CSF 
concentrations tend to suggest that the more severely a SCI patient is injured, as 
determined by the AIS grade, the higher the concentrations of a structural biomarker. 
The GFAP and Tau concentrations also reflect what may be a functional ‘ceiling 
effect’ with the AIS grading system.  Conceptually, if the spinal cord is traumatically 
injured to a degree that produces a functionally ‘complete’ AIS A injury, doubling 
the mechanical severity of injury may increase the biological extent of injury, but 
would still result in the identical injury grading according to the AIS. This increased 
biological extent of injury, however, may be reflected in the CSF concentrations of 
structural biomarkers such as Tau and GFAP.  However, there is also a considerable 
variability in the concentrations among the most severely damaged spinal cords, 
i.e. the AIS A patients. A possible explanation for this variety, may be the time 
that the different samples were obtained. Our  data showed that this variability in 
timing significantly influenced the NFH, NSE and S-100β concentrations in AIS 
A patients. 
Another possible explanation for this variety may the CSF flow in the spinal 
column. Considering that the CSF flow is blocked by canal occlusion in most SCI 
patients, this occlusion restricts the diffusion of structural biomarkers in the CSF. 
In other words, a CSF puncture prior to a surgical decompression distally of a canal 
occlusion may generate a false-negative value in a severely injured spinal cord. This 
may limit the clinical and diagnostic capabilities of CSF biomarkers.   
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Our results should be interpreted in the context of specific study limitations. 
We presented the study results of 16 SCI patients. As we used strict inclusion criteria, 
the interpretation of our results is limited by the small sample size patient numbers. 
The less severely injured SCI patients who improved in their AIS grade seemed 
to have lower biomarker concentrations, however, the great variability and small 
numbers severely limits the conclusions drawn from our analysis. In addition, our 
study population limits us from using a biochemical model with statistical power 
as proposed by a previous study. Also, our study protocol was not standardized 
for several putative confounders such as treatment regimens and blood pressure 
augmentation. The method of obtaining CSF differed between the two centers. As 
the purpose of this study was to analyze CSF samples obtained within 24 hours, we 
believe that this has not influenced our results. However, the time between the  injury 
and CSF sampling differed considerably amongst the patients in our study, ranging 
from 3 hours to 24 hours , and our  data showed that this variability in timing 
significantly influenced the NFH, NSE and S-100β concentrations. Future studies 
therefore should perform CSF sampling on predetermined time intervals. Lastly, 
although the AIS is a recognizable benchmark for the baseline neurologic assessment 
of the acute SCI patient, the AIS is a questionable outcome measurement, since it 
does not address the functional capabilities. 
Also the diagnostic capabilities of current biomarkers will not exceed that of the 
initial neurological assessments, so long as they are compared to these neurological 
ssessments as the comparative gold standard.  Future studies are needed to determine 
whether structural biomarkers could be used as diagnostic markers in those SCI 
patients where a valid baseline neurological assessment cannot be obtained.
In chapter 4, we explained that conventional Magnetic Resonance Imaging 
(MRI) does not provide enough information about the integrity of critical long white 
matter tracts responsible for the observed functional deficits after SCI. Although 
there are numerous reports about the sensitivity and usefulness of diffusion-weighted 
MRI (DWI) in traumatic brain injury, the number of DWI studies in spinal cord 
injury is limited. We prospectively evaluated the imaging findings from conventional 
MRI and DWI within 24 hours post-injury in 7 patients with a suspected tSCI. In 
addition, the findings of other studies were compared with our own data. 
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Eighteen tSCI patients (11 from the retrieved publications and 7 prospectively 
from our own study population) were included. No relations were identified 
between the images and ASIA or Spinal Cord Independence Measurements II 
(SCIM II) indoor mobility scores. The detection rates of hyperintense signals on T2-
weighted and DW imaging did not show significant differences at 94% and 72%, 
respectively. In addition, there were no significant differences in detection rates or 
diffusion abnormalities between subjects in whom DW images were obtained with 
a maximum b-factor of 1000 or <1000 s/mm2. Based on these results, T2-weighted 
and DW imaging appeared to have a comparable detection rate for spinal cord 
damage within 24 hours post-injury. This is the first study, that reported on DWI 
within 24 hours post-injury. 
The major limitation of our study was the qualitative interpretation of DW 
imaging. This approach was chosen, as our study purpose was to perform a descriptive 
analysis. In addition, no standardized Apparent Diffusion Coefficients (ADC’s) 
values exist to date and the included studies used different imaging techniques and 
b-factors. With this method, however, we could not identify differences between 
different abnormal ADC’s as both were recoded as restricted diffusion. When MR 
imaging becomes more easily accessible in hospitals, future studies can begin to 
analyse the prognostic capabilities of DWI within the first 24 hours or earlier, on 
a larger scale. This development must go hand in hand with the latest hardware 
and software developments and improvements. Future neuroradiologic studies in 
SCI patients should also focus on using standardized neurological and functional 
outcomes.  
In chapter 5, we evaluated the applied definitions of the most common SCI 
syndrome, i.e. the traumatic central cord syndrome (TCCS). The currently applied 
TCCS diagnostic criteria and quantitative data regarding the ‘disproportionate 
weakness’ between the upper extremity motor scores (UEMS) and lower extremity 
motor scores (LEMS) described in original studies reporting on TCCS subjects were 
studied. Out of 30 retrieved studies, we identified seven different clinical descriptors 
that have been applied as TCCS diagnostic criteria. Nine studies reporting on a total 
of 312 TCCS patients were eligible for analysis. The mean total UEMS was 10.5 
motor points (based on the Medical Research Council scale) lower than the mean 
total LEMS. 
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One could question, however, if this quantified diagnostic criterion alone 
may be seen as over-simplistic and that associated symptoms may also need 
consideration. We therefore evaluated the need for the introduction of quantitative 
TCCS diagnostic criteria for clinical research purposes. The majority of the 156 
surgeons (61%) who completed our survey considered a proposed difference of at 
least 10 points of power in favour of the lower extremities as an acceptable cutoff 
criterion for a diagnosis of TCCS. In addition, any difference in motor strength 
between the upper and lower extremities was considered by 23% of the responders 
to be a ‘disproportionate’ difference in power.
Based on part 1 and 2, we considered a difference of at least 10 motor score 
points between upper and lower extremity power a face valid, quantitative and 
reproducible diagnostic TCCS criterion. However, the introduction of quantitative 
diagnostic TCCS criteria may be considered unnecessary due to a lack of impact 
on treatment decision-making.The neurological recovery and functional outcomes 
between TCCS patients and motor incomplete tetraplegic patients was therefore 
compared. Although minimally significant differences in chronic phase LEMS and 
UEMS outcomes were identified between TCCS and non-TCCS patients after 
stratification by the AIS, our data showed no significant differences in functional 
upper and lower extremity outcomes at 6 or 12 months post-injury in 248 traumatic 
motor incomplete tetraplegics using data from the European Multicenter study 
about Spinal Cord Injury (EM-SCI).
In chapter 6, we questioned the clinical and scientific relevance of incomplete 
tetraplegic patients being labeled as the not ‘classic’ Brown-Séquard syndrome (BSS) 
or Brown-Séquard-plus syndrome (BSPS). The neurological and functional recovery 
between the tetraplegic BSPS and incomplete tetraplegic patients (non-BSPS) 
was compared using EM-SCI data. In 148 tetraplegic patients, 30 were diagnosed 
with BSPS. Except for a clinically non-relevant difference in bladder function, 
no significant differences were identified in other SCIM II subitems and ASIA 
motor or sensory scores between BSPS and non-BSPS patients when stratified for 
injury severity. This chapter, like chapter 2, also demonstrated that the favourable 
neurological and functional outcomes in patients with BSPS is predominantly 
determined by AIS. 
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In chapter 7, we evaluated the outcome in the rare acute spinal cord ischaemia 
syndrome (ASCIS). The neurological outcome between paraplegic patients with 
ASCIS or tSCI was investigated. In addition, the influence of SCI aetiology on 
the total SCIM II scores was evaluated. We questioned whether it is justified to 
include SCI patients with a different aetiology in the same study population. Out 
of 93 paraplegics, 20 ASCIS and 73 tSCI patients were identified using data from 
the Hamburg database. After 12 months post-injury, no relevant differences in 
neurological outcome were identified between ASCIS and tSCI patients; however, 
the total SCIM-II scores were significantly higher in tSCI patients. Our explanation 
for this difference is that ASCIS patients were older and the ageing patient has 
more comorbidity, less functional reserves and/or learning abilities, which could 
imply less efficiency in the rehabilitation process and thus less functional recovery. 
Remarkably, when using the linear regression analysis with the predictors variables 
gender, age, SCI severity and aetiology for 12 months post-injury total SCIM-II 
scores, the aetiology was not a significant predictor in this model. 
In chapters 5 and 6, data was used from the EM-SCI database. In this database, 
patients with acute traumatic spinal cord injury are tested and documented within 
a fixed time schedule (acute, 4, 12, 24 and 48 weeks) after spinal cord injury and 
must comply with clearly defined inclusion criteria. The examinations consist of 
a standard set of neurological, neurophysiological and functional  assessments. 
The collected data from each center is sent to the coordinating center in Zürich 
in regulary time intervals to be joined into the central database. The successful 
EM-SCI consortium consists of 19 SCI centers across Europe. The purpose of the 
database is to investigate:
•	 the relationship between electrophysiological, neurophysiological and  
 functional measurements
•	 the prognostic value of the measurement outcome
•	 the mechanisms of spontaneous recovery
•	 investigate the efficacy of new treatment strategies
The chapters 5 and 6 revealed no differences between patients with SCI syndromes 
and patients without these SCI syndromes. The traumatic SCI syndromes defined 
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within the International Standards for the Neurological Classification of Spinal 
Cord Injury are not universally accepted, at least with respect to the correspondence 
between clinical features and underlying neuropathology. An obvious shortcoming 
of classifying patients by means of the International Standards is that many cases 
defy clear-cut classification because they mix two or more syndromes. This situation 
is not unexpected, since the neuropathology of cord injuries is typically complex 
and diverse and involves many parts of the cord. The classification into ‘‘pure’’ 
syndromes may be the exception rather than the rule. In chapter 5 and 6, the study 
populations were not corrected for other SCI syndromes. These other syndromes 
therefore could have been absorbed into either TCCS, BSPS, non-TCCS or non-
BSPS patients.  
Our focus of the three-article series was the motor impairment of the upper 
extremities compared to the lower extremities. The TCCS is not merely a motor 
impairment, but also has varying sensory deficits. To illustrate, our survey showed 
that most participants agreed with our proposed quantified TCCS criterion, a 
considerable number (40%) felt that this single criterion would be insufficient for 
research purposes. Our criterion does not take the sensory deficit into account, 
however, the most prominent and clinically most relevant symptom is the motor 
impairment. In addition, chapter 2 revealed that most of the participating surgeons 
(76%) held the opinion that TCCS had a favourable prognosis for neurological and/
or functional recovery compared with non-TCCS incomplete tetraplegic patients. 
The last article of our three-article showed that the AIS grading system, and not the 
diagnosis TCCS, is a more important parameter for neurological and functional 
outcomes in motor incomplete tetraplegics. 
In chapter 6, we were unable to identify a single “classic” BSS patient in 
the EM-SCI database. Based on our results and the current BSS definition of the 
International Standards for the Neurological Classification of Spinal Cord Injury 
which states that BSS patients have a “relatively	greater	ipsilateral	proprioceptive	and	
motor	loss	and	contralateral	loss	of	sensitivity	to	pain	and	temperature”, we suggest that 
it is not necessary to define the BSPS as a separate SCI syndrome apart from BSS. 
However, we limited our analysis to the tetraplegics and our results therefore cannot 
be translated to the paraplegics. We therefore suggest that future BSS studies should 
be directed at defining quantitative BSS diagnostic criteria using the same steps 
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like we did in chapter 5, to investigate the neurological and functional outcome 
compared with other incomplete SCI patients.
Chapter 7 revealed no differences between SCI patients with a traumatic 
or ischemic aetiology. In the retrospective analysis of ASCIS patients using the 
Hamburg database, we limited our analysis to paraplegic patients. Although ASCIS 
most commonly occurs in the midthoracic spinal cord, it also occurs in the cervical 
spinal cord. Our results therefore cannot simply be translated to the tetraplegic 
patient. In addition, the idiopathic cause of ASCIS still made up 35% despite 
extensive diagnostic workup. It has been suggested that an idiopathic cause for 
ASCIS has a more favourable outcome. However, in 7-36% of the ASCIS patients 
the cause of the spinal cord infarction remains undefined. 
Several common limitations in chapter 5,6 and 7, warrant consideration. Firstly, 
several putative confounders such as treatment regimens, including administration 
of methylprednisolone, blood pressure augmentation and urgent spinal cord 
decompression, are not standardized within the EM-SCI consortium. Secondly, 
co-morbidities, rehabilitation programs, and walking aids have not been registered 
in detail within the EM-SCI database. Thirdly, the small sample sizes in the three 
studies resulted in limited statistical power of the analyses, especially the regression 
analysis in chapter 6. Fourthly, we used dichotomized SCIM outcome measures 
in chapter 5.3  Although the use of dichotomized SCIM outcome measures has 
not yet been validated, the clinical relevance and utility of this method has been 
demonstrated in previous studies. 
Based on the results of the chapters 5 and 6, we concluded that the AIS 
grading system, and not syndrome classification, continues to be the best available 
prognostic parameter for neurological and functional outcomes in SCI patients. We 
recommend that for future outcome studies in SCI patients, subjects should not be 
selected based on, or stratified by, TCCS and BSPS, but rather by the severity of the 
initial injury as quantified by the AIS grading system. In addition, future studies 
should consider including both patients with a traumatic or ischaemic aetiology in 
the study population.
C
ha
pt
er
 8
8
187
Recommendations for future studies
Future structural biomarker studies should use a larger cohort to determine 
their diagnostic value in patients where a valid neurological baseline can not be 
obtained. However, given the limitations addressed in this thesis and logistic 
difficulties in obtaining and processing these samples, the diagnostic value of the 
current biomarkers may be limited within the first 24 hours.   
The main problem for DWI in SCI patients is the availability in most 
hospitals. However, when MR imaging becomes more easily accessible in hospitals, 
its diagnostic value may improve. In addition, software and hardware improvements 
have also improved the quality of the images obtained. Future neuroradiological 
studies should focus on DWI combined with diffusion-tensor imaging to evaluate 
the injury within the spinal cord within the first 24 hours post-injury. These findings 
should then be correlated with neurological and functional outcome data.
Although this thesis investigated  TCCS; the BSPS and the ASCIS still lack 
uniform criteria. The latter, unfortunately, also consists of a group of patients 
with an idiopathic cause. Whether these are true ischaemic SCI patients remains 
controversial. As the diagnostic modalities are improving this group will become less 
heterogenic. Although the aetiology in ASCIS patients is different than traumatic 
SCI, both should be considered as an acute threat to the spinal cord and patients 
should be treated within 24 hours to improve the neurological en functional 
outcomes. Future ASCIS studies should be aimed at improving the diagnostic 
modalities and therapeutic interventions. Future BSPS studies should first try to 
define an uniform and quantified criterion for the diagnosis BSPS.  
This thesis has not addressed the cauda equina and conus medullaris syndromes. 
These syndromes are also believed to have favourable neurological and functional 
outcomes. Unfortunately both syndromes also lack uniform criteria, however, 
given the neurological complexity and variety of both syndromes, defining uniform 
criteria may not be that simple. This is still a major issue in future SCI research that 
needs to be addressed. If this is tackled, than both can be compared with the “true” 
SCI patient to compare the neurological en functional outcomes.
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Samenvatting en algehele discussie
De levensverwachting van patiënten met een dwarslaesie (SCI) is toegenomen 
de laatste jaren. De verwachting is dat dit nog verder zal toenemen door de huidige 
traumaopvang, chirurgische ingrepen, antibiotica en verbeterde revalidatie. De 
zoektocht naar een “genezing” waarbij een klinisch betekenisvolle verbetering 
wordt bewerkstelligd, is echter nog volop bezig. Verondersteld wordt echter dat SCI 
patiënten binnen 24 uur posttrauma, baat hebben bij een vroege decompressie van 
het ruggenmerg.  
In hoofdstuk 1 hebben we het belang van het beter in kaart brengen van de ernst 
van het ruggenmergletsel benadrukt. Deze ernst hebben we binnen dit perspectief 
verdeeld in 2 thema’s; de dwarslaesiesyndromen en de ernst van het primaire 
ruggenmergletsel. Het neurologisch onderzoek volgens de American Spinal Injury 
Association (ASIA) wordt pas betrouwbaar geacht wanneer dit na 72 uur posttrauma 
wordt verricht bij SCI patiënten. Dit tijdsinterval van 72 uur geeft de beperkingen 
aan van het neurologische onderzoek, aangezien de eerste 24 uur na het ongeval 
worden beschouwd als de belangrijkste uren voor neuroprotectieve interventies. 
Verondersteld wordt dat patiënten met een complete SCI minder goed reageren 
op interventies dan patiënten met een incomplete SCI. Een betere inschatting en 
differentiatie van de ernst van het initiële ruggenmergletsel, zou artsen in theorie 
kunnen helpen bij het kiezen van beschikbare en/of experimentele behandelopties 
in deze eerste 24 uur. Daarnaast is het belangrijk dat SCI studies stratificeren en 
proberen de heterogeniteit van de studiepopulaties te beperken om het effect van 
eventuele therapieën betrouwbaarder te kunnen bepalen. Binnen dit perspectief 
worden de dwarslaesiesyndromen vaak als een aparte entiteit beschouwd. Ondanks 
de vele toepassingen wordt het gebruik van syndroomclassificaties beperkt door 
gevarieerde en onnauwkeurige definities. Tevens worden patiënten met bepaalde 
dwarslaesiesyndromen soms geëxcludeerd, omdat wordt gedacht dat deze patiënten 
de heterogeniteit van de studiepopulatie beïnvloeden. Een werkgroep bestaande uit 
SCI experts besloot tijdens the International Campaign for Cures of Spinal Cord 
Injury Paralysis dat in klinische trials patiënten met het traumatisch centraal koord 
syndroom (TCCS) mogelijk anders gestratificeerd dienen te worden dan andere SCI 
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patiënten met een motorisch incomplete traumatische SCI. De hypothese achter dit 
advies is dat het “gunstige” herstel bij patiënten met een dwarslaesiesyndroom, de 
variabiliteit van de studieresultaten teveel zou kunnen beïnvloeden. 
 
In hoofdstuk 2, wordt de huidige stand van zaken omtrent neurochemische 
biomarkers en hun potentiële diagnostische waarde in diermodellen en patïenten 
met een ruggenmergletsel gereviewed. Enkele studies tonen aan dat de biomarkers 
S-100β, Neuron-specific enolase (NSE), Neurofilament light chain en Glial fibrillary 
acidic protein (GFAP) significant verhoogd zijn na een (experimentele) SCI. Gezien 
de beperkingen van het ASIA onderzoek binnen 24 uur posttrauma, welke worden 
genoemd in hoofdstuk 1, is er een noodzaak voor gevalideerde kwantitatieve 
standaarden voor het vaststellen van de ernst van een ruggenmergletsel. Gebaseerd 
op de resultaten van deze literatuurstudie, werd vastgesteld dat het noodzakelijk is 
dat neurochemische biomarkers worden geëvalueerd en gevalideerd in toekomstige 
klinische trials. 
In hoofdstuk 3, worden de concentraties van de liquor biomarkers GFAP, 
NSE, S-100β, tau en neurofilament high chain (NFH) en de relatie met de ASIA 
impairment scale (AIS)  gradering beschreven in 16 patiënten met een traumatische 
SCI. De concentraties van  alle markers waren verhoogd onafhankelijk van het 
ruggenmergletsel gemeten met de AIS gradering. De concentraties van NSE, 
S-100β en NFH waren verhoogd in patiënten met een motorisch complete SCI 
vergeleken met patiënten met een incomplete SCI. De data laat echter geen 
significante verschillen zien in de concentraties van S-100β, Tau, GFAP en NFH 
tussen patiënten met een ernstig ruggenmergletsel (AIS A) en patiënten met een 
minder ernstig ruggenmergletsel (AIS D).
Een mogelijke verklaring voor de variabiliteit van onze resultaten is de 
gemiddelde tijd van 14 uur tussen tijdstip van het ongeval en liquorafname. De 
resultaten van de STASCIS trial laten zien dat een chirurgische decompressie 
binnen 24 uur na het ongeval in patiënten met een traumatische SCI is geassocieerd 
met een verbeterde neurologische uitkomst. Deze resultaten geven nogmaals de 
noodzaak van een accurate voorspelling voor de ernst van een SCI binnen deze 
24 uur. Deze tijdsduur van 24 uur zou echter te lang of te kort kunnen zijn voor 
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sommige biomarkers om hun maximale concentraties te bereiken. Hierdoor zou 
er theoretisch geen betrouwbare correlatie met de ernst van het ruggenmergletsel 
kunnen worden gemeten. 
De gemiddelde biomarkerconcentraties zijn hoger in de meer ernstige 
ruggenmergletsels zoals gemeten met de AIS gradaties. De concentraties van 
GFAP en Tau laten daarnaast ook de beperkingen zien van de AIS gradaties. Een 
beschadigd ruggenmerg kan bijvoorbeeld leiden tot een AIS A. Een ernstiger 
beschadigd ruggenmerg is nog steeds een AIS A, terwijl er hogere concentraties 
van biomarkers worden gemeten. In onze data werd in AIS A patiënten die 
neurologisch niet herstelden een 9.5 keer hogere concentratie van GFAP en 2.5 keer 
hogere concentratie van  Tau waargenomen, vergeleken met AIS A patiënten die 
neurologisch verbeterden naar een AIS B. Er is echter ook een grote variabiliteit van 
biomarkerconcentraties binnen de AIS A groep. Een verklaring voor deze verschillen 
is het tijdstip van afname. De data laat zien dat het tijdstip van afname een significante 
invloed heeft op de NFH, NSE en S-100β concentraties in AIS A patiënten. Een 
mogelijk andere verklaring zou de liquorstroom in het wervelkanaal kunnen zijn. 
Er vanuit gaande dat deze stroom geblokkeerd is in de meeste patiënten met een 
complete dwarslaesie, zou het kunnen zijn dat hierdoor de diffusie van markers in 
liquor ook gelimiteerd is. Met andere woorden, een lumbale punctie voorafgaande 
aan een decompressie distaal van een occlusie in het spinale kanaal zou hierdoor 
vals negatieve waardes kunnen geven in patiënten met een ernstig ruggenmergletsel. 
Hierdoor zouden de diagnostische en klinische mogelijkheden van liquormarkers 
beperkt kunnen zijn. 
Er moeten enige kanttekeningen bij de resultaten van deze studie worden 
gemaakt. Als eerste werden hier de resultaten van maar 16 patiënten gepresenteerd. 
Deze kleine studiepopulatie maakt de interpretatie van de resultaten beperkt. Door 
de kleine studiepopulatie was het ook niet mogelijk om een biochemisch model te 
maken met voldoende statistische power. Mogelijk dat met een grotere studiepopulatie 
er wel een correlatie tussen de AIS gradaties en biomarkerconcentraties kan worden 
aangetoond. Daarnaast zijn verschillende confounders zoals het behandelstramien 
in de vorm van het toedienenen van methylprednisolon en bloeddrukondersteuning 
van het ruggenmerg niet gestandaardiseerd binnen dit onderzoek. Daarnaast is de 
methode van liquorafname verschillend tussen de 2 deelnemende centra, echter 
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aangezien we alleen de afgenomen monsters binnen 24 uur na het ongeval hebben 
onderzocht, zijn we van mening dat dit onze resultaten niet heeft beïnvloed. 
Het tijdstip van afname daarentegen verschilt tussen de verschillende patiënten 
met een range van 3 tot 24 uur na het trauma. De data laat zien dat dit tijdstip 
een significante invloed heeft op de concentraties van NFH, NSE en S-100β. 
Toekomstig onderzoek zal de afname van hersenvocht op vaste tijdstippen moeten 
laten plaatsvinden.  Daarnaast is het gebruik van de AIS gradatie als uitkomstmaat 
twijfelachtig aangezien deze niet correleert met de functionele capaciteiten. Als 
laatste is de AIS gradatie de gouden standaard waarmee dit onderzoek vergeleken 
wordt. Hierdoor zullen de onderzochte biomarkers in deze analyses niet beter zijn 
dan het initiële neurologische onderzoek. Verdere studies zijn nodig om te bepalen 
of structurele biomarkers kunnen worden gebruikt als een diagnostische marker in 
patiënten met een traumatische SCI waar een betrouwbaar neurologisch onderzoek 
niet van kan worden verkregen.
 
In hoofdstuk 4, wordt uitgelegd dat conventionele Magnetic Resonance 
Imaging (MRI) niet genoeg informatie verschaft over de mate van beschadiging 
van de klinisch belangrijke witte stof. Deze witte stof is verantwoordelijk voor 
de functionele afwijkingen bij een dwarslaesie. Er zijn meerdere studies over de 
sensitiviteit en nut van diffusion-weighted MRI (DWI) in traumatisch hersenletsel, 
echter het aantal studies bij patiënten met een traumatische SCI zijn beperkt. In de 
studie werden de conventionele MRI en DWI binnen 24 posttrauma in 7 patiënten 
met een verdenking op een traumatische SCI, prospectief geanalyseerd. Daarnaast 
werden de bevindingen van andere studies toegevoegd aan onze beschrijvende 
analyse. In totaal werden 18 patiënten geïncludeerd (11 patiënten uit de gevonden 
studies en 7 prospectief uit onze eigen database). Er werd geen relatie gevonden 
tussen de geanalyseerde beelden en ASIA of SCIM II mobiliteit binnenshuis. 
Het detectiepercentage van hyperintense afwijkingen op de T2-gewogen en DWI 
opnames waren 94% en 72% respectievelijk. Tussen deze 2 opnames werden geen 
significante verschillen aangetoond in het aantonen van afwijkingen in het myelum. 
Daarnaast werden er geen significante verschillen gevonden in het vaststellen van 
myelumafwijkingen of diffusieabnormaliteiten in het myelum tussen de patiënten 
waar de DWI opnames waren vervaardigd met een maximale b-factor van 1000 
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of  <1000 s/mm2. Het lijkt erop dat T2-gewogen opnames en DWI vergelijkbare 
resultaten geven als het gaat om het aantonen van myelumafwijkingen binnen 24 
posttrauma. 
De belangrijkste beperking van deze studie is het aantal patiënten in onze 
studiepopulatie. Daarnaast is de kwalitatieve interpretatie van de DWI een 
belangrijke beperking binnen onze studieopzet. Ook werden in de geïncludeerde 
studies verschillende technieken en b-factor’s voor het verkrijgen van de DWI 
beelden gebruikt. Echter tot op heden bestaan er nog geen gestandaardiseerde 
Apparent Diffusion Coefficients (ADC’s) waardes. Aangezien ons doel was om een 
kwalitatieve analyse te beschrijven, werden echter geen kwantitatieve verschillen in 
ADC’s gevonden aangezien deze allemaal werden gecodeerd als een verminderde 
ruggenmergdiffusie. Wanneer MRI onderzoek makkelijker toegankelijk wordt 
in ziekenhuizen, kunnen toekomstige studies de prognostische waarde van DWI 
binnen 24 uur posttrauma op een grotere schaal onderzoeken. Deze ontwikkeling 
zal echter samen moeten gaan met de nieuwste hardware en software verbeteringen. 
Toekomstige neuroradiologische studies in dwarslaesiepatiënten moeten daarnaast 
ook gestandaardiseerde neurologische en functionele uitkomstmaten gebruiken.  
In hoofdstuk 5 worden de gebruikte definities van het meest voorkomende 
dwarslaesiesyndroom, het traumatisch centraal koordsyndroom, geëvalueerd. De 
gebruikte definitie van het traumatisch centraal koordsyndroom en de kwantitatieve 
data met betrekking tot het “disproportionele” verschil tussen de motorische scores 
van de bovenste extremiteiten (UEMS) en de onderste extremiteiten (LEMS) werden 
geëvalueerd. In de 30 gevonden TCCS studies, werden zeven verschillende TCCS 
definities gevonden. In totaal werden 312 TCCS patiënten uit negen studies gebruikt 
voor de analyse waarin het disproportionele verschil kon worden gekwantificeerd. 
Het gemiddelde UEMS (gebaseerd op de Medical Research Council scale) was 10.5 
motorische punten lager dan de gemiddelde LEMS.
Hoewel dit een eerste stap is naar een kwantificatie van het disproportionele 
verschil in de kracht tussen de armen en benen, kan worden afgevraagd of dit 
mogelijk niet te gesimplificeerd  is en dat de andere symptomen ook mee moeten 
worden genomen in een TCCS definitie. Met dit doel werd daarom met behulp 
van een vragenlijst de noodzaak voor het introduceren van gekwantificeerde TCCS 
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criteria voor wetenschappelijk onderzoek geëvalueerd. Het merendeel van de 156 
chirurgen (61%) die de vragenlijsten invulde, vond het afkappunt van 10 motorische 
punten of meer in voordeel van de LEMS acceptabel voor de diagnose TCCS of 
niet. Merkwaardig genoeg vond  23% van de deelnemers elk verschil in motorische 
scores tussen de UEMS en LEMS een disproportioneel krachtsverschil.
Gebaseerd op deel 1 en 2 werd het afkappunt van 10 of meer motorische 
punten tussen de bovenste en onderste extremiteiten als een valide, kwantitatief en 
reproduceerbaar diagnostisch criterium voor de diagnose TCCS of niet beschouwd. 
Echter de introductie van een TCCS criterium heeft mogelijk geen enkele impact 
op de keuze van behandeling. In deel 3 hebben we daarom het neurologische 
en functionele herstel tussen TCCS patiënten en andere motorisch incomplete 
tetraplegische patiënten vergeleken. In deze studie werd gebruik gemaakt van de 
EM-SCI data waarbij 248 patiënten met een traumatische en motorisch incomplete 
dwarslaesie werden geïncludeerd. Hoewel na stratificatie voor de AIS minimaal 
significante verschillen werden gevonden in de LEMS en UEMS tussen TCCS 
en patiënten zonder TCCS, werden er geen significante functionele verschillen 
gevonden na 6 of 12 maanden. 
In hoofdstuk 6 wordt de klinische en wetenschappelijke relevantie van de 
diagnose Brown-Séquard-plus syndrome (BSPS) bij incomplete tetraplegische 
patiënten bestudeerd. Het neurologische en functionele herstel tussen BSPS en 
andere incomplete tetraplegen (non-BSPS) werd vergeleken met behulp van 
de EM-SCI database. In de onderzoeksgroep van 148 tetraplegen werd bij 30 
patiënten de diagnose BSPS gesteld. Behalve voor een klinisch niet relevant verschil 
in blaasfunctie, werden geen significante verschillen gevonden in de subitems van 
de Spinal Cord Independence Measurements II (SCIM) scores. Ook werden er 
geen verschillen aangetoond in de motorische of sensorische scores tussen BSPS 
en non-BSPS patiënten, wanneer deze gestratificeerd worden voor de AIS. Ook 
in dit hoofdstuk wordt wederom aangetoond dat het “gunstige” neurologische en 
functionele herstel in BSPS patiënten voornamelijk wordt bepaald door de AIS.
In hoofdstuk 7 worden de neurologische en functionele uitkomsten in 
patiënten met een ischemische dwarslaesie (ASCIS) geëvalueerd. De neurologische 
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uitkomsten tussen paraplegen met een ASCIS of een traumatische dwarslaesie 
werden vergeleken. Tevens werd gekeken wat de invloed is van etiologie van de 
dwarslaesie, ischemisch of traumatisch, op de totale SCIM II scores. Het doel 
hiervan was om te evalueren of het gerechtvaardigd is om dwarslaesiepatiënten met 
verschillende etiologieën in een studie te includeren. Uit de Hamburg database 
werden van de 93 paraplegen, 20 ASCIS en 73 traumatische dwarslaesiepatiënten 
geïdentificeerd. Twaalf maanden na het initiële begin van de dwarslaesie werden 
geen klinisch relevante neurologische verschillen gevonden, echter de totale SCIM 
II scores waren significant hoger in de traumatische dwarslaesiepatiënten. 
Een mogelijke verklaring hiervoor is dat ASCIS patiënten gemiddeld ouder 
zijn dan patiënten met een traumatische dwarslaesie. Oudere patiënten hebben meer 
comorbiditeiten, minder functionele reserves en/of leer capaciteiten met als gevolg 
minder efficiëntie in het revalidatieproces en daardoor ook minder functioneel 
herstel. Opvallend is dat in de lineaire regressie analyse met de variabelen geslacht, 
leeftijd AIS en etiologie op de totale SCIM II scores na 12 maanden; de etiologie 
geen significante voorspeller is op de SCIM II uitkomst. 
De hoofdstukken 5 en 6 tonen aan dat er geen neurologische en functionele 
verschillen bestaan tussen patiënten met SCI syndromen en patiënten zonder 
SCI syndromen. Als het gaat om de klinische verschijnselen en de onderliggende 
neuropathologie, zijn de traumatische SCI syndromen binnen de ASIA standaarden 
niet universeel geaccepteerd. Tijdens het classificeren hebben veel patiënten 2 of 
meer syndroompresentaties. Deze tekortkoming in het classificeren is op zich niet 
vreemd, aangezien de neuropathologie van ruggenmergletsels zeer complex en 
divers is. Tevens kunnen meerdere delen van het ruggenmerg aangedaan zijn. De 
“pure” syndromen komen dus zelden voor. De onderzoeksgroepen in hoofdstukken 
5 en 6 werden niet gecorrigeerd voor andere dwarslaesiesyndromen. Hierdoor kan 
er een overlap van verschillende syndromen zijn ontstaan binnen de studiepopulatie 
beschreven in hoofdstuk 5 en 6. 
De focus van het drieluik in hoofdstuk 5 over TCCS is de motorische 
beperking van de bovenste extremiteiten vergeleken van de onderste extremiteiten. 
De TCCS is niet beperkt tot deze motorische beperking, maar heeft daarnaast 
ook een sensibel component. Ter illustratie, onze enquête liet zien dat de meeste 
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deelnemers akkoord gingen met het voorgestelde gekwantificeerde TCCS criterium. 
Een groot deel van de deelnemers (40%) vond dit voorstel echter te gesimplificeerd 
voor onderzoeksdoeleinden. Ons voorgestelde criterium houdt geen rekening met 
het sensibele deficit, echter bij TCCS is het meest prominente en klinisch meest 
belangrijke symptoom de motorische beperking. Opvallend is ook dat het overgrote 
deel van de deelnemende chirurgen (76%) van mening was dat TCCS patiënten een 
betere prognose hebben met betrekking tot neurologisch en/of functioneel herstel in 
vergelijking met non-TCCS patiënten. Het laatste artikel van ons drieluik laat zien 
dat de AIS gradatie en niet de diagnose TCCS de belangrijkste parameter is voor 
de neurologische en functionele uitkomsten in motorisch incomplete tetraplegen. 
In hoofdstuk 6, werd geen enkele klassieke Brown-Séquard syndroom (BSS) 
patiënt geïdentificeerd in de EM-SCI database. De huidige definitie voor het BSS 
binnen de ASIA standaarden is als volgt: “patiënten	hebben	relatief	meer	verlies	van	
ipsilaterale	 propriocepsis	 en	 motoriek	 en	 er	 is	 sprake	 van	 contralateraal	 verlies	 van	
pijnsensatie	 en	 temperatuurszin.” Gebaseerd op onze resultaten, lijkt het erop dat 
het niet nodig is om BSPS en BSS als verschillende syndromen te definiëren voor 
onderzoeksdoeleinden. Onze analyse is echter beperkt tot tetraplegen waardoor 
deze resultaten mogelijk niet naar paraplegen vertaald kunnen worden. Toekomstig 
onderzoek naar BSPS moet zich richten op het definiëren van kwantitatieve 
diagnostische criteria waarbij gebruik wordt gemaakt van dezelfde stappen als in 
ons drieluik in hoofdstuk 5. Hierdoor kunnen de neurologische en functionele 
uitkomsten adequater worden vergeleken tussen BSPS patiënten en andere patiënten 
met incomplete dwarslaesies. 
In hoofdstuk 7, werden geen neurologische en functionele verschillen gevonden 
tussen dwarslaesiepatiënten met een traumatische of ischemische origine. De 
retrospectieve analyse in deze studie bleef echter beperkt tot de paraplegen. Hoewel 
ischemische dwarslaesies met name voorkomen in het midthoracale ruggenmerg, 
kan het ook voorkomen in het cervicale ruggenmerg. Onze resultaten kunnen 
daardoor mogelijk niet vertaald worden naar tetraplegische patiënten. Daarnaast 
bleef in 35% van de gevallen de oorzaak van de dwarslaesies onbekend, ondanks de 
uitvoerige diagnostische work up. Er zijn aanwijzingen dat ASCIS patiënten met 
een idiopathische oorzaak  mogelijk een betere herstel hebben. In 7-36% van de 
ASCIS patiënten blijft de oorzaak van het ruggenmerginfarct echter onbekend. 
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In de hoofdstukken 5,6 en 7 zitten enkele gemeenschappelijke beperkingen. 
Als eerste zijn enkele confounders zoals het behandelstramien in de vorm van het 
toedienen van methylprednisolon, bloeddrukondersteuning en vroege decompressie 
van het ruggenmerg niet gestandaardiseerd binnen het EM-SCI consortium. Als 
tweede zijn comorbiditeiten en de revalidatieprogramma’s niet geregistreerd in de 
EM-SCI database. Als derde bestaan de onderzoeksgroepen uit kleine aantallen wat 
leidt tot een beperkte statistische power van de analyses; met name de regressieanalyse 
in hoofdstuk 6. Als vierde werd gebruik gemaakt van gedichotomiseerde SCIM 
uitkomstmaten in hoofdstuk 5.3. Alhoewel het gebruik van gedichotomiseerde 
SCIM uitkomstmaten nog niet gevalideerd is, is de klinische relevantie en het 
gebruik van deze methode reeds aangetoond in eerdere studies.
Op basis van de resultaten in hoofdstukken 5 en 6, kunnen we concluderen dat 
de AIS gradering en niet syndroomclassificatie; de best beschikbare en prognostische 
parameter is voor de neurologische en functionele uitkomsten in traumatische 
dwarslaesiepatiënten. We adviseren dat toekomstige studies met traumatische 
dwarslaesiepatiënten, patiënten niet selecteren of stratificeren op basis van TCCS of 
BSPS. In plaats hiervan dient de ernst van het letsel te worden weergegeven middels 
de AIS gradering. Ook kunnen toekomstige dwarslaesiestudies overwegen om zowel 
ischemische als traumatische dwarslaesiepatiënten gezamenlijk te includeren in de 
onderzoekspopulatie.
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Dankwoord
Het laatste hoofdstuk is zowaar een feit. De laatste kilometers in deze marathon 
waren ook in mijn geval een zware dobber. Als eerste wil ik alle patiënten bedanken 
voor hun deelname in dit onderzoek. Veel mensen hebben een bijdrage geleverd aan 
de totstandkoming van dit promotieboekje. In het bijzonder wil bedanken:
Prof. Dr. A. van Kampen, mijn promotor. Beste Albert, ik kwam destijds 
met de beginselen van dit project naar je toe met de vraag of je hierop zou willen 
toezien.  Ik heb veel gehad aan je commentaar en begeleiding. Tevens dank voor 
het vertrouwen tijdens het aannemen en je begeleiding in het eerste deel van mijn 
opleiding tot Orthopedisch Chirurg. Ik hoop mijn vaardigheden nog verder te 
kunnen ontwikkelen onder je supervisie. 
Dr. H. van de Meent, mijn co-promotor. Beste Henk, als beginnend agnio 
Orthopedie een gesprekje samen met jou en Allard over onderzoek heeft geresulteerd 
in dit boekje. Je filosofische inslag heeft me altijd erg geïnspireerd. Daarnaast heb 
ik gretig gebruik mogen maken van je scherpe analytische vermogens om het 
onderzoek naar een hoger niveau te kunnen tillen. Ondanks een moeizame start 
met onze studies is het gelukt om het project uiteindelijk te doen slagen. Dank voor 
je begeleiding gedurende deze periode.
Dr. A.J.F. Hosman, mijn co-promotor. Beste Allard, jouw enthousiasme voor 
de wervelkolom heeft me ook warm doen draaien voor deze tak van sport binnen de 
Orthopedie. Daarnaast heb je me gestimuleerd om een half jaar in de Hamburgse 
keuken te kijken.  Je kritische en directe houding hielden me altijd scherp als dat 
weer eens nodig was. Onze eindeloze discussies met een flinke dosis humor in de 
barak over van alles en nog wat zal ik missen. Ook jij bedankt voor begeleiding 
gedurende mijn promotie. Ik verheug me nu al op de  academische stage waarin je 
ongetwijfeld mij weer de fijne kneepjes van het vak mag gaan leren.
Dr. J.J. van Middendorp, mijn paranimf. Beste Joost, ondertussen heb je 
jij je allang ontdaan van het s’je en nu mag ik eindelijk volgen. Als partner-in-
crime heb ik vaak van je onderzoekscapaciteiten gebruik mogen/moeten maken. 
Daarnaast hebben we samen een paar leuke stukjes kunnen schrijven. Ook zal ik 
onze congresbezoeken in Florence en New Delhi niet vergeten. Uiteindelijk heb je 
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besloten om je volledig te storten op het onderzoek. Joost, nogmaals dank voor onze 
prettige samenwerking en het ga je goed in ‘onderzoeksland’. 
Harmen Kleinlugtenbelt, mijn paranimf. beste Harmen. Bedankt dat je de 
zware rol van paranimf op je wilde nemen.
De manuscriptcommissie: dank voor het beoordelen van mijn manuscript.
Dr. M.M. Verbeek, beste Marcel. We hebben denk ik geen mailuitwisseling 
gehad waarin het woord biomarker niet voorkwam. Dank voor je commentaar en 
supervisie over het liquorproject. 
Herman de Reus, beste Herman. Eindeloos vaak heb ik je moeten lastig vallen 
op het liquor lab. Gelukkig vond je het nooit vervelend als ik weer eens vragen had. 
Dank voor alle tijd en moeite die je in het project hebt gestoken.
Drs. A.M. van der Vliet, beste Ton. Het MRI-DWI onderzoek in Nijmegen is 
destijds door jou op poten gezet en ik mocht hier dankbaar gebruik van maken. Jij 
ook bedankt voor je supervisie. Het ga je goed in het UMCG.
Dr. R. Thietje und Dr. S. Hirschfeld, lieber Roland und Sven. Ich habe in 
den 6 Monaten bei euch auf der Station viel gelernt und fand dies sehr lehrreich. 
Ich möchte mich natürlich auch bei euch für die erfolgreiche und gesellige Zeit 
bedanken.
Dr. B.K. Kwon, dear Brian. I would like to thank you for your cooperation in 
our conjoined biomarker project.  It started with some questions in an e-mail and 
ended in a combined project. I cannot thank you enough for your comments and 
ideas concerning the biomarker project. Perhaps we can combine forces again in a 
Holland-Canada project?
Dr. J. Křiž, dear Jiří. Thank you for your hospitality during our visit in Prague 
and my gratitude for your cooperation in this project.
Prof. Dr. M.M. Thurnher, dear Majda. Thank you for your invaluable support 
in our MRI-DWI project. It took a while to get the paper accepted, but without 
your help this would not have been successful.
I would like to thank all members of the European Multicenter study of Human 
Spinal Cord Injury for their assistance in data collection and data processing. 
Daniël, Jaap en Marloes. We zijn de laatste der Mohikanen geweest die de 
academische kar hebben mogen trekken in barakkistan. Uitvoerige discussies 
afgewisseld met potjes darten bleken een goede combinatie tot het succesvol 
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afsluiten van een promotietraject. Ondanks dat het gebouw de nieuwbouw niet 
heeft overleefd, blijven er gelukkig veel goede herinneringen over. Nogmaals dank 
voor de fantastische tijd die we in dit zwarte bijgebouwtje hebben gehad. 
De stafleden en arts-assistenten heelkunde  uit de Isala Klinieken in Zwolle. 
Bedankt voor de geweldige en leerzame vooropleiding die ik heb gehad in het 
Zwolse. 
De stafleden uit de ROGO Oost voor de gezellige werksfeer en leerzame 
omgeving. De collega’s voor de prettige werksfeer; we are truly living the dream! 
Pa en Ma, jullie verdienen wat dat betreft de meeste dank en lof. Jullie zijn 
degenen die me onvoorwaardelijk hebben gesteund tijdens mijn studie en carrière. 
Dankzij jullie ben ik gekomen waar ik momenteel ben, iets waarvoor ik jullie 
waarschijnlijk nooit genoeg kan bedanken. Hopelijk zijn jullie net zo trots op me 
als ik op jullie ben.
Miranda Dood, lieve Miranda. Als laatste genoemd, maar het belangrijkste 
in mijn leven. Deze promotie is ook jouw verdienste. Zonder je steun, had ik het 
project niet succesvol kunnen afronden. Daarnaast is het promotieboekje in jouw 
handen prachtig geworden. Bedankt voor de geweldige tijd samen!
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